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Chapter 1
General introduction
Function defines form and form defines function. Multicellular organisms have devel-
oped organs, tissues and compartments with cells specifically differentiated to perform
a certain function efficiently. For instance, an adequate barrier protects the internal
organs from the outside, the epithelium. In more complex animals, the epithelium is a
dynamic tissue layer with highly differentiated, tightly interconnected cells. Depending
on its microenvironment, the epithelial pluripotent stem cell may mature in different
directions. For example, the intestinal epithelium has divergent biological tasks: being
the barrier between the body and the outside world, digesting food, absorption of the
resulting mix while keeping the indigestible bulk and associated microflora inside the
lumen. The intestinal stem cell can therefore diffentiate into different celltype that per-
forms specific tasks [Radte and Clevers, 2005]. 
In order to grow, repair or adapt, differentiated cells and pluripotent prolifera-
tive cells have to be in perfect balance. A well-organized intercellular communication
system is required to balance growth, repair and differentiation for the development
and maintenance of adult tissue. 
Cell adhesion molecules (CAMs)
Both local and systemic communication are a prerequisite for well-organized
and functioning tissues. Systemic communication is e.g. mediated by hormones, enzy-
mes? and cytokines. Local intercellular communication in a tissue, also involves many
different types of molecules. Since the last decade, it has become clear that cell adhesion
molecules (CAMs) also serve as communication and regulatory modalities. CAMs are
known to maintain tissue integrity, but accumulating data suggests that the distinction
between adhesion and signaling can no longer easily be made. Since CAMs participate in
tissue development, migration, differentiation and cell death they would be better def-
ined as morphoregulating molecules. A clear example is the formation of a double neu-
ral tube as a result of β-catenin overexpression [Funayama et al, 1995].
Cellular adhesion molecules (CAMs) are classified into four major groups:
integrins, selectins, immunoglobulin-like (Ig-like) super family and cadherins, (see
figure 1). However, other (families of) adhesion molecules have been described, for
example, mucins, syndecans, CD44, protein zero and Ep-CAM. 
Integrins mediate cell adhesion to extracellular matrix (ECM) components as
well as intercellular adhesion. These cell surface receptors are present in neural, endo-
thelial and epithelial tissue. Each integrin is a heterodimer, where ligand and function
specificity is determined by combinations of different α and β sub-units. The affinity
of integrins for their specific ligands may vary, resulting in dynamic cell-ECM or 
cell-cell interactions. Integrins also participate in outside-in signaling that can lead to
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rins, i.e. E-, P-, and N-cadherin, are type I molecules that mediate epithelial or neuronal
homotypic cell-cell adhesions. These transmembrane molecules are composed of five
repeating, Ca2+-binding domains in the extracellular domain that mediate the homoty-
pic cell-cell adhesion. These molecules are involved in embryonic development and in
maturing, differentiating tissues. In the following paragraph, classical cadherins will be
discussed more extensively.
The cadherin/catenin adhesion complex
Classical cadherins play a critical role in epithelia, where they establish and
maintain cell polarity [McNeil et al., 1990; Natkhe et al., 1993], morphogenisis
[Wheelock et al., 1992; Larue et al., 1996] and regulation of proliferation and program-
med cell death [Hermiston et al., 1995; Hermiston et al., 1996; Takahashi et al., 1996;
Zhu et al., 1996]. A dynamic regulation of cadherins is a prerequisite for directing these
cellular processes.
Several cadherins, classical and non-classical, can be expressed in one type of tis-
sue. Although different classical cadherins bind to the same cytosolic proteins via their
cytoplasmic tails, downstream signals originating from cadherin-mediated contacts are
both cadherin-specific and cell-context-specific [for review see Wheelock and Johnson,
2004]. During the gradual transformation of squamous epithelium towards low- and
high grade squamous intraepithelial lesions (SILs), both qualitative as well as quantitati-
ve changes in expression patterns were observed [De Boer et al., 1999]. E-cadherin
expression virtually disappears from the intercellular connections, while P-cadherin
becomes the predominant cadherin in high-grade SILs and modulates the expression of
differentiation markers (involucrin, cytokeratin-13). While P-cadherin emerges, γ-cate-
nin replaces β-catenin, and becomes the predominant catenin linking cadherins to the
cytoskeleton. Also, the assembly of desmosomes is affected during progression of SILs
and is accompanied by a dramatically decreased expression of desmogleins and desmo-
plakins (I, II). The authors concluded that, during development of cervical lesions, sub-
stantial changes occur in cell-cell junctions [De Boer et al., 1999]. These result in cellular
junctions dissimilar from those of reserve cells, basal cells, or cells of immature squa-
mous metaplasia, despite morphological similarity between these cell types and cells of
high-grade lesions [De Boer et al., 1999]. In some cases of primary squamous cell carcin-
oma of the oral cavity, the loss of immunohistochemical staining of the desmosomal
components desmoglein and desmoplakin correlated well with the loss of differentia-
tion, degree of invasion and presence of lymph node metastases [Hiraki et al.,1996]. 
The intercellular domain of E-cadherin can bind several intracellular accessory
molecules, together forming a complex that is able to bind to the cytoskeleton or to start
signal transduction (see figure 2): β-catenin links E-cadherin to α-catenin that can bind
to the F-actin cytoskeleton. The binding to the cytoskeleton strongly anchores the cell-
cell adhesion complex 
Cadherin-independent pools of α-catenin and β-catenin have been localized at
the lateral membrane. It was suggested that these pools are nothing more than reservoirs
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changes in gene expression [Wei et al., 1997; Gimond et al., 1999; Kim and Yamada,
1997].
Selectins participate in the homing of lymphocytes to lymph nodes, as well as in
leukocyte extravasation in inflamed tissue. They are expressed on leukocytes and endo-
thelium and are transmembrane or GDI-linked molecules. The molecule consists of a
Ca2+-dependent C-type lectin domain, a single EGF-like repeat and several repeats that
can bind molecules of the complement cascade, and mediates heterotypic adhesion bet-
ween leucocytes and endothelium. 
The members of the Ig-like superfamily of CAMs (IgSF) are required in diffe-
rent stages of brain development, including neuronal migration, axon pathfinding, tar-
get recognition and synapse formation. In the adult, functions of neuronal networks are
maintained by a diversity of transmembrane - and secreted members of IgSF proteins in
the nervous system. The complexity of IgSF protein function results from different
levels of regulation including gene expression, protein localization, and protein inter -
actions. IgSF proteins all consist of immunoglobulin (Ig) domains, which are double,
100 amino acid β-pleated sheets, stabilized by disulphide bonds. Often, fibronectin III
repeats are present in the molecule. Both heterophilic and homophilic adhesions can be
mediated by Ig-like molecules, as was demonstrated for N-CAM and ICAM-1/2/3 (bin-
ding to integrins). 
The members of the cadherin superfamily (classical, non-classical, protocad-
herins and desmosomes) mediate neural and epithelial cell-cell adhesion and thereby
maintain cell polarity and regulate differentiation. [Birchmeier 1995]. Classical cadhe-
rins are expressed in a wide variety of epithelial and neural tissues. The classical cadhe-
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FIGURE 1
associated antigen expressed by colon, gastric and pancreatic carcinomas and at the
time named mAb17-1A [Herlyn et al., 1979]. Later investigations have demonstrated
Ep-CAM expression in breast, prostate, ovarian, lung and renal cancer [Spizzo et al.,
2004, 2006; Went et al., 2005, 2006]. There are several synonyms for Ep-CAM since Ep-
CAM has been independently identified in different studies. In each the antigen was
named after the antibody recognising it. Different names are still being used today.
Therefore, the use of “EpCAM” was unanimously proposed by the scientific community
to be used, to facilitate comprehension [Baeurle and Gires, 2007]. Moreover, Ep-CAM
was included in the human cluster of differentiation as CD326.
A de novo expression in squamous carcinomas and an overexpression of Ep-CAM in
other carcinomas explains why Ep-CAM was recognized as a pan-carcinoma antigen.
Later publications demonstrated that Ep-CAM is also expressed in most simple, colum-
nar epithelia, but is absent in mature squamous epithelium [Litvinov et al., 1994a,b].
Ep-CAM expression is associated with proliferation in vitro [Litvinov et al., 1996].
Ep-CAM is the product of the GA733-2 gene on chromosome 4q [Linnenbach
et al., 1993]. The GA733-2 gene consists of 9 exons, all of which (partly) contain protein-
coding sequences. No TATA or CAAT boxes have been identified but the putative pro-
motor sequence contains consensus binding sites for Sp1 and AP-1 transcription fac-
tors. Exon 1, the 5’-UTR, encodes a signal peptide sequence. Exons 2 to 6 encode the
extracellular domain of the Ep-CAM molecule, exon 7 for the transmembrane region,
and exon 8 and 9 for the cytoplasmic domain. The 3’-UTR may encode a signal for speci-
fic degradation of mRNA encoding cytokines, lymphokines or some proto-oncogenes.
Another sequence has been identified as a consensus sequence in the 3’ region of inflam-
matory mediators. These sequences suggest that Ep-CAM expression may be regulated
at the mRNA level.
The encoded molecule is composed of 314 amino acids, comprising a 42 kDa type I gly-
coprotein that mediates Ca2+ -independent homotypic cellular adhesions. Ep-CAM is
capable of mediating cell aggregation, preventing cell scattering and directing cell segre-
gation [Litvinov et al., 1994a]. The cytoplasmic domain is necessary for localization at
cell-cell boundaries and adhesion regulation through the cytoskeleton which is most
likely performed via α-Actinin [Balzar et al., 1998]. (see figure 2). Ep-CAM shows adhe-
sive properties when introduced into murine fibroblasts that lack the capacity to form
intercellular interactions [Litvinov et al., 1994b; Balzar et al., 1999]. Further studies
revealed that Ep-CAM mediated adhesions can not be stucturally distinguished from E-
cadherin mediated adhesions but co-localize . However, Ep-CAM mediated adhesions
could not be detected in tight junctions and desmosomes [Balzar et al., 1999]. A model
for the development of Ep-CAM mediated adhesion has been proposed by Balzar et al.,
[Balzar et al., 1999]. This model is based on the observation that when introduced in
fibroblasts both E-cadherin and Ep-CAM compete for the same type of anchor sites on
F-actin; in initial cell-cell contacts. In mature cell-cell contacts, the underlying cortical
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that provide catenins for the assembly of the cadherin adhesion complex. However,
other cytosolic proteins may bind the catenins, thereby generating transduction of vari-
ous signals. First, β-Catenin was found to be a key player in Wnt1- signaling. In vertebra-
tes, binding of Wnt (growth factor/ proto-oncogene) to its receptor, ultimately results
in β-catenin or plakoglobin inducing embryonic axis formation in Xenopus laevis.
Second, the tumor suppressor gene product Adenomatous Polyposis Coli (APC) pro-
tein is known to bind γ- and β-catenin.Wild type APC is responsible for cytoplasmic
degradation of β-catenin. In colorectal cancer cells expressing a mutant APC protein,
the mutant APC cannot bind to cytosolic β-catenin, and elimination of cytosolic β-cate-
nin does not occur; Third, an EGF-receptor-induced tyrosine phosphorylation of β-
catenin and plakoglobin suppresses E-cadherin function. 
Destabilization of the cadherin mediated adhesion complexes is achieved, for
example by GTPase effector IQGAP1, that binds β-catenin or α-catenin. Also, pp120
can shuttle between cadherin mediated adhesion complexes and a cytoplasmic pool. A
selective uncoupling of pp120 from E-cadherin destroys the strong adhesion mediated
by E-cadherin [Aono et al., 1999, Thoreson et al., 2000]. 
Obviously, cadherin expression and cadherin signaling are modulated by a
complex of pathways, involving many other molecules [for review see Wheelock and
Johnson, 2004]. 
Ep-CAM
Besides cadherins, most epithelial cells also express the epithelial cell adhesion
molecule named Ep-CAM. In 1979 Ep-CAM was first identified as a human tumour-
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This complex of CD44v4-v7-tetraspanin-EpCAM-claudin-7 is formed by pancreatic
tumor cell lines [Ladwein et al., 2005]. These carcinoma-specific complexes can influ-
ence cell-cell adhesion, cell-matrix adhesion, and apoptosis resistance, and they appear
to be involved in processes that promote carcinogenesis, i.e., metastasis [Schmidt et al.,
2004]. The EpCAM-claudin-7 complex is frequently observed in highly metastatic
tumours, such as pancreatic and colorectal carcinomas, supporting the hypothesis that
the tetraspanin complexes support tumor progression by promoting metastasis.
Pi3K
Phosphoinositide 3-kinase (Pi3K) phosphorylates the 3’ position of the inosi-
tol ring on phosphaditylinositol. Many cellular functions are affected by the activity of
Pi3K, since it is essential in signal transduction and membrane traffic. The enzyme is
ubiquitously expressed, and is activated upon binding of the regulatory subunit p85 to
receptors associated with growth factors. The p85 subunit subsequently binds the cata-
lytic subunit p110α, which then catalyzes the phosphorylation of phosphoinositide 3,4-
biphosphate (PIP2). A critical downstream target in this signaling transduction path-
way is the activation of protein Ser-Thr kinase AKT1, also known as PKB, that effects
multiple cellular processes, including cellular proliferation, apoptosis and cell scatte-
ring [Royal et al., 1997]. It also contributes to tumorigenesis [Klippel et al., 1998,
Kennedy et al., 1997]. The gene PIK3CA, which encodes the p110α subunit, is localized
on 3q26. The 3q amplification is also the most consistent chromosomal aberration
found in cervical cancer, and is implicated in the progression of dysplastic cervical epi-
thelial cells into invasive cancer [for review see Rooney 1999; Ried et al., 1999].
An in vitro model of epithelial MDCK cells demonstrated that the engagement
of E-cadherins in homotypic cellular adhesions promotes an increase of Pi3K-depen-
dent activation of Akt and the translocation of Akt to the nucleus [Pece et al., 1999]. The
activation of Pi3K in response to adherens junction assembly involves the concomitant
recruitment of Pi3K to E-cadherin-containing protein complexes [Pece et al.,1999].
Pi3K activation modulates the E-cadherin mediated adhesions and both Pi3K and E-
cadherin can bind α-Actinin [Shibasaki 1994]. A signaling pathway involving both Ep-
CAM and Pi3K is plausible and this pathway may affect the regulation of cadherin-
mediated adhesion complexes.
Expression of exogenous p85 in mouse keratinocytes increases the metabolic
stability of β-catenin and increases the signaling of β-catenin leading to transcription of
a reporter gene [Espada et al., 2005]. Both effects are results of the formation of β-cate-
nin/p85 and inhibition of β-catenin/APC complexes and these are independent of PI3K
or GSK activity. These findings suggest that p85 can act as a direct metabolic regulator of
β-catenin activity [Espada et al., 2005].
GTPases
Over the years, it has been demonstrated that cadherin- mediated adhesion
requires the activation of cytosolic proteins of the Rho family of small GTPases [Braga et
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actin contains both adhesion molecules in close proximity but in distinct clusters. In
polarized cells, primary cell-cell contacts also contain Ep-CAM and E-cadherin
clusters. The release of ZO-1 (carried by the cadherins to the apical part of the lateral
membrane), leads to the formation of the apical junctional complex including the tight
junction and adherens junction. Ep-CAM molecules are ‘squeezed out’ and directed to
more basal regions of the lateral membrane [Balzar et al., 1999].
Ep-CAM as signaling adhesion molecule 
Until recently, distinct roles for cell adhesion and signaling pathways were
assigned to adhesion molecules and signal receptors, respectively. However, quantitavi-
ve changes, in for example E-cadherin, affect crucial parameters of epithelial morpho-
genesis [Gumbiner 1996]. The suggestion that adhesion systems within a cell may act as
regulators of other adhesion systems, opens new perspectives on signaling that is rele-
vant for understanding of rearrangements in cellular or tissue organization [Edelman
1993; Rosales et al., 1995; Gumbiner 1996]. Many studies since have been focused on the
signaling properties of adhesion molecules. 
Several studies suggest that Ep-CAM expression affects intercellular processes.
Mammary gland development is affected at all stages by introduced Ep-CAM overexpres-
sion in transgenic mice [Balzar et al., 2001]. Ep-CAM expression is detected at low levels in
the primary ducts of mammary gland epithelia of virgin mice. During pregnancy, the
expression levels gradually increase, parallel to the proliferative status. During the diffe-
rentiating stage of lactation, Ep-CAM expression in the ducts returns to instrinsic levels
and almost disappears from the alveolar cells. E-cadherin expression remains virtually
unchanged during the stages of active proliferation or differentiation. Ep-CAM not only is
associated, but also is directly involved in mammary gland morphogenesis. In Ep-CAM
transgenic virgin mice, elevated Ep-CAM expression increases the active growth of pri-
mary ducts and induces secondary branching and budding of mammary gland epitheli-
um [Balzar et al., 2001]. A complete cycle of pregnancy, delivery and lactation results in
extreme ductal hyperplasia and lobular hypoplasia, while involution is partially distur-
bed because Ep-CAM expression prevents apoptosis and sustains cell proliferation pre-
venting involution of the mammary gland to pre-pregnancy morphology.
Tubular branching of the mammary gland can be blocked by activation of
phosphoinositide 3-kinase (Pi3K), as was observed in WAP/TGFα-transgenic mice or
in a transgenic mice model mimicking insuline-like growth factor signaling that was
treated with Pi3K-inhibitor [Sandgren et al., 1995; Neuenschwander et al., 1996]. The
results of the mammary gland model in Ep-CAM transgenic mice suggest a morphore-
gulating role for Ep-CAM, and it is plausible that this signaling pathway involves Pi3K.
Ep-CAM as an oncogenic signaling molecule
Recently, EpCAM was shown to interact directly with CD44v4-v7 [Schmidt et
al., 2004], a tumor metastasis-promoting CAM, and with claudin-7, a tight junction
protein [Ladwein et al., 2005].
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It is clear that Rho activity is essential for cadherin -dependent adhesion [Braga et al.,
1997; Takaishi et al., 1997]. The bacterial toxin C3 transferase inhibits the endogenous
Rho, which results in a very fast removal of cadherins from newly formed or mature
junctions.
Experimental data demonstrated that Cdc42 inhibition resulted in a reduction
of aggregation capacity observed in E-cadherin transfected fibroblasts [Fukata et al.,
1999], but Cdc42 inhibition does not prevent cadherin localization at junctions. 
A specific target of both Rac and Cdc42 is IQGAP1 [Fukata et al., 1999]. It inter-
acts with β-catenin in the same region as α-catenin does, and competition between _-
catenin and IQGAP1 can regulate the binding of E-cadherin/ β-catenin to the cytoskele-
ton. The postulated hypothesis of initial and mature cell-cell contacts mediated by
either Ep-CAM or E-cadherin implies the transformation of both stress fibers and corti-
cal actin.
Embryonic development, cell proliferation, maturation, differentiation, epi-
thelial to mesenchymal transformation, carcinogenesis are just a few examples of pro-
cesses that involve coherent signaling pathways between adhesion molecules, growth
factors, intracellular transporters, and many other molecules in order to maintain tissue
integrity in high eukaryotes. 
Aim and outline of the investigations
This thesis aims to explore the signaling pathways activated by Ep-CAM, and
their putative morphoregulatory function. In chapter 2, the biological characteristics
and expression patterns of Ep-CAM that are known from the literature are summarized.
In general, ectopic Ep-CAM abrogates the adherens junctions that are mediated by 
E-cadherin. Chapter 3 is focused on the effects of Ep-CAM on E-cadherin- and N-cadhe-
rin- mediated adhesions in both double transfected murine fibroblasts as well as Ep-
CAM transfected human epithelial cells. Subsequently, the site of interaction in the E-
cadherin adhesion complex that [could be affected]. by Ep-CAM is studied in two cell
models (chapter 4). Ep-CAM is introduced into fibroblasts that express either one of
two different E-cadherin/α-catenin fusion proteins, and the effect of Ep-CAM expres-
sion on the chimeric molecules is studied. The results indicate that Ep-CAM most likely
shifts the adhesion strength from strong to weak by affecting E-cadherin at the juxta-
membrane domain, or the COOH- terminal region of α-catenin. Chapter 5 describes the
reversebility of this mechanism; decreasing Ep-CAM expression in tumor cells leads to
the restoration of E-cadherin- mediated adhesions and the epithelial phenotype. The
results of many studies of the effect of on Pi3K manipulation in epithelial cells are simi-
lar to those observed for Ep-CAM. In chapter 6, the role of Ep-CAM in signal transducti-
on pathways involving Pi3-kinase will be discussed. Finally, the potential diagnostic
value of Ep-CAM expression in epithelial tumors is reviewed (chapter 7). The last chap-
ter (chapter 8) summarizes the results presented in preceding chapters and discusses
future prospectives.
and its disturbance during the development of a malignant phenotype 15
General introduction
al., 1997; Hordijk et al., 1997]. The Rho small GTPases belong to the Ras superfamily of
GTPases and are regulated by guanide nucleotides. GTPases bound to guanide triphos-
phate (GTP) are in an active state and ready for signaling. Upon hydrolysis of GTP and
liberation of the phosphate (resulting in guanide diphosphate, GDP), the associated
GTPase is inactivated. Members of the Rho family are Rho, Rac and Cdc42, participate
in several cellular processes including actin cytoskeleton reorganization involving cell
adhesion, cytokinesis and motility [Van-Aelst and D’Souza 1997]. In epithelial cells, the
activity of small Rho GTPases is required in both the formation as well as the disassem-
bly of cadherin- mediated junctions [Braga et al., 1999; Hordijk et al., 1997; Takaishi et
al., 1997; Zhong et al., 1997]. RhoGTPase Cdc42 and Rac1 regulate the basolateral traf-
ficking for the post-Golgi transport of E-cadherin before p120 interacts with E-cadhe-
rin, resulting in polarized cells [Wang et al., 2005]. These actions of the GTPases are also
involved in the transformation to a malignant phenotype.
A specific target for Rho is pp120 [Anastasiades et al, 2000; Noren et al 2000].
Not only can pp120 regulate cadherins, expression of pp120 in fibroblasts also induces
enhanced motility and marked changes in cell shape [Reynolds et al., 1996]. Expression
of pp120 leads to inhibition of Rho (see figure 3). Furthermore, it has been suggested
that Rac activation in these cells may strengthen the cadherin – dependent adhesion
[Hordijk et al., 1997; Takaishi et al., 1997]. On the other hand, Rac activation in kerati-
nocytes can specifically remove cadherins from newly formed and stable cell-cell con-
tacts [Braga et al., 2000]. 
Manon Winter Co-ordination of epithelial junctional systems, 14
Chapter 1
FIGURE 3
Chem 1999, 274(37):26044-26050
Funayama N, Fagotto F, McCrea P, Gumbiner BM. Embryonic axis induction by the armadillo repeat
domain of beta-catenin: evidence for intracellular signaling. J Cell Biol 1995, 128(5):959-968
Gimond C, van Der Flier A, van Delft S, Brakebusch C, Kuikman I, Collard JG, Fassler R, Sonnenberg A.
Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requi-
res activation of members of the rho family of GTPases and downregulation of cadherin and catenin
function. J Cell Biol 1999, 147(6):1325-1340
Gumbiner BM.Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell
1996, 84(3):345-357
Hermiston ML, Gordon JI.In vivo analysis of cadherin function in the mouse intestinal epithelium:
essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell
death. J Cell Biol 1995, 129(2):489-506
Hermiston ML, Wong MH, Gordon JI.Forced expression of E-cadherin in the mouse intestinal epi-
thelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a
self-renewing system. Genes Dev 1996, 10(8):985-996
Herlyn M, Steplewski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by
means of monoclonal antibodies. Proc Natl Acad Sci USA 76: 1438-1442
Hiraki A, Shinohara M, Ikebe T, Nakamura S, Kurahara S, Garrod DR.Immunohistochemical staining
of desmosomal components in oral squamous cell carcinomas and its association with tumour beha-
viour. Br J Cancer 1996, 73(12):1491-1497
Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC, Collard JG. Inhibition of inva-
sion of epithelial cells by Tiam1-Rac signaling. Science 1997, 278(5342):1464-1466
Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N.The PI 3-kinase/Akt sig-
naling pathway delivers an anti-apoptotic signal. Genes Dev 1997, 11(6):701-713
Kim LT, Yamada KM.The regulation of expression of integrin receptors. Proc Soc Exp Biol Med 1997,
214(2):123-131
Klippel A, Escobedo MA, Wachowicz MS, Apell G, Brown TW, Giedlin MA, Kavanaugh WM, Williams
LT. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular
changes characteristic of oncogenic transformation. Mol Cell Biol 1998, 18(10):5699-5711
Ladwein M, Pape UF, Schmidt DS, Schnolzer M, Fiedler S, Langbein L, Franke WW, Moldenhauer G,
Zoller M. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein
claudin-7. Exp Cell Res 2005, 309:345-357
Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M, Kemler R. A role for cadherins in tissue for-
mation. Development 1996, 122(10):3185-3194
and its disturbance during the development of a malignant phenotype 17
General introduction
References 
Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB. Inhibition
of RhoA by p120 catenin. Nat Cell Biol 2000, 2(9):637-644
Aono S, Nakagawa S, Reynolds AB, Takeichi M.p120(ctn) acts as an inhibitory regulator of cadherin
function in colon carcinoma cells. J Cell Biol 1999, 145(3):551-562
Balzar M, Bakker HA, Briaire-de-Bruijn IH, Fleuren GJ, Warnaar SO, Litvinov SV.Cytoplasmic tail
regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol.
1998, 18(8):4833-43
Balzar M, Prins FA, Bakker HA, Fleuren GJ, Warnaar SO, Litvinov SV.The structural analysis of adhe-
sions mediated by Ep-CAM. Exp Cell Res 1999, 246(1):108-121
Balzar M, De Boer CJ, Breuer M, Warnaar SO Fleuren GJ, Litvinov SV: Ectopic Ep-CAM induces ductal
morphogenesis and hyperplasia in mammary glands. 2001. Thesis “The biology of the epithelial cell
adhesion molecule”, 2001, pp. 128-147
Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007, 96(3):417-423
Birchmeier W, Hulsken J, Behrens J. Adherens junction proteins in tumour progression. Cancer Surv
1995, 24:129-140
Braga VM, Machesky LM, Hall A, Hotchin NA.The small GTPases Rho and Rac are required for the
establishment of cadherin-dependent cell-cell contacts. J Cell Biol 1997, 137(6):1421-1431
Braga VM.Small GTPases and regulation of cadherin dependent cell-cell adhesion. Mol Pathol 1999,
52(4):197-202
Braga VM, Betson M, Li X, Lamarche-Vane N. Activation of the small GTPase Rac is sufficient to dis-
rupt cadherin-dependent cell-cell adhesion in normal human keratinocytes. Mol Biol Cell 2000,
11(11):3703-3721
De Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV. Expression of Ep-CAM in normal,
regenerating, metaplastic, and neoplastic liver. J Pathol 1999, 188(2):201-206
De Boer CJ, van Dorst E, van Krieken H, Jansen-van Rhijn CM, Warnaar SO, Fleuren GJ, Litvinov SV.
Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in
the uterine cervix. Am J Pathol 1999, 155(2):505-515
Edelman GM. A golden age for adhesion. Cell Adhes Commun 1993,1(1):1-7
Espada J, Peinado H, Esteller M, Cano A. Direct metabolic regulation of beta-catenin activity by the
p85alpha regulatory subunit of phosphoinositide 3-OH kinase. Exp Cell Res 2005, 305(2):409-17
Fukata M, Kuroda S, Nakagawa M, Kawajiri A, Itoh N, Shoji I, Matsuura Y, Yonehara S, Fujisawa H,
Kikuchi A, Kaibuchi K. Cdc42 and Rac1 regulate the interaction of IQGAP1 with beta-catenin. J Biol
Manon Winter Co-ordination of epithelial junctional systems, 16
Chapter 1
Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G.Genomic changes defining the genesis,
progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation.
Genes Chromosomes Cancer 1999, 25(3):195-204
Royal I, Fournier TM, Park M Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell
motility and tubulogenesis. J Cell Physiol 1997, 173(2):196-201
Rooney PH, Murray GI, Stevenson DA, Haites NE, Cassidy J, McLeod HL. Comparative genomic
hybridization and chromosomal instability in solid tumours. Br J Cancer 1999, 80(5-6):862-73
Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC.Inhibition of mammary gland
involution is associated with transforming growth factor alpha but not c-myc-induced tumorigene-
sis in transgenic mice. Cancer Res 1995, 55(17):3915-3927 
Schmidt DS, Klingbeil P, Schnölzer M, Zöller M. CD44 variant isoforms associate with tetraspanins
and EpCAM. Exp Cell Res 2004, 297(2):329-347
Shibasaki F, Fukami K, Fukui Y, Takenawa T. Phosphatidylinositol 3-kinase binds to alpha-actinin
through the p85 subunit. Biochem J 1994, 302 ( Pt 2):551-557 
Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R,Metzger U, von Castelberg B,
Bart R, Stopatschinskaya S, Kochli OR, Haas P, Mross F, Zuber M, Dietrich H, Bischoff S, Mirlacher M,
Sauter G, Gastl G. High Ep-CAM expression is associated with poor prognosis in node-positive bre-
ast cancer. Breast Cancer Res Treat 2004, 86: 207-213 
Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G,
Zeimet AG. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prog-
nostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 2006,
103: 483- 488
Takahashi K, Suzuki K.Density-dependent inhibition of growth involves prevention of EGF receptor
activation by E-cadherin-mediated cell-cell adhesion. Exp Cell Res 1996, 226(1):214-222
Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y. Regulation of cell-cell adhesion by rac and rho
small G proteins in MDCK cells. J Cell Biol 1997, 139(4):1047-1059
Thoreson MA, Anastasiadis PZ, Daniel JM, Ireton RC, Wheelock MJ, Johnson KR, Hummingbird DK,
Reynolds AB. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol
2000, 148(1):189-202
Van Aelst L, D'Souza-Schorey C.Rho GTPases and signaling networks. Genes Dev 1997, 11(18):2295-2322 
Wang B, Wylie FG, Teasdale RD, Stow JL. The polarized trafficking of E-cadherin is regulated by Rac1
and Cdc42 in MDCK cells. Am J Physiol Cell Physiol 2005 (e-pub ahead of print)
Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H. Expression of epithelial cell
adhesion molecule (EpCam) in renal epithelial tumors. Am J Surg Pathol 2005, 29(1):83-88
and its disturbance during the development of a malignant phenotype 19
General introduction
Linnenbach AJ, Seng BA, Wu S, Robbins S, Scollon M, Pyrc JJ, Druck T, Huebner K. Retroposition in a
family of carcinoma-associated antigen genes. Mol Cell Biol 1993, 13(3):1507-1515
Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO.Ep-CAM: a human epithelial antigen is a
homophilic cell-cell adhesion molecule. J Cell Biol 1994a, 125(2):437-446
Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epitheli-
al glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun 1994b, 2(5):417-428
Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ, Warnaar SO.
Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and
the disappearance of markers for terminal differentiation. Am J Pathol 1996, 148(3):865-875
Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK, Shen CY. PIK3CA
as an oncogene in cervical cancer. Oncogene 2000, 19(23):2739-2744
McNeill H, Ozawa M, Kemler R, Nelson WJ. Novel function of the cell adhesion molecule uvomorulin
as an inducer of cell surface polarity. Cell 1990, 62(2):309-316
Nathke IS, Hinck LE, Nelson WJ Epithelial cell adhesion and development of cell surface polarity:
possible mechanisms for modulation of cadherin function, organization and distribution. J Cell Sci
Suppl. 1993, 17:139-145
Neuenschwander S, Schwartz A, Wood TL, Roberts CT Jr, Hennighausen L, LeRoith D.Involution of
the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin
Invest 1996, 97(10):2225-2232
Niessen CM, Hulsman EH, Rots ES, Sanchez-Aparicio P, Sonnenberg A. Integrin alpha 6 beta 4 forms
a complex with the cytoskeletal protein HD1 and induces its redistribution in transfected COS-7
cells. Mol Biol Cell 1997, 8(4):555-566 
Noren NK, Liu BP, Burridge K, Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family
GTPases. J Cell Biol 2000, 150(3):567-580
Pece S, Chiariello M, Murga C, Gutkind JS Activation of the protein kinase Akt/PKB by the formation
of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-
kinase with the E-cadherin adhesion complex. J Biol Chem 1999, 274(27):19347-19351
Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-
1909 
Rosales C, O'Brien V, Kornberg L, Juliano R.Signal transduction by cell adhesion receptors. Biochim
Biophys Acta 1995, 1242(1):77-98
Reynolds AB, Daniel JM, Mo YY, Wu J, Zhang Z. The novel catenin p120cas binds classical cadherins
and induces an unusual morphological phenotype in NIH3T3 fibroblasts. Exp Cell Res 1996,
225(2):328-337
Manon Winter Co-ordination of epithelial junctional systems, 18
Chapter 1
Chapter 2 
The biology of 17-1A antigen 
(Ep-CAM)
J Mol Med 1999, 77: 699-712
Balzar M, Winter MJ, de Boer CJ, Litvinov SV
Abstract
The glycoprotein recognized by the monoclonal antibody 17-1A is present on
most carcinomas, which makes it an attractive target for immunotherapy. Indeed, adju-
vant treatment with mAb 17-1A did successfully reduce the 5 years mortality among
colorectal cancer patients with minimal residual disease. Currently the antibody is
approved for clinical use in Germany, and is on its way for approval in a number of other
countries. New immunotherapeutic strategies targeting the 17-1A antigen are in deve-
lopment or even in early phase clinical trials. Therefore, a better understanding of the
biology of the 17-1A antigen may result in improved strategies for the treatment and
diagnosis of human carcinomas. In this review the properties of the 17-1A antigen are
discussed concerning tumor biology and the function of the molecule. This 40 kDa 
glycoprotein functions as an Epithelial Cell Adhesion Molecule, therefore the name 
Ep-CAM was suggested. Ep-CAM mediates Ca2+ independent homotypic cell-cell
adhesions. Formation of Ep-CAM mediated adhesions has a negative regulatory effect
on adhesions mediated by classic cadherins, which may have strong effects on the diffe-
rentiation and growth of epithelial cells. Indeed, in vivo expression of Ep-CAM is rela-
ted to increased epithelial proliferation and negatively correlates with cell differentia-
tion. A regulatory function of Ep-CAM in the morphogenesis of epithelial tissue has
been demonstrated for a number of tissues, in particular pancreas and mammary gland.
The function of Ep-CAM should be taken into consideration when developing new the-
rapeutic approaches targeting this molecule.
Introduction
The monoclonal antibody (CO)17-1A was one of the first mAbs generated
against an antigen that is often present at the cell surface of human carcinoma cells
(Herlyn et al., 1979; Koprowski et al., 1979). Since mAb 17-1A recognizes a tumor-asso-
ciated antigen expressed by a majority of human epithelial neoplasias, the 17-1A anti-
gen had attracted major attention as a target for immunotherapy to combat human car-
cinomas (Ragnhammar et al., 1993; Mellstedt et al., 1991; Riethmuller et al.,
1994/1998). Already by the early ’90s, hundreds of patients were treated with the 17-1A
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The transcribed mRNA is approximately 1.5 kB. The 5’-untranslated regions from inde-
pendently isolated Ep-CAM mRNAs revealed a variation in the size of this region, con-
taining either 16 or 160 bases (Perez and Walker, 1989; Simon et al., 1990). All reported
sequences for Ep-CAM mRNAs were identical in their coding part, namely an open rea-
ding frame of 942 bases. The 3’-untranslated region contains two possibly important
motifs (Perez and Walker, 1989). The first sequence (ATTTA) has been proposed to be a
signal for specific degradation of mRNA for cytokines, lymphokines, and some proto-
oncogenes (Shaw and Kamen, 1986). The second sequence (TTATTTAT) has been iden-
tified as a consensus sequence in the 3’ region of the inflammatory mediators (Caput et
al., 1986). This suggests that the expression of Ep-CAM may be highly regulated at the
mRNA level. We have analyzed Ep-CAM mRNAs from a large number of carcinoma cell
lines, but found no variations in the splicing of exons encoding the intracellular domain
of the molecule (unpublished results). Moreover, no mRNA splice variants that encode
different isoforms of Ep-CAM have been reported so far.
The GA733 gene family
The only molecule known to be homologous to Ep-CAM is the GA733-1 gene
product (or EGP-1/Trop-2) that shares 49% homology with the Ep-CAM amino acid
sequence. Taking into account conserved substitutions, the two antigens have a similari-
ty of 67% (Szala et al., 1990). Ep-CAM and GA733-1 share two highly homologous
regions (Szala et al., 1990). The first region spans 39 residues of the extracellular
domain, and is characterized by 79% identical amino acids and a 97% similarity. The
second region represents the transmembrane domain. The combined results of molecu-
lar cloning, DNA sequencing, amino acid sequence comparison, and chromosome
mapping studies indicate that both exon shuffling and retroposition have been factors
in the evolution of the GA733 gene family (Linnenbach et al., 1993). The intronless
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mAb, but the treatment applied as various forms was not effective against solid tumors.
However, the post-operative treatment of colorectal cancer patients gave promising
results, since adjuvant treatment with 17-1A successfully reduced the 7 years mortality
among Duke’s C colorectal cancer patients with minimal residual disease (Riethmuller
et al., 1994/1998). In line with these results, the antibody was approved in 1995 for routi-
ne clinical use in Germany. Moreover, other immunotherapy strategies targeting the 17-
1A antigen are in the process of development, suggesting that in the near future this
molecule will be (widely) targeted in new clinical trials to combat carcinomas.
The 40 kDa glycoprotein recognized by 17-1A has been described under various
names originating from the name of the respective mAb (e.g. MH99, AUA1, MOC31,
323/A3, KS1/4, GA733, HEA125 etc.) that was raised against the molecule (Herlyn et al.,
1979; Mattes et al., 1983; Durbin et al., 1990; De Ley et al., 1988; Edwards et al., 1986;
Varki et al., 1984; Momburg et al., 1987). The corresponding cDNA had been indepen-
dently cloned by a number of groups using different names (e.g. KSA, EGP, EGP40,
GA733-2) for the encoded molecule (Perez and Walker, 1989; Strnad et al., 1989; Simon
et al., 1990; Szala et al., 1990). A few years ago, we have demonstrated that the 17-1A anti-
gen can function as a homophilic cell-cell adhesion molecule, and suggested the name
Ep-CAM (Epithelial Cell Adhesion Molecule) that reflects its tissue specificity and
function (Litvinov et al., 1994a/b). This review discusses the properties of the 17-1A
antigen, alias Ep-CAM. Recent findings point towards a major morphoregulatory func-
tion for this molecule, not only relevant for epithelial tissue development, but also for
carcinogenesis and tumor progression. A better understanding of the biology of the 17-
1A antigen may prove useful in developing improved strategies for the treatment and
diagnosis of human carcinomas. The name Ep-CAM will be used further in this review
irrespective of the designation chosen for this molecule by the original group whose
results are discussed.
The gene
Ep-CAM is encoded by the GA733-2 gene (Linnenbach et al., 1993). The human
gene with a minimal estimated size of approximately 14 kb is located on chromosome 4.
The GA733-2 locus maps to chromosomal region 4q. The putative GA733-2 promoter
contains consensus binding sites for the Sp1 and AP-1 transcription factors, but no
TATA or CAAT boxes were found (Linnenbach et al., 1993). Comparison between geno-
mic and cDNA sequences reveals that the GA733-2 gene consists of nine coding exons as
depicted in figure 1 (Linnenbach et al., 1993). Amino acid sequences encoded by exon 1
correspond to a signal peptide sequence. Exons 2 to 6 encode for sequences forming the
extracellular domain. The transmembrane region is encoded by exon 7. Exon 8 encodes
a 15 amino acid portion of the cytoplasmic domain, including a cluster of six positively
charged amino acids. Exon 9 encodes the remaining 13 amino acids of the cytoplasmic
domain, the stop codon, and the 3’-untranslated region.
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FIGURE 1 Structure of the GA733-2 and GA733-1 genes (after Linnenbach et al [19]). The GA733-2 gene, 
encoding the human transmembrane glycoprotein Ep-CAM, consists of a total of 
nine exons located on chromo some 4. The retroposition of GA733-2 mRNA into chromo some
1 resulted in the intron-less GA733-1 gene.
which is even better illustrated by the homology between mouse and human Ep-CAM.
The nucleotide sequence of mouse Ep-CAM is 80% identical to human Ep-CAM. The
homology of the amino acid sequence is even higher, namely 82% (Bergsagel et al., 1992).
Tissue Pattern Expression
Expression during embryonic development 
Relatively little information is available concerning the expression of Ep-CAM
during human embryonic development. Ep-CAM expression is detected in fetal lung,
kidney (proximal tubules), liver, pancreas, skin, and germ cells. At different stages of
lung development, epithelial cells express Ep-CAM (Kasper et al., 1995). As early as the
embryonic stage (week 7-8 embryo), relatively high levels of Ep-CAM are expressed by
the epithelial cells of the primordial lung. In fact, during the remaining period of deve-
lopment (pseudoglandular, canalicular, and alveolar stage), and throughout adult life,
epithelial cells of the lung reveal immuno-reactivity for Ep-CAM (Kasper et al., 1995).
The majority of hepatocyte precursors are Ep-CAM positive in the liver of week 8
embryos, but negative in adult liver (De Boer et al., 1999). During pancreatic develop-
ment Ep-CAM is co-expressed with N-CAM and E-cadherin in week 18 embryos
(Cirulli et al., 1995). Moreover, it was reported that in fetal pancreas the highest Ep-
CAM expression was detected in developing islet-like cell clusters budding from the
ductal epithelium (Cirulli et al., 1998). These cell clusters with an up-regulated Ep-
CAM expression (during development) are thought to become the early endocrine cells.
In fetal skin of 8-12 week embryos, keratinocytes are Ep-CAM positive, and during
development of the hair follicle high levels of Ep-CAM expression were detected (our
unpublished results). For the formation of the primitive sex cords in humans, Ep-CAM
is expressed at the embryonic stages by germ cells during migration at day 10.5 and early
gonad assembly at day 12.5 (Anderson et al., 1999). In human embryos, no Ep-CAM
expression was observed in thymus, but in mice Ep-CAM is expressed in thymus epithe-
lium and thymocytes in adult tissue, and even higher in fetal thymus (Farr et al., 1991;
Nelson et al., 1996).
In studies using the mAb’s GZ1, GZ2, and GZ20 that recognize rat Ep-CAM, the
molecule was reported to be expressed during the very early stages of embryogenesis
(Schiechl et al., 1986/1987; Tarmann et al., 1990). Immunocytochemistry revealed the
expression of Ep-CAM in fertilized oocytes, the two-cell stage, and some cells of the
morula. At the blastocyst stage, the zona pellucida showed no Ep-CAM staining, where-
as the trophoblast and inner-cell mass were positive. Rat embryos of 8.5 days (at the
stage of the three germ layers) revealed positive staining for both the ectoderm and
entoderm, while mesoderm was negative. At day 11.5, rat embryos expressed Ep-CAM
in all epithelia including those of mesodermal origin, such as the Wolffian duct and
coelomic epithelium. In contrast, neural and connective tissue revealed no Ep-CAM
expression. Embryos of 14.5 days showed expression in all epithelia, except the
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GA733-1 gene probably originates from the retroposition of Ep-CAM mRNA into a
region on chromosome 1 as depicted in figure 1. The retroposition event, which resulted
in the GA733-1 gene, most likely preceded the divergence of avian and mammalian spe-
cies approximately 300 million years ago (Linnenbach et al., 1993). After retroposition,
the GA733-1 evolved independently of Ep-CAM, and may be viewed as a molecule that
belongs to the GA733 family rather than a protein closely related to Ep-CAM.
The molecule encoded by the GA733-1 gene is slightly larger than Ep-CAM
(Linnenbach et al., 1993). The polypeptide backbone contains four N-linked glycosyla-
tion sites that result in a 50 kD glycoprotein. The molecule can be phosphorylated
within its cytoplasmic tail at serine 303 that is absent in the Ep-CAM cytoplasmic
domain (Basu et al., 1995). The conserved tyrosine residue that is present in both mole-
cules has never been reported to be phosporylated. Phosphorylation of the cytoplasmic
serine residue suggests a possible role for GA733-1 as cell surface receptor involved in
signal transduction. Indeed, stimulation of human carcinoma cells with anti-GA733-1
mAbs induced an intracellular calcium signal (Ripani et al., 1998). 
At least five mAbs are known that specifically recognize GA733-1, namely RS7,
MR23, 162-46.2, MOv 16, T16 (Ripani et al., 1998; Stein et al., 1994; Fornaro et al.,
1995). The five mAbs do not reveal cross-reactivity with Ep-CAM epitopes (our unpu-
blished result; Ripani et al., 1998). Moreover, no mAb specific for Ep-CAM has been
shown to react with the GA733-1 protein.
The GA733-1 molecule is also mainly expressed in epithelial tissue. GA733-1
expression levels are low in tissues with a relatively high Ep-CAM expression, such as
colon and lung tissue (Stein et al., 1994). In contrast, GA733-1 is expressed at relatively
high levels in Ep-CAM negative epithelium. In skin, the GA733-1 molecule is present in
supra-basal and spinous layers of the epidermis with increased expression levels in the
more differentiated cells (Klein et al., 1987). It is also interesting that a substantial decrea-
se in GA733-1 expression was detected in breast carcinoma cell lines as compared to
immortalized normal epithelium (our unpublished results), but the significance of this
is unclear. Recently, the GA733-1 gene was genetically linked to the autosomal recessive
disorder Gelatinous Drop-Like corneal Dystrophy (GDLD), since 33 out of 40 disease
alleles (83%) in a panel of Japanese families were reported to have deleterious mutations
causing truncation of the GA733-1 protein (Tsujikawa et al., 1999). The function of
GA733-1, possibly overlapping with that of Ep-CAM, is unknown and requires further
investigation.
Evolutional conservation of Ep-CAM
Using Southern blot analysis, sequences homologous to the human GA733-1
and GA733-2 genes were detected in monkey, mouse, hamster, and chicken (Linnenbach
et al., 1993). Polyclonal antibodies directed against human Ep-CAM detected homolo-
gous proteins in mice, rats, and non-human primates (Zaloudik et al., 1997). MAbs 17-
1A and 323/A3 cross-react with hamster and rhesus monkey Ep-CAM respectively (our
unpublished results). Thus, Ep-CAM seems to be highly conserved among high vertebra,
Manon Winter Co-ordination of epithelial junctional systems, 24
Chapter 2
(Momburg et al., 1987; Bumol et al., 1988). Further, no Ep-CAM expression was detec-
ted in cells of lymphoid origin. The level of expression may differ significantly between
the individual tissue types. In the gastrointestinal tract, gastric epithelium expresses
very low levels of Ep-CAM. Expression levels are substantially higher in small intestine,
and in colon Ep-CAM is probably expressed at the highest levels among all epithelial cell
types. Glandular epithelium of the gall-bladder shows Ep-CAM expression (Momburg
et al., 1987), but the transitional epithelium (urothelium) of the bladder is only slightly
positive (Zorzos et al., 1995). In the lower respiratory tract, the trachea, bronchi, bron-
chioles, and alveoli are Ep-CAM positive (Momburg et al., 1987). In adult liver the bile
ducts are Ep-CAM positive, whereas hepatocytes are negative (De Boer et al., 1999).
Most epithelial cells of the kidney, such as cells of the proximal tubules, distal tubules,
and ducts, reveal Ep-CAM expression (Momburg et al., 1987). In pancreas Ep-CAM
expression has been detected in the ductal epithelium, acini, and some expression in the
islets (Momburg et al., 1987; Cirulli et al., 1998). In skin, the sweat ducts and the prolife-
rative zone of the hair follicle reveal Ep-CAM staining, whereas keratinocytes and mela-
nocytes are mainly negative (Momburg et al., 1987; Tsubura et al., 1992). Within the
basal layers of the epidermis some Ep-CAM reactivity can be observed in the reserve
cells, since mAb MH99 was reported to be reactive with some cells within the basal layer
of skin keratinocytes (Klein et al., 1987). The glands of the endocrine system (thyroid,
parathyroid, pituitary and adrenal glands) contain Ep-CAM positive epithelium
(Momburg et al., 1987). In mammary glands, the ductal epithelium reveals relatively
high Ep-CAM expression as compared to the lower levels in alveolar epithelium
(Edwards et al., 1986; Momburg et al., 1987). Ep-CAM expression is detected in most
epithelial tissues of the female genital tract (ovaries, oviducts, cervix, and uterus).
Normal endocervical glandular epithelium (both columnar and reserve cells) reveals
high expression levels for Ep-CAM, whereas ectocervical squamous epithelial cells do
not express the molecule (Litvinov et al., 1996). Some Ep-CAM expression may be
detected in the basal cells of morphologically normal ectocervical tissue, but only in
areas bordering lesions of cervical intraepithelial neoplasia (Litvinov et al., 1996). In tis-
sues of the male genital tract, some of the epithelial cells in testis, epididymis, seminal
vesicle, and prostate reveal Ep-CAM expression (Momburg et al., 1987).
Correlation with benign and malignant tumor development 
Active proliferation in a number of epithelial tissues is associated with increa-
sed or de novo Ep-CAM expression (Zorzos et al., 1995; Litvinov et al., 1996; High et al.,
1996). This is especially evident in tissues that normally reveal no or low levels of Ep-
CAM expression, such as squamous epithelium. At the early stages of neoplasias of the
uterine cervix, de novo expression of Ep-CAM is often observed in areas with atypical,
undifferentiated cells of the squamous epithelium (Litvinov et al., 1996). Thus, in cervi-
cal intraepithelial neoplasia (CIN) grades I and II, the basal and suprabasal cells are Ep-
CAM positive, while grade III lesions reveal up to 100% positive cells in all layers of the
squamous epithelium. Moreover, a clear increase in both the number of positive cells
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Müllerian duct. Finally, day 17.5 embryos expressed Ep-CAM in all epithelia including
glandular tissue such as pancreas anlage and thyroid, whereas neural tissue, lymphatic
organs, muscular tissue, liver parenchyma, and the gonads remained negative (Tarmann
et al., 1990). These studies suggest an important role for Ep-CAM in embryonic deve-
lopment. However, to evaluate the importance of Ep-CAM during embryogenesis or
morphogenesis of individual tissue, further studies (especially with tissue-targeted
gene disruption) are required.
Expression in normal adult tissues
Based on immunohistochemical data, Ep-CAM is a strictly epithelial molecule
in adult humans (Table 1). Ep-CAM is detected at the baso-lateral cell membrane of all
simple (especially glandular), pseudo-stratified, and transitional epithelia. In contrast,
normal squamous stratified epithelia are negative for Ep-CAM. In adult human tissues
no expression was found in mesenchymal, muscular, and neuro-endocrine tissues
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TABLE 1 Distribution of Ep-CAM in normal human adult tissues. The level of Ep-CAM expression 
by specific cell types within epithelial tissues is indicated by - for no expression, 
+ for low expression levels, ++ for intermediate expression levels, and +++ for high 
expression levels. Data on distribution and expression levels was summarised from 
multiple studies using different Ep-CAM specific monoclonal antibodies including 
unpublished data from own lab.
Malignant proliferation is nearly always associated with Ep-CAM expression at some
stage of tumor development. Most carcinomas, but no other tumor types express high
levels of Ep-CAM (table 2). However, Ep-CAM expression in carcinomas can be
heterogeneous, and is probably affected by a shift of tumor cell differentiation to either
mesenchymal or squamous (in squamous carcinomas) cell phenotypes. It has been
reported for dysplastic oral mucosa that well-differentiated squamous cell carcinomas
are negative for Ep-CAM, whereas poorly differentiated squamous cell carcinomas are
Ep-CAM positive (High et al., 1996). Most squamous carcinomas are Ep-CAM positi-
ve, except for (Ep-CAM negative) squamous carcinoma of the skin. The expression of
Ep-CAM distinguishes squamous cell carcinoma of the skin from the Ep-CAM positive
basal cell carcinoma (Tellechea et al., 1993). In the majority of squamous and adeno-
carcinomas of the uterine cervix varying levels of Ep-CAM expression were detected
(Litvinov et al., 1996). However, as compared to CIN III, some decrease in the expres-
sion (both intensity and number of positive cells) is observed in areas of squamous dif-
ferentiation.
Ep-CAM as a marker protein for differential diagnosis
In human tissue Ep-CAM is expressed only in epithelium and neoplasias deri-
ved from epithelia. Therefore, the molecule may be used as a marker to distinguish epi-
thelial neoplasias from neoplasias derived from non-epithelial tissues. Ep-CAM positi-
ve tumors are derived from epithelial cells, whereas Ep-CAM negative tumors may be
originating from non-epithelial as well as epithelial tissues. Further, Ep-CAM may be
used as a marker to histologically differentiate between epithelial neoplasias.
Occasionally, difficulties in the histological differential diagnosis between basal-cell
carcinoma (BCC) and squamous-cell carcinoma (SCC) of the skin may arise. Basal
squamous cell epithelioma, a tumor combining morphological properties of BCC and
SCC, is one common example of these difficulties, but also other histological types of
BCC may be erroneously interpreted as SCC (Tellechea et al., 1993). Staining for Ep-
CAM demonstrated that all BCC’s were diffusely and intensely labeled, whereas none of
the SCC’s expressed Ep-CAM, irrespective of histological type or grade of differentia-
tion (Tellechea et al., 1993). In liver neoplasias, Ep-CAM was expressed in almost all
cholangiocarcinomas, whereas the majority of hepatocellular carcinomas were Ep-
CAM negative, suggesting that hepatocellular carcinoma originates from a highly diffe-
rentiated precursor (De Boer et al., 1999). The results also indicate that Ep-CAM can be
used as an additional immunohistochemical marker to distinguish cholangiocarcin-
oma from hepatocellular carcinoma due to the differential expression in these epithelial
tumors. Finally, it was demonstrated that Ep-CAM could be used as a marker to discri-
minate carcinomas from Ep-CAM negative mesotheliomas, except for the epithelioid
type (Ryan et al., 1997).
It has been demonstrated for squamous cell carcinomas of the head and neck
that expression of the classic cell adhesion molecule, E-cadherin, correlates inversely
with lymph node metastasis (Schipper et al., 1991). It is also reported that E-cadherin
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and the level of Ep-CAM expression is observed during the progression from CIN I to
CIN III. Expression of Ep-CAM in atypical cells of CIN lesions correlated with the
disappearance of markers for squamous differentiation and enhanced proliferation. In
weak, mild, and severe oral mucosal dysplasias high levels of Ep-CAM expression were
detected in basal and suprabasal cells with a clear border between Ep-CAM positive dys-
plastic cells and Ep-CAM negative normal epithelial cells (High et al., 1996). 
In glandular epithelium of the gastrointestinal tract, one can observe a clear
gradient of decreasing expression of Ep-CAM from crypts to villae (Schiechl et al.,
1986/1987). The level of Ep-CAM
expression correlates with the prolife-
rative activity of intestinal cells, and
inversely correlates with their diffe-
rentiation (Schiechl et al., 1986).
Dysplastic or metaplastic prolifera-
tion corresponds to an increase
(sometimes to very high levels) in Ep-
CAM expression. In gastric epitheli-
um that normally expresses low levels
of Ep-CAM, a strong expression of
Ep-CAM is observed in proliferative
metaplastic lesions, such as intestinal
metaplasia (unpublished results).
Even in colon, where the epithelium
expresses the highest levels of Ep-
CAM, the development of polyps is
reported to be associated with an
increased expression of the molecule.
Hepatocytes are Ep-CAM positive
during embryonic development
(week 8 embryos), but negative in
adult liver (De Boer et al., 1999).
However, during liver regeneration
processes cells that morphologically
resemble precursor stem cells are Ep-
CAM positive, but as they mature into
hepatocytes, they become again Ep-
CAM-negative (De Boer et al., 1999).
Dysplastic lesions of the bladder epi-
thelium (urothelium) reveal increa-
sed Ep-CAM expression as compared
to normal urothelium (Zorzos et al.,
1995). 
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TABLE 2 Ep-CAM expression in human malignant 
neoplasias. Most carcinomas express Ep-
CAM, whereas tumors derived from non-
epithelial tissues are Ep-CAM negative. The
level of Ep-CAM expression by tumor cells
is indicated by - for no expression, + for low
expression levels, ++ for intermediate
expression levels, and +++ for high expres-
sion levels. Data on distribution and
expression levels was obtained from multi-
ple studies using different Ep-CAM specific
monoclonal antibodies and reflects the
pattern of Ep-CAM expression rather than a
reactivity of a particular antibody.
The extracellular domain
When mice are immunized with cells derived from human carcinomas, the
extracellular domain of the Ep-CAM molecule is one of the most immuno-dominant
epitopes at the cell surface. This has resulted in a large number of monoclonal antibo-
dies developed to tumor associated antigens which are specifically reactive with the Ep-
CAM extracellular domain. Figure 2A presents a list of monoclonal antibodies directed
against epitopes on the Ep-CAM molecule. Studies with mutant Ep-CAM molecules
showed that all known mAbs have their epitopes located within one of the structural
domains of the Ep-CAM extracellular domain (Balzar et al., submitted). Thus, mAbs
17-1A, 323/A3, KS1/4, GA733, MOC31, VU1D9, K931 all react with one of the partially
overlapping epitopes in the first EGF-like repeat. Previous cross-inhibition studies sho-
wed that these mAbs can be subdivided into three major groups according to epitopes
(Schon et al., 1993). MAb 2G8 recognises the second EGF-like repeat, while mAbs
MM104, and 311-1K1 react with the cystein-poor region.
The 265 amino acid containing extracellular domain starts at the N-terminus
with a signal sequence containing 11 hydrophobic residues. Signal peptidase cleavage
probably occurs seven residues after the core sequence, between alanine 23 and glutami-
ne 24 (Szala et al., 1990). Sequence analysis of the Ep-CAM extracellular domain shows
that the N-terminal cysteine-rich half contains two EGF-like repeats with the motifs
CX1CX8CX7CX1CX10C (position 27-59) and CX32CX10CX5CX1CX16C (position 66-
135), followed by a cysteine-poor domain (Figure 2A). The first and second EGF-like
repeats of Ep-CAM are closely related to respectively the fourth and fifth EGF-like repe-
ats within the rod-like domain of nidogen (positions 776-809 and 819-889), a laminin-
binding extracellular matrix protein (Simon et al., 1990; Mann et al., 1989). Within the
second EGF repeat there is a high homology region (SD>7) between Ep-CAM and nido-
gen molecules that is not limited by cystein residues only. The second EGF-like repeat of
Ep-CAM also shows homologies to the thyroglobulin type I repeat (96-160;
CX23CX10CX6CX1CX19C) which can also be found in placental protein 12 (150-225;
CX29CX10CX10CX1CX20C), and an inhibitor of cysteine proteinases, Equistatin, isola-
ted from the sea anemone Actinia equina (Lenarcic et al., 1997).
In contrast to the fourth repeat of nidogen, the first repeat of Ep-CAM does not contain a
potential β-hydrohylation site, which makes Ca2+ binding by Ep-CAM highly unlikely.
According to their structure and some consensus motifs, the EGF-like repeats can be sub-
divided into three major types I, II, and III (Apella et al., 1988). The EGF-like repeats of
Ep-CAM reveal the closest homology to repeats of types II and III, which are also present
in molecules like nidogen, EGF precursors, the LDL receptor, L-selectin, and PECAM
(Apella et al., 1988; Davis et al., 1990). The high homology between the EGF-like repeats
in Ep-CAM and the rod-like domain of nidogen would predict an Ep-CAM extracellular
domain structure as depicted in figure 2B. This structure differs from a loop-like structu-
re as was previously suggested (Schon et al., 1993; Thampoe et al., 1988; Helfrich et al.,
1994). However, when the EGF-like repeats of Ep-CAM are expressed individually, they
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functions as an invasion suppressor molecule (Behrens et al., 1989). Since Ep-CAM
functions as an intercellular adhesion molecule, like E-cadherin, it has been claimed
that the expression might reduce the metastasizing capability of tumor cells, and corre-
late with a better prognosis of carcinoma patients (Basak et al., 1998). Thus, Ep-CAM
may also be useful as a marker for increased malignant potential in the diagnosis of can-
cer patients. Indeed, a lack of Ep-CAM expression in the primary tumor of laryngeal
carcinomas significantly correlated with nodal metastasis (Takes et al., 1997). Further,
the expression of Ep-CAM increases from baseline levels in normal oral epithelium to
high levels in mild, moderate, and severe dysplasias, but both invasive well-differentia-
ted and invasive poorly-differentiated squamous cell carcinoma revealed reduced or no
Ep-CAM expression (High et al., 1996). In contrast, Ep-CAM was reported to function
as a marker for increased malignant potential in transitional cell carcinoma of the blad-
der, since the percentage of cells expressing Ep-CAM increases from grade I to grade III
(Zorzos et al., 1995). Further, in a large cohort of primary breast tumors, high levels of
Ep-CAM expression correlated with larger tumor size and infiltrated lymph nodes
(Tandon et al., 1990). Thus, it seems that Ep-CAM plays a dual role in tumorigenesis,
which requires further investigation.
Immunohistochemical detection
The results obtained by immunohistochemical analysis of human tissues with a
variety of mAbs against Ep-CAM were approximately identical. All published antibo-
dies react with cryostat tissue sections, and most of them do not loose their reactivity to
the antigen after paraformaldehyde (4%) fixation of tissues, but are sensitive to gluta-
raldehyde or formalin fixation and tissue embedding in parrafin. A simple antigen
retrieval procedure (treatment with trypsin/pronase) allows immunohistochemical
staining with anti-Ep-CAM antibodies of formalin fixed, and parrafin embedded tissu-
es. Some of the mAbs were reported to have reactivity with Ep-CAM on routinely fixed
histological material without pre-treatment, but the reactivity was substantially redu-
ced. The areas of relatively low Ep-CAM expression that are well detected on frozen sec-
tions may be negative in trypsine pre-treated formalin sections, whereas the areas of
high Ep-CAM expression are well detected in pre-treated formalin sections (unpublis-
hed results). Moreover, histological data obtained with low affinity mAbs (e.g. 17-1A or
AUA-1) may differ from the results obtained with high affinity mAbs (e.g. 323A3 or
GA733), as mainly the areas of high expression levels are detected with low-affinity
mAbs in immuno-histochemistry.
The Ep-CAM molecule
The largest open reading frame of Ep-CAM encodes for a 314 amino acid poly-
peptide (figure 2A), which contains a 23 amino acid leader sequence, a 242 amino acid
extracellular domain with two EGF-like repeats within the cysteine-rich N-terminal
part, a 23 amino acid transmembrane domain, and a 26 amino acid cytoplasmic
domain.
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The sequence of the Ep-CAM molecule predicts the presence of three potential N-lin-
ked glycosylation sites (Figure 2A). It is likely that all three sites are used, and that the
attached carbohydrates contain mannose oligosaccharide chains (Durbin et al., 1990;
Schon et al., 1993). Blocking N-linked glycosylation using tunicamycin results in a sin-
gle polypeptide chain of approximately 34 kDa (Thampoe et al., 1988). Since most car-
cinoma cell lines produce multiple Ep-CAM form of approximately 38, 40, and 42 kDa
(Litvinov et al., 1994), the polypeptide backbone may be differently glycosylated.
Whether the different Ep-CAM forms differ functionally has never been reported.
Treatment of cells with O-glycanase does not cause changes in the molecular weight of
the Ep-CAM molecule, suggesting that no O-linked glycosylation is involved (Thampoe
et al., 1988).
The Ep-CAM molecule may exist as two additional post-translationally modi-
fied variants, namely a cleaved and a non-cleaved form. Pulse-chase studies have shown
that Ep-CAM is synthesized as a 34 kDa protein, which is glycosylated to a 40 kDa glyco-
protein. After longer chase periods a 32 kDa Ep-CAM form appears, which is derived
from the 40 kDa form by proteolysis (Thampoe et al., 1988). As is depicted in Figure 2B,
at the position arginine 80 of the Ep-CAM amino acid sequence a potential cleavage site
is present for trypsin-related proteolytic enzymes (Szala et al., 1990; Bjork et al., 1993).
After cleavage, the two fragments remain covalently cross-linked via disulphide-bridges
under native conditions, whereas reduction of the disulphide-bridges generates a 6 kDa
and 32 kDa peptide fragment. Epithelial and carcinoma derived cell lines reveal diffe-
rent degrees of cleavage (our unpublished results; Thampoe et al., 1988). Some cell lines
contain only the 40 kDa non-cleaved Ep-CAM form, while others reveal both the 32 kDa
and 40 kDa Ep-CAM protein. Moreover, the incubation of lysates from cell lines with
only the 40 kDa Ep-CAM protein in the presence of lysates from cell lines having both
Ep-CAM forms, results in the conversion of the 40 kDa non-cleaved protein into a 32
kDa molecule (Thampoe et al., 1988). Although cell-type specific cleavage might be a
mechanism for generating specific differences in cell surface glycoproteins, the signifi-
cance of cleavage for the function of Ep-CAM has never been demonstrated.
The transmembrane and cytoplasmic domains
The transmembrane region contains 23 hydrophobic amino acid residues, and
is followed by a relatively short 26-residue highly charged cytoplasmic domain. The
cytoplasmic domain contains the internalization motif NPXY, which was identified in
many cell surface receptors, such as the LDL receptor and mannose 6-phosphate recep-
tor (Hopkins, 1992). The tyrosine residue present in the internalization motif is conser-
ved in the Ep-CAM and GA733-1 cytoplasmic tails. Although GA733-1 can be phospho-
rylated at serine 303, the unique tyrosine residue that is present in the tails of both
Ep-CAM and GA733-1 was never reported to be phosporylated (our unpublished
results; Basu et al., 1995).
Besides the internalization motif, the relatively short cytoplasmic tail of Ep-
CAM also contains two α-actinin binding sites (Balzar et al., 1998). Motif comparison
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are properly folded and reproduce the epitope profile of the respective repeat within the
intact molecule (Balzar et al., submitted). Furthermore, as was demonstrated with extra-
cellular domain deletion mutants, the repeats function as independent modules in adhe-
sive interactions of Ep-CAM molecule (Balzar et al., submitted). This strongly suggests
that the modular structure, analogous to the respective region of the nidogen rod-
domain, is the conformation of the Ep-CAM molecule (Figure 2B). 
Many transmembrane molecules with EGF-like repeats are involved in cell
adhesion or signaling (Davis, 1990). Structural analysis of Ep-CAM suggested possible
involvement of Ep-CAM in either cell-substrate or cell-cell adhesion (Simon et al.,
1990). Ep-CAM was also frequently proposed to function as a growth factor receptor,
but no actual experimental data has ever been presented to support this.
Manon Winter Co-ordination of epithelial junctional systems, 32
Chapter 2
FIGURE 2 Structure of Ep-CAM. (A) The Ep-CAM polypeptide consists of 314 amino acids. The numbers 
above the short black arrows indicate the amino acid residues. The encircled N indicates
sites for N-glycosylation. Below: the epitopes recognized by the indicated Ep-CAM-specific
mAbs. (B) Conformation of the Ep-CAM protein. The di-sulfide bridges formed by cystein
residues within the N-terminal half of the extracellular domain may result in two conforma-
tional models for the Ep-CAM molecule: a loop-like conformation (as suggested by Schon et
al. [53]), and a conformation based on correct folding of the EGF-like repeats. The new data
strongly points to the correctness of the latter model (Balzar et al., submitted). Black arrow
indicates the potential proteolytic cleavage site at the position of Arg80.
Ep-CAM is capable of associating to the actin cytoskeleton via the cytoplasmic tail.
Treatment of Ep-CAM expressing cells with the actin de-polymerizing agent cytochala-
sin D results in the destruction of Ep-CAM mediated adhesions and internalization of
the Ep-CAM molecule (Balzar et al., 1998). In contrast, agents disrupting other types of
cytoskeleton (intermediate filaments or microtubuli) do not result in the internaliza-
tion of Ep-CAM. Moreover, Ep-CAM molecules involved in cell-cell interactions may
be discriminated from the remaining cellular pool by detergent solubility using the mild
zwitterionic detergent CHAPS. It is also demonstrated that Ep-CAM interacts with the
actin-based cytoskeleton via direct binding of the cytoplasmic domain to α-actinin
(Balzar et al., 1998). Two domains within the cytoplasmic tail are capable of α-actinin
binding, as probably both are required for interactions that secure the formation of cell-
cell contact. Whether other molecules are involved in the association of Ep-CAM to the
cytoskeleton needs to be further investigated.
In L-cells transfectants the opposing intercellular membranes are brought into
a close proximity at Ep-CAM mediated cell-cell contacts, but no structures resembling
junctional complexes, such as adherens junctions or desmosomes, were identified at
these contacts (Balzar et al., 1999). In L cells co-transfected with Ep-CAM and E-cadhe-
rin both molecules localize at cell-cell contact sites, forming independent adhesions
with no Ep-CAM detectable within morphologically distinguishable cadherin-media-
ted adherens junctions. In epithelial and carcinoma cell lines Ep-CAM and E-cadherin
co-localized almost at the complete lateral membrane. However, no co-localization was
observed between Ep-CAM and components of the tight junction (occludin and ZO-1),
desmosomes (desmoplakins), or cell-matrix adhesions (β1-integrin) (Balzar et al.,
1999). Ultra-structural analysis of the localization of Ep-CAM in normal colon tissue by
immuno-electron microscopy confirmed the results of cell lines. In polarized epithelial
cells of normal human colon, Ep-CAM was present at the lateral cell membrane inclu-
ding the adherens junction areas, but was fully excluded from the apical cell membrane,
tight junctions, and desmosomes (Balzar et al., 1999).
Function of Ep-CAM in epithelia
Inducing the internalization of Ep-CAM molecules from the cell surface by
anti-Ep-CAM mAbs excluding Ep-CAM from the participation in adhesive interactions
of epithelial cells, results in a decrease in the degree of aggregation (Litvinov et al.,
1994b). Furthermore, disengagement of Ep-CAM mediated cell-cell interactions by Ep-
CAM specific mAbs in human fetal pancreatic cells results in a significant increase in
both insulin and glucagon gene transcription (Cirulli et al., 1998). This suggests that
Ep-CAM internalization from the cell surface and/or functional inactivation of Ep-
CAM by mAbs, may be a signaling event in the differentiation of pancreatic islet cells
(Cirulli et al., 1998). In contrast, an increased expression of Ep-CAM, as demonstrated
for the different stages of cervical intra-epithelial neoplasia, correlates with increased
proliferation and a loss of markers for (terminal) differentiation (Litvinov et al., 1996).
In normal and transformed human keratinocytes, the expression of Ep-CAM is also
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in the cytoplasmic tails of molecules interacting with α-actinin reveal no clear similari-
ties, except for the arginine and lysine-rich consensus that can be found in the first Ep-
CAM α-actinin binding site (RKKRMAK), and the α-actinin binding sites in ICAM-1
(RKIKK) and L-selectin (RRLKKGKKSKR) (Balzar et al., 1998). The involvement of the
cytoplasmic domain for Ep-CAM function will be further discussed below.
Ep-CAM mediated cell-cell adhesion
When Ep-CAM is expressed in L cells (murine fibroblasts incapable of intercel-
lular adhesion), the resulting transfectants are capable of forming aggregates. The Ep-
CAM molecules are present at the surfaces of interacting cells, concentrated at the cell-
cell boundaries. The transfectants do not interact with parental L cells, which suggests
that Ep-CAM is involved in homotypic adhesion (Litvinov et al., 1994). The adhesions
mediated by Ep-CAM are relatively weak, as compared to some other adhesion molecu-
les, such as classical cadherins. However, Ep-CAM adhesions are sufficiently strong to
suppress the scattering of L cell transfectants in matrigel (Litvinov et al., 1994), or inva-
sion of transfectants through reconstructed basement membrane (Basak et al., 1998).
Based on the inhibition of metastasis of Ep-CAM transfected tumor cells in mice, as
compared to control tumor cells (Basak et al., 1998), it may be claimed that Ep-CAM
expression correlates with a better prognosis of carcinoma patients. Indeed, results of a
study investigating markers for the assessment of nodal metastasis in laryngeal carcin-
omas revealed that a loss of Ep-CAM expression in the primary tumor correlated with
nodal metastasis, high incidence of local recurrence, and poor prognosis (Takes et al.,
1997).
When transfected in Ep-CAM-negative human epithelial cells, and expressed at
average levels observed in carcinoma cell lines, Ep-CAM is capable to mediate aggrega-
tion in the absence of calcium (Litvinov et al., 1994a/b). When carcinoma cells are allo-
wed to aggregate in the absence of calcium, the degree of aggregation can be reduced by
the presence of mAb 323/A3 specific for Ep-CAM (Litvinov et al., 1994b). Furthermore,
it has been shown that the aggregation of human fetal pancreatic cells can be blocked
with anti-Ep-CAM mAbs KS1/4 and 323/A3 (Cirulli et al., 1998).
The cytoplasmic domain is required for Ep-CAM to mediate intercellular adhe-
sion, since L-cell transfectants expressing Ep-CAM mutants lacking the complete cyto-
plasmic domain are not capable of forming aggregates, in contrast to the wild-type Ep-
CAM transfectants. However, both L-cell transfectants expressing wild-type Ep-CAM
or cytoplasmic domain deletion mutants are capable of binding to Ep-CAM coated
solid phase, indicating that the extracellular domain is capable of forming Ep-CAM
intercellular adhesions (Balzar et al., 1998). Because the cytoplasmic domain deletion
mutant is not capable of inducing the aggregation of L-cell transfectants, this indicates
that as long as the counter-receptor Ep-CAM molecule is “fixed”, the extracellular
domain is sufficient for adhesion. Thus, deletion of the cytoplasmic domain of the Ep-
CAM molecule results in a protein that still has homophilic specificity, but is incapable
of forming stable adhesions.
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Place of Ep-CAM among other adhesion molecules
Structurally Ep-CAM does not resemble any of the four major families of cell
adhesion molecules, namely cadherins, integrins, selectins, and members of the immu-
noglobulin CAM super-family (Horwitz and Hunter, 1996; Aplin et al., 1998). The Ep-
CAM extracellular domain contains EGF-like repeats, which are also present in selectins
(Kansas et al., 1994), and members of the lin-12/notch/GLP-1 transmembrane receptor
family (Artavanis-Tsakonas et al., 1995). Based on the presence of EGF-like repeats in
the extracellular domain, Ep-CAM was proposed to function as a cell adhesion molecule
(Simon et al., 1990), or a cell surface receptor capable of signal transduction (Fornaro et
al., 1995). Despite the fact that the molecule is capable of mediating homophilic adhesi-
ve interactions, there is not sufficient evidence that Ep-CAM mediated adhesions are
required for epithelial cell support. Other molecules, such as receptor protein tyrosine
phosphatases (Brady-Kalnay et al., 1995), molecules involved in defining cell fate of the
lin-12/notch/GLP-1 receptor family (Artavanis-Tsakonas et al., 1995), and molecules
involved in juxtacrine signaling are capable of adhesive interactions as well. The border
between intercellular adhesion and juxtacrine signaling, as two different functions, is
becoming less clear, since many “classical” adhesion molecules (e.g. N-CAM and E-cad-
herin) were demonstrated to function as signaling morphoregulators (Cunningham,
1995). Figure 3 shows a comparison of Ep-CAM with other cell surface receptors parti-
cipating in either adhesion or juxtacrine signaling indicating that some of the receptors
share structural similarities with Ep-CAM. A secreted form, typical for most juxtacrine
signaling molecules, is not reported for Ep-CAM. The recently reported data concer-
ning the organization of Ep-CAM mediated adhesions suggest that it resembles more a
typical adhesion molecule, being connected to actin microfilaments (Balzar et al.,
1998). However, the exact role of Ep-CAM in epithelial cell functioning remains to be
further investigated.
Immunotherapy targeting Ep-CAM
The generation of mAbs for immunopathological diagnosis of cancer resulted
in the discovery of antigens expressed by tumor cells (Koprowski et al., 1979; Oosterwijk
et al., 1986). Many of these antibodies were specific for cell surface antigens of the tumor
cells. Ep-CAM was one of the most immunogenic proteins to which antibodies were
generated in mice immunized with carcinoma cells. Since Ep-CAM localizes at the cell
surface of most carcinomas, the molecule is an attractive target for immunotherapy. Ep-
CAM directed therapy against carcinomas started with treatment using unconjugated
mAbs, which has resulted in some anti-tumor effects (Ragnhammar et al., 1993;
Mellstedt et al., 1991; Weiner et al., 1993). However, after a decade of mAb therapy on
solid tumors in patients, it can be concluded that naked mAbs generally lack the efficacy
to eradicate solid established tumor masses (Lobuglio and Saleh, 1992). This lack of effi-
cacy is believed to be caused by very poor localization of mAbs in larger tumors. The
capacity of mAbs to eliminate single tumor cells in carcinoma patients may prevent the
outgrowth of metastasis and could therefore be crucial for the survival of patients.
and its disturbance during the development of a malignant phenotype 37
The biology of 17-1A antigen (Ep-CAM)
inversely correlated with differentiation (Schon et al., 1995). Moreover, in transformed
keratinocytes Ep-CAM directly correlates with cell proliferation (Schon et al., 1995).
Thus, there is a clear connection between Ep-CAM and signaling cascades leading to a
regulation of proliferation and differentiation.
Increased expression of Ep-CAM in cells interconnected by classic cadherins (E-
or N-cadherin) has a negative effect on cadherin-mediated adhesions, whereas Ep-CAM
mediated adhesions become predominant (Litvinov et al., 1997). Overexpression of Ep-
CAM in cadherin positive cells causes no change in the total amount of cellular cadherin,
but decreases the association of the cadherin/catenin complex with the cytoskeleton. As
the Ep-CAM expression increases, the total amount of α-catenin decreases, whereas cel-
lular β-catenin levels remain constant (Litvinov et al., 1997). The adhesion-defective
mutant of Ep-CAM lacking the complete cytoplasmic domain has no effect on adhesions
mediated by classic cadherins, suggesting that the cytoplasmic domain is involved in the
regulation of cadherin-mediated adhesions. Negative effects on cadherin mediated
adhesions by increased expression of Ep-CAM were also observed in L cell transfectants
expressing both Ep-CAM and chimeras of E-cadherin, where the truncated cytoplasmic
domain of cadherin was replaced by either complete or a fragment of (α-catenin (Winter
et al., submitted). Although several important molecules present in the cytoplasmic
complex of E-cadherin (such as (β-catenin and α-actinin) are excluded from the cyto-
skeleton anchor of the E-cadherin/α-catenin chimeras, the negative effect of Ep-CAM
was still observed. This suggests that Ep-CAM affects the link between the α-catenin and
F-actin by a yet unknown mechanism. The observed co-localization of Ep-CAM and E-
cadherin at the lateral membrane in epithelial cells may be important for the modulating
effect of Ep-CAM on cadherin-mediated junctions (Balzar et al., 1998).
Increased Ep-CAM expression correlates with proliferation, decreased cadhe-
rin-mediated adhesion, and a less differentiated phenotype suggesting that Ep-CAM
regulates the strength of intercellular adhesion, and provides epithelial cells with flexi-
ble interconnections necessary for epithelial morphogenesis and tissue maintenance.
This has been shown in at least one model, the ontogeny of the human pancreas.
Developmentally regulated expression of Ep-CAM plays a morphoregulatory role
during the development of pancreatic islets of Langerhans (Cirulli et al., 1998).
Blocking of Ep-CAM by mAbs affected the transcription of genes encoding the pancrea-
tic enzymes glucagon and insulin (Cirulli et al., 1998). The opposite, affected differenti-
ation by forced expression of Ep-CAM, was shown for mammary gland epithelium.
Human Ep-CAM ectopically expressed in the mammary glands of transgenic mice leads
to ductal hyperplasia and affects the differentiation of both lobular and ductal cells
(Balzar et al., submitted). In mammary glands of virgin transgenic female mice active
secondary branching of ducts and enhanced proliferation (phenomena often observed
in mice with forced expression of a growth factor relevant for mammary cell prolifera-
tion) was observed. For example, the ectopic expression of heregulin, a member of the
neuregulin family of ligands of erbB receptor tyrosine kinases involved in signal trans-
duction, induces similar mammary gland morphogenesis (Krane and Leder, 1996).
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retargeting activated T cells to micrometastatic carcinoma cells (Kufer et al., 1997).
Activation of Ep-CAM specific T cells was also achieved both in vitro and in vivo by pep-
tide vaccination (Ras et al., 1997) or DNA vaccination (our unpublished results). To
overcome problems with respect to MHC-restricted target recognition by T-cells, and
down-regulation of MHC molecules expression by tumor cells, chimeric T cell recep-
tors specific for Ep-CAM were generated that were able to lyse tumor cells in vitro (Van
Ratingen et al., submitted). Expression of these chimeric T cell receptors in cytotoxic T
lymphocytes from patients by retroviral transduction, might be valuable for T cell based
immunotherapy of carcinoma patients.
Since Ep-CAM has high expression levels in some normal human adult tissues
(e.g. colon), one can expect toxicity as a side effect of a therapeutic approach. Indeed,
infusion of carcinoma patients with high affinity mAbs against Ep-CAM (e.g. GA733)
was accompanied by mild and short-lasting gastro-intestinal toxicity (Herlyn et al.,
1991). Thus, appropriate pre-clinical models are required to study the efficacy and toxi-
city of newly developed strategies. Transgenic mice expressing human Ep-CAM in epi-
thelial tissues might serve as such a model and have recently been generated (Balzar et
al., submitted).
Concluding remarks
Many classic cell adhesion molecules, i.e..integrins or selectins, have recently
been identified as components of signaling cascades. Moreover, signaling from various
cell adhesion molecules is regarded as a major mechanism of controlling processes as
proliferation, differentiation, and (programmed) cell death (Edelman, 1986; Gum -
biner, 1996). The function of CAM’s is not only mechanically attach cells to adjacent
cells and substrates, but also to respond to changes in the environment and adjust the
biological response of cell through outside-in signaling. Since the adhesions mediated
by Ep-CAM are relatively weak, as compared to cadherin-mediated adhesions or des-
mosomes, one may question their relevance for maintaining the epithelial tissue archi-
tecture. On the other hand, Ep-CAM does resemble “classic” adhesion molecules, since
it associates to the cytoskeleton and forms independent adhesions (Balzar et al.,
1998/1999). Although no true junctions are observed for Ep-CAM, the molecule is cle-
arly capable of moving adjacent cell membranes together at the areas of reciprocal
homotypic interactions.
The ability of Ep-CAM to regulate cadherin-mediated adhesions, tissue mor-
phogenesis and the transcription of genes (as was found for the pancreatic enzymes glu-
cagon and insulin) indicates that the molecule is involved in signal transduction regula-
ting epithelial morphogenesis.
The (over-) expression of Ep-CAM correlates with both benign and malignant
hyper- proliferation of epithelial cells. However, the exact role of Ep-CAM in tumor
development remains unclear. Ep-CAM-mediated cell-cell adhesions prevent cell scat-
tering, suggesting that the molecule might prevent metastasis. However, the negative
and its disturbance during the development of a malignant phenotype 39
The biology of 17-1A antigen (Ep-CAM)
Indeed, when Dukes C colorectal carcinoma patients with surgically resected solid
tumor were treated for minimal residual disease with the Ep-CAM specific mAb 17-1A,
this resulted in a 30% increase in the 7-year survival of 17-1A treated patients as compa-
red to non-treated patients (Riethmuller et al., 1998). Since mAb 17-1A is a low affinity
antibody, better immunotherapy results may be obtained using high affinity mAbs
(Velders et al., 1995). However, it has been demonstrated that treatment with high affi-
nity mAbs, such as GA733 and 323/A3, may cause damage to Ep-CAM positive normal
epithelial tissues resulting in toxicity problems (Herlyn et al., 1991).
Recently, other strategies targeting Ep-CAM have been developed for the treat-
ment of carcinomas, although most of them are only tested in pre-clinical studies. To
provide better mAb tumour retention, high-affinity recombinant phage antibodies
directed against Ep-CAM were developed (Roovers et al., 1998). Recombinant bispeci-
fic single chain antibodies specific for both Ep-CAM and the CD3/T cell receptor com-
plex demonstrated (approximately 1000-fold) higher specific cytotoxicity against
tumor cells in vitro (Kufer et al., 1997; Helfrich et al., 1998). Therefore, these bispecific
single chain antibodies may result in improved therapy of minimal residual disease by
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FIGURE 3 Schematic domain structure of Ep-CAM in comparison to other cell surface proteins 
involved in either cell-cell adhesion or transmembrane/ juxtacrine signaling.
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effect of Ep-CAM on cadherin-mediated adhesions may actually promote invasion and
metastasis from carcinoma nodules. Thus, the dualistic role of Ep-CAM in tumor deve-
lopment requires further investigation. 
Since Ep-CAM is expressed by most carcinomas, the molecule has attracted the
attention in the field of cancer immunotherapy. Two important issues must be addres-
sed for major improvements in Ep-CAM targeted immunotherapy. First, Ep-CAM
expression is heterogeneous in carcinomas, which may cause partial eradication of the
tumor after treatment. Second, since Ep-CAM is an epithelial differentiation antigen,
and not a tumor-specific antigen, immunotherapy may have severe side effects causing
toxicity to normal tissues. An increased interest for the biological properties of the Ep-
CAM molecule (as can be observed from recent publications) will ultimately contribute
to a better understanding of the function of Ep-CAM in development, maintenance,
and tumorigenesis of epithelial tissues. Moreover, it will also contribute to development
of new therapeutic strategies employing this antigen as a target.
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Abstract
The contribution of noncadherin-type, Ca2+-independent cell-cell adhesion
molecules to the organization of epithelial tissues is, as yet, unclear. A homophilic, epi-
thelial Ca2+-independent adhesion molecule (Ep-CAM) is expressed in most epithelia,
benign or malignant proliverative lesions, and during embryogenesis. Here we demon-
strate that ectopic Ep-CAM, when expressed in cells interconnected by classic cadherins
(E- or N-cadherin), induces segregation of the transfectants from the parental cell type in
co-aggregation assays and in cultured mixed aggregates, respectively. In the latter assay,
Ep-CAM-positive transfectants behave like cells with a decreased strength of adhesion as
compared to the parental cells. Using transfectants with an inducible Ep-CAM cDNA
construct, we demonstrate that increasing expression of Ep-CAM in cadherin-positive
cells leads to abrogation of adherens junctions. Overexpression of Ep-CAM has no influ-
ence on the total amount of cellular cadherin, but affects the interaction of cadherins
with the cytoskeleton, since a substantial decrease in the detergent-insoluble fraction of
cadherin molecules was observed. Similarly, the detergent-insoluble fractions of α- and
β-catenins decreased in cells overexpressing Ep-CAM. While the total β-catenin content
remains unchanged, a reduction in total cellular α-catenin is observed as Ep-CAM
expression increases. As the cadherin-mediated cell-cell adhesions diminish, Ep-CAM-
mediated intercellular connections become predominant. An adhesion-defective
mutant of Ep-CAM lacking the cytoplasmic domain has no effect on the cadherin-medi-
ated cell-cell adhesions. The ability of Ep-CAM to modulate the cadherin-mediated cell-
cell interactions, as demonstrated in the present study, suggests a role for this molecule in
development of the proliferative, and probably malignant, phenotype of epithelial cells,
since an increase of Ep-CAM expression was observed in vivo in association with hyper-
plastic and malignant proliferation of epithelial cells.
Introduction
Tissue and organ morphogenesis can be viewed as the result of interactions of
various cell populations. One important type of intercellular interactions involved in
the processes of tissue morphogenesis, morphogenetic movement of cells, and segrega-
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thelia, which are Ep-CAM negative, de novo expression of this molecule is associated
with metaplastic or neoplastic changes. Thus, in ectocervical epithelia, expression of
Ep-CAM occurs in early pre-neoplastic lesions (Litvinov et al., 1996); most squamous
carcinomas of the head and neck region are Ep-CAM positive (Quak et al., 1990), and
basal cell carcinomas are Ep-CAM positive in contrast to the normal epidermis
(Tsubura et al., 1992).
In many tumors that express Ep-CAM heterogeneously, an Ep-CAM-positive
cell population may be found within an Ep-CAM negative cell population, with both
cell types expressing approximately equal levels of cadherins, as illustrated in Figure 1A
by a case of basal cell carcinoma. In glandular tissues such as gastric epithelium, which
are low/negative for Ep-CAM, expression of Ep-CAM is related to the development of
early stages of intestinal metaplasia (our unpublished observation). Even in tissues with
relatively high Ep-CAM expression, such as colon, the development of polyps is accom-
panied by an increase in Ep-CAM expression (Salem et al., 1993). In intestinal metapla-
sia one may observe Ep-CAM-positive cells bordering morphological normal cells that
are Ep-CAM negative (as illustrated in Figure 1B). Ep-CAM-positive cells bordering
Ep-CAM-negative epithelial cells may also be found in some normal tissues such as hair
follicles (Tsubura et al., 1992).
From the examples presented, an increased or the novo expression of Ep-CAM
is often observed in epithelial tissues in vivo.Expression of an additional molecule that
may participate in cell adhesion in the context of other adhesion systems may have cer-
tain effects on the cell-cell interactions. Therefore, we have investigated whether the
increased/de novo expression of Ep-CAM in epithelial cells (a) has any impact on inter-
actions of positive cells with the parental Ep-CAM-negative cells, and (b) modulates in
any way intercellular adhesive interactions of cells interconnected by E-cadherin, which
is the major morphoregulatory molecule in epithelia.
Here we demonstrate that expression of Ep-CAM by some cells in a mixed cell
population expressing classical cadherins induces segregation of the Ep-CAM-positive
cells from the parental cell population due to a negative effect on cadherin junctions
caused by expression of Ep-CAM. The cadherin-modulating properties observed for
Ep-CAM suggest a role for this molecule in the development of a proliferative and meta-
plastic cell phenotype, and probably in the development and progression of malignan-
cies.
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tion of cell types, are adhesions mediated by cell adhesion molecules (Steinberg and
Pool, 1982; Edelman, 1986; Cunningham  et al., 1995; Takeichi  et al., 1995; Gumbiner,
1996). Except for their direct mechanical role as interconnectors of cells and connectors
of cells to substrates, cell adhesion molecules are also believed to be responsible for a
variety of dynamic processes including cell locomotion, proliferation, and differentia-
tion. There is also evidence that the adhesion systems within a cell may act as regulators
of other cell adhesions, thereby offering a means of signaling that is relevant for rearran-
gements in cell or tissue organization (Edelman, 1993; Rosales et al., 1995; Gumbiner,
1996).
In many tissues, a critical role in the maintenance of multicellular structures is
assigned to cadherins, a family of Ca2+-dependent, homophilic cell-cell adhesion mole-
cules (Takeichi  et al., 1991; Gumbiner, 1996). In Epithelia this critical role belongs to E-
cadherin, which is crucial for the establishment and maintenance of epithelial cell pola-
rity (McNeil et al., 1990; Näthke et al., 1993), morphogenesis of epithelial tissues
(Wheelock and Jensen, 1992; Larue et al., 1996), and regulation of cell proliferation and
programmed cell death (Hermiston and Gordon, 1995; Hermiston et al., 1996;
Takahashi and Suzuki, 1996; Wilding et al., 1996; Zhu and Watt, 1996). Expression of
different types of classic cadherin molecules (Nose et al., 1988; Friedlander et al., 1989;
Daniel et al., 1995), and even quantitative differences in the levels of the same type of
cadherin (Steinberg and Takeichi, 1994) may be responsible for segregation of cell types
in epithelial tissues. The phenotype of epithelial cells may be modulated by expression
of combinations of different types of cadherins (Marrs et al., 1995; Islam et al., 1996).
However, cadherins represent only one of the intercellular adhesions systems that are
present in epithelia, along with adhesion molecules of the immunoglobulin superfami-
ly, such as carcinoembryonic antigen (Benchimol et al., 1989) and others. The actual
contribution of Ca2+-independent non-junctional adhesion molecules to the forma-
tion and maintenance of the epithelial tissue architecture and epithelial cell morpholo-
gy is not clear.
We have recently demonstrated that a 40-kD epithelial glycoprotein, which we
have designated epithelial cell adhesion molecule (Ep-CAM) (Litvinov et al., 1994a),
may perform as a homophilic, Ca2+-independent intercellular adhesion molecule,
capable of mediating cell aggregation, preventing cell scattering, and directing cell
segregation. This type I transmembrane glycoprotein consists of two EGF-like domains
followed by a cysteine-poor region, a transmembrane domain, and a short (26 amino
acid) cytoplasmic tail, and is not structurally related to the four major types of CAMs,
such as cadherins, integrins, selectins, and the immunoglobulin superfamily (for review
see Litvinov, 1995). Ep-CAM demonstrates adhesion properties when introduced into
cell systems that are deficient in intercellular adhesive interactions (Litvinov et al.,
1994a). However, the participation of the Ep-CAM molecule in supporting cell-cell
interactions of epithelial cells was not evident (Litvinov et al., 1994b).
Most epithelial cells types coexpress E-cadherin (and sometimes other classic
cadherins) and Ep-CAM during some stage of embryogenesis. In adult squamous epi-
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Labeling of Cells and Sorting Experiments
For cell sorting experiments, the cells were labelled according to the manufac-
turer’s protocol with fluorescent dyes (PKH-2 [green fluorochromo]. or PKH-26 [red
fluorochrome]; Zynaxis Cell Science Inc., Malvern, PA), that incorporate the menbra-
ne’s lipid bilayer. The fluorochromes provide a stable labeling of living cells and do not
interfere with with either cell surface proteins or with the cells behaviour and interacti-
ons (Horan et al., 1990; Litvinov et al., 1994a). Cell sorting/patterning experiments were
performed as described elsewhere (Nose et al., 1988; Litvinov et al., 1994). Briefly, cells
were dissociated with TC, washed in Dulbecco’s PBS, labeled with one of the fluorochro-
mes, washed three times in 50% FCS in DME, resuspended in DME containing 0.8%
FCS and 1 mg/ml DNAse (Boehringer Mannheim Corp.), mixed at various ratios
depending on the experiment, and allowed to aggregate as described for the aggregation
assays. After 1-2 h of aggregation, the suspension of aggregates was analyzed under a
confocal microscope (model MRC-600; Bio-Rad Laboratories, Carlsbad, CA). Images
from different areas of the preparation were taken, and the number of cells of each color
in the aggregates was determined. To study the segregation/patterning of cells in aggre-
gates, the two cell types labeled with different fluorescent dyes were mixed at equal rati-
os, spun down, and allowed to aggregate in the pellet during the next 2 h at 37oC. The
large aggregate formed was mechanically dispersed into smaller fragments, which were
further cultured in suspension on a rotating platform (at 140 rpm). After 30 min and 24
h of culture, respectively, samples of aggregates were fixed with 4% formaldehyde in
PBS/1 mM CaCl2, and analyzed with confocal microscopy.
Antibodies
Anti-Ep-CAM antibodies were 323/A3 (against human Ep-CAM; Litvinov et
al., 1994) and G8.8 (against murine Ep-CAM; Nelson et al., 1996). The antibodies
against epitopes in extracellular domains of human E-cadherin and human P-cadherin
were obtained from Thamer diagnostica BV (clones HECD-1 and NCC-CAD-299, res-
pectively; Uithoorn, The Netherlands). A mAb against an epitope in the extracellular
domain of N-cadherin (clone GC-4) was obtained from Sigma Chemical Co. (St. Louis,
MO). Antibody to the cytoplasmic domain of classical cadherins (clone CH-19; Sigma
Chemical Co.) strongly reactive with N-cadherin and weak with other cadherin types,
was used for immunoblotting experiments. Two mAbs against murine E-cadherin were
used: one reactive with an epitope in the cytoplasmic domain (clone 36; Transduction
Laboratories, Lexington, KY), and one reactive with the extracellular domain of the
molecule (ECCD-2; Takara Shuzo Co., Shiga, Japan). Antibodies to α-catenin (clone
αCAT-7A4; Zymed Laboratories, South San Francisco, CA) and β-catenin (clone 14;
Transduction laboratories) both had cross-species reactivity. For immunoblotting
experiments on immunoprecipitates, a polyclonal rabbit anti-serum to α-catenin was
used (gift of J. Behrens, Max Delbruck Center for Molecular Medicine, Berlin,
Germany).
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Materials and Methods
DNA Constructs 
The SmaI-BglII fragment of human Ep-CAM cDNA was used for the wild-type
Ep-CAM expression construct, as reported earlier (Litvinov et al., 1994a). Mutant Ep-
CAM with a truncated cytoplasmic tail (Mu1) was generated by PCR amplification of
the fragment of Ep-CAM cDNA corresponding to amino acids 1-289. The wild-type
and mutant Ep-CAM cDNAs were cloned into pCEP4 and pMEP4 vectors (Invitrogen
BV, Leek, The Netherlands) under control of cytomegalovirus or metallothionein II
promotors, respectively. Both vectors used contain the Epstein-Barr virus’s origin of
replication and the EBNA-1 gene, which allow both episomal replication and self-sup-
port of the plasmid to large copy numbers in human cells. In murine cells, both vectors
integrate into the cellular DNA.
Cells and Transfections
The murine E-cadherin transfected L (LEC) cells (clone LUN.6), and the HCA
clonal cell line isolated from the SV-40 immortalized normal epithelial cell line HBL-
100 were recloned in our laboratory before transfections (provided by J. Hilkens, The
Netherlands Cancer Institute, Amsterdam, The Netherlands). L cells (L929), colon car-
cinoma cell line (LS180), mammary carcinoma cells (MCF-7), and the pancreatic car-
cinoma cell line (CAPAN) were obtained from American Type Culture Collection
(Rockville, MD). The normal human mammary-epithelium derived cell line (RC-6)
and the squamous carcinoma cell line (U2) were cultured in DME with 10% FCS (provi-
ded by E. Schuuring, Leiden University, Leiden, The Netherlands), as were all cell lines.
Cells were transfected using the DOTAP reagent (Boehringer Mannheim Corp.,
Mannheim, Germany) as described earlier (litvinov et al., 1994a). For murine cells, the
stable clones obtained were either grown as isolated clones, or were pooled; human
transfected cell lines were continuously cultered in the presence of selection marker
(Hygromycin, 1 mg/ml; Boeringer Mannheim Corp.). 48 h before the experiments, cells
were passaged into medium without hygromycin. To induce the expression of cun-
structs under the control of the metallothionein promotor (pMEP4 vector), CdCl2 was
added to the culture medium at concentrations of 2-50 μM depending on the cell line.
Cell Aggregation Assay
Cell aggregation assays were performed as described earlier (Litvinov et al.,
1994a). The cells were detached with either TC treatment (Hank’s buffer with 0.01%
trypsin and 1 mM CaCl2), or by 0.2% EDTA in Hank’s buffer. The degree of cell aggrega-
tion was calculated as D = (N0 - Nt)/N0, where Nt is the number of remaining particles
at the incubation time point t, and N0 is the initial number of particles corresponding to
the total number of cells.
Manon Winter Co-ordination of epithelial junctional systems, 50
Chapter 3
Immunoprecipitation and Immunoblotting
Cells were lysed with extraction buffer (as described above), the lysates were
clarified by centrifugation in a centifuge for 10 min at 15,000 rpm (5415C; Eppendorf
Scientific Inc), and used for immunoprecipitation. 5 μg of a specific mAb was added to a
lysate from 5x106 cells in 1 ml, and incubated at 4°C in an end-to-end rotator for 1 h. 100
(l of 50% protein G-sepharose slurry (Pharmacia Biotech, Inc, Uppsala, Sweden) was
then added to each tube, and the tubes were further incubated for 1 h. The immunoab-
sorbent beads were washes four times with 1 ml of the extraction buffer, and the precipi-
tates were dissolved in Laemmli’s sample buffer (1% SDS, 10% glycerol, 10 mM EDTA,
125 mM Tris/HCL, pH 6.8) containing 2% 2-mercapto-ethanol, boiled for 10 min, and
used for further immunoblotting experiments. Immunoblotting was performed as ear-
lier described (Litvinov et al., 1994), using the alkaline-phosphatase Protoblot system
(Promega Corp., Madison, WI), or the enhanced chemiluminescent detection system
(Amersham Intl., Little Chalfont, UK).
and its disturbance during the development of a malignant phenotype 53
Ep-CAM affects the E-cadherin mediated adhesion
Immunofluorescence Microscopy
Cells growing on either glass slides or in multiwell chamber slides (Nunc,
Naperville, IL) were fixed for 10 min in -20°C methanol, rinsed quickly in -20oC aceto-
ne, and allowed to dry. The preparations were blocked in 5% skim milk solutions in PBS
for 30 min at 37°C, and indirect immunofluorescent staining was performed using a
specific mAb and a goat anti-mouse IgG-FITC conjugate (Southern Biotechnologies,
Birmingham, AL). The preparations were analyzed with a confocal microscope.
Reflection Contrast Microscopy and Electron Microscopy
Both were performed as described (Prins et al., 1993). Cell aggregates were fixed
with 2% paraformaldehyde/1.25% glutaraldehyde, postfixed with 1% Osmium tetroxi-
de, embedded in Epon, and ultrathin sectioned. The preparations were examined, res-
pectively, with a microscope equipped for epi-illumination (model Orthoplan; Leitz,
Wetzlar, Germany), and an electron microscope (model CM10; Philips Electron Optics,
Eindhoven, The Netherlands).
Flow Cytometry
The expression of Ep-CAM was detected on living cells by using F(ab) frag-
ments of mAb 323/A3 directly conjugated with 5(6)-Carboxy-fluorescein-N-hydroxy-
succinimide ester (FLUOS), a FITC-like fluorochrome. The conjugation was performed
according to the manufacturer’s protocol (Boehringer Mannheim Corp.). To detect the
cell surface expression of murine E-cadherin or human N-cadherin the mAbs ECCD-2
and GC-4 were used. The bound mAb was detected with an appropiate species-specific
anti-IgG FITC conjugate (Southern Biotechnologies).
Cell lysis and Cell Extraction with Detergents
Cells of various transfected cell lines were seeded at equal density on 10-cm
Petri-dishes 48 h before lysis and cultured the last 24 h in either the presence or absence
of Cd2+ cations in the medium. To prepare total cell lysates, cell on the dishes were rinsed
twice with ice-cold PBS (pH 7.4), and lysed in 1 ml boiling 1% SDS/10 mM EDTA. The
extraction of detergent-soluble cadherins and catenins was performed as described by
Hinck et al. (1994). Cells were rinsed three times with cold PBS, and 2 ml of cold extrac-
tion buffer (50 mM Tris/HCl, pH 7.0, 50 mM NaCl, 3 mM MgCl2, 0.5% Triton X-100,
300 mM sucrose, and protease inhibitor [complete; Boehringer Mannheim Corp.])
were added to the cells. Cells were incubated for 45 min on a shaker at 4oC, detached with
a scraper, collected, and spun down in a centrifuge for 10 min at 15,000 rpm (5415C;
Eppendorf scientific, Inc., Hamburg, Germany). The pellet was lysed with boiling 1%
SDS/10 mM EDTA and then boiled for 5 min. The lysates obtained with boiling SDS
were spun through a spin column (Quiashredder; Quiagen Inc., Hilden, Germany) to
reduce the viscosity caused by DNA, and the preparations obtained were used for gel
electrophoresis. The protein content was determined for each sample by measuring the
optical density at 224 nm of a sample aliquot prediluted with 4% SDS.
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FIGURE 1 Examples of Ep-CAM expression by some cells within an E-cadherin-positive cell population. 
(A) Heterogeneous expression of Ep-CAM in a basal cell carcinoma, as detected by immuno-
fluorescent staining with mAb 323/A3 to Ep-CAM (green fluorescence); red fluorescence
indicates the expression of E-cadherin (mAb HECD-1). 
(B) The de-novo expres-
sion of Ep-CAM in
gastric mucosa in rela-
tion to the develop-
ment of intestinal
metaplasia; immuno-
histochemical staining
with mAb 323/A3. Note
the bordering of 
Ep-CAM positive and
negative cells. 
possible heterotypic interactions between Ep-CAM and E-cadherin (Figure2). LEC-C
and LEC-Ep cells, when mixed, showed segregation in suspension coaggregation assays
(Figure 2). Although some aggregates contained cells of both types, and the segregation
could be described as partial only, the two cell types did show a clear preference for inde-
pendent aggregation.
Immunoblotting revealed that LEC-C and LEC-Ep cells expressed approxima-
tely equal levels of E-cadherin molecules (Figure 2B). Since even relatively minor diffe-
rences in the levels of cadherin expression may affect cell-cell interaction (Steinberg and
Takeichi, 1994), we repeated this experiment with five pairs of cell lines obtained from
several independent transfections. The degree of cell segregation varied (as estimated
by the relative proportion if mixed aggregates formed), and correlated positively with
the level of Ep-CAM expression at the surface of double transfectants (not shown).
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Results
Ep-CAM directs segregation within E-cadherin positive cells
To investigate to what extent the expression of Ep-CAM in epithelia modulates
the interactions of Ep-CAM-positive cells with neighboring Ep-CAM negative cells, we
have established a simple model: murine fibroblast L cells transfected with murine 
E-cadherin, and a derived cell line additionally supertransfected with Ep-CAM. The
murine L cell fibroblasts have previously been used to demonstrate the adhesion pro-
perties of both E-Cadherin (Nagafuchi et al., 1987), and Ep-CAM (Litvinov et al., 1994);
these cells are able to support the functional activity of both molecules and do not
express endogenous cadherins or murine Ep-CAM (as was tested with a mAb specific
for murine Ep-CAM; data not shown).
LEC cells demonstrated all mor-
phological changes related to E-
cadherin expression reported for
other E-cadherin transfectants
of L-cells Nagafuchi et al., 
1987; Chen and Öbrink, 1991;
Wesseling et al., 1996). LEC cells
were supertransfected with
either Ep-CAM cDNA under the
control of the constitutive cyt-
omegalovirus promotor (LEC-
Ep cells), or with the blank
pCEP4 expression vector (LEC-
C cells). These transfected cell
lines were established without
clonal isolation and represented
a mix of >200 individual clones
from each transfection. Additio -
nally, L cells transfected only
with the Ep-CAM cDNA were
established (LEp cells).
When mixed in suspen-
sion, neither LEC nor LEp cells
interacted with the parental L
cells. The LEC and LEp cells also
did not interact with one ano-
ther, as was tested in coaggrega-
tion assays performed to exclude
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FIGURE 2 Cell segregation directed by Ep-CAM. L cells 
were transfected with cDNA for E-cadherin (LEC)
or Ep-CAM (LEp), and the E-cadherin transfec-
tants were additionally supertransfected with
either Ep-CAM cDNA (LEC-Ep) or blank vector
(LEC-C). (A) Pairs of transfected cells were
tested in co-aggregation assays: dispersed cells
of two types (Type 1 + Type 2), each labeled with
a different fluorescent dye, were mixed at equal
concentrations. After 2 h of culturing in suspen-
sion, cell aggregates consisting of >10 cells were
analyzed for the presence of cells of each type.
The data is presented as percentage of aggrega-
tes (y-axis) containing the respective percenta-
ge of the Type 2 cells (x-axis). (B) Expression of E-
cadherin and Ep-CAM in the transfectants, as
determined by immunoblotting in total cell lysa-
tes using antibodies to E-cadherin and human
Ep-CAM (323/A3), respectively.
FIGURE 3 Segregation of Ep-CAM positive  
LEC cell transfectants from
parental cells in multi-cellular
aggregates. LEC-C and LEC-Ep
cells, labeled with the fluores-
cent dyes PKH-26 and PKH-2, res-
pectively, were mixed at a 1:1
ratio, sedimented, and allowed to
form an aggregate. This aggrega-
te, in which both cell types were
represented in a random pattern,
was mechanically dispersed, and
the smaller aggregates obtained
were further cultured in suspen-
sion for 24 h, fixed, and analyzed.
The micrographs present optical
cross-sections at the equatorial
area of the aggregates after 24 h,
as seen with a confocal microsco-
pe. The artificial colors were
assigned to the cells depending
on the color of the fluorochrome
and the cell type: LEC-C (red);
LEC-Ep (white) cells. The figures
show similar cell patterning in
different size aggregates in the
range of <100 to ~1,000 cells. A
dark area in the middle of some
aggregates is an optically non-
transparent zone.
After being cultured for 24 h at different concentrations of Cd2+, the cells were detached
with EDTA and subjected to aggregation assays in the presence of Ca2+ to allow both Ep-
CAM and E-cadherin adhesions systems to participate in cell aggregation. The results
showed that prior culturing in the presence of CdCl2 had no effect on the aggregation
rate of the control LEC-MC cells, whereas the aggregation of Ep-CAM transfectants
decreased in direct proportion the levels of Ep-CAM expressed (Figure 4C). The diffe-
rences in aggregation were reproducible in independent experiments and were highly
significant (P < 0.01; Student’s t test).
Not only were the aggregation rates for cells expressing Ep-CAM reduced, but
also the morphology of the aggregates was different from those formed by the control
cells. Thus, most of the LEC-MC cells produced tight, large aggregates, whereas LEC-
MEp.6 cells mainly formed small aggregates (Figure 4D). This was clearly related to the
levels of Ep-CAM expressed by the cells, as the aggregates formed by LEC-MEp.6 cells
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When mixed as monocellular suspensions and sedimented together, LEC-C and LEC-
Ep cells were able to establish connections in the pellet. The resulting large aggregate,
formed by randomly distributed cells of both types, was mechanically dispersed into a
number of smaller aggregates. After 24 h of culturing these aggregates in suspension, it
was found that the LEC-C cells formed the tight core of the aggregates, with the LEC-Ep
cells forming the external layer. This structure was observed for all aggregates irrespecti-
ve of their size, with the latter ranging from 100 to more than 1,000 cells (Figure 3).
When either LEC-C or LEC-Ep cells were mixed with the differentially labeled cells of
self-type, no cell patterning was observed, indicating that segregation was unrelated to
the labeling and other experimental procedures.
The positioning of cells in mixed structures (to the inner or outer layer, respec-
tively) is determined by the relative strength of intercellular connections between the
cells of each type (Steinberg and Pool, 1982; Foty et al., 1996). In this respect, the Ep-
CAM transfectants of E-cadherin-positive cells interacted with the parental cells as did
cells with a relatively decreased strength of cell-cell adhesion. In contrast to what could
be expected from the expression of an additional intercellular adhesion molecule, the
overall strength of intercellular adhesion among LEC cells seemed to become reduced
upon the expression of Ep-CAM. Since Ep-CAM is a relatively weak adhesion molecule
compared to E-cadherin (Litvinov et al., 1994a), it is highly suggestive that the E-cadhe-
rin-mediated cell-cell adhesions in LEC-Ep cells were negatively affected because of Ep-
CAM expression.
Expression of Ep-CAM suppresses the E-cadherin-mediated cell aggre-
gation
Ep-CAM-mediated aggregation in suspension is rather slow, with ~40% of
aggregation reached in 120 min for L cells with high levels of Ep-CAM expression
(Litvinov et al., 1994a). In contrast, E-cadherin-mediated cell aggregation is relatively
fast, as L cell transfectants expressing E-cadherin reach the plateau level of aggregation
(50-80%) within 30 min, at which time the aggregation mediated by Ep-CAM is hardly
noticable (not shown). If Ep-CAM is indeed able to negatively affect the E-cadherin-
mediated cell-cell adhesion, the aggregation rates of E-cadherin/Ep-CAM transfectants
should inversely correlate with the levels of Ep-CAM expression.
To investigate this, LEC cells with inducible Ep-CAM expression (LEC-MEp)
were established by introducing the Ep-CAM cDNA under the control of an inducible
metallothionein promotor. This promotor can give high levels of expression upon
induction, but is leaky, with the construct being expressed to a certain level without
induction with heavy metal ions. We selected two individual clones (LEC-MEp.6 and
LEC-MEp.2) with different basal levels of Ep-CAM expression. Both the total number
of Ep-CAM molecules (Figure 4A), as well as Ep-CAM expressed at the cell surface
(Figure 4B), could be gradually induced in cells of isolated clones by increasing the
Cd2+ concentrations in the medium ≤ 10 μM. A control cell line was prepared by trans-
fecting a blank pMEP4 vector into LEC cells (LEC-MC cells).
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FIGURE 4 Effect of increasing expression of Ep-CAM on cell-cell interactions in L cell E-cadherin 
transfectants (LEC). LEC cells were super-transfected with Ep-CAM cDNA under the control
of the methallothionein promotor (clones LEC-Mep.2 and LEC-Mep.6), or with blank vector
(LEC-MC). Induction of Ep-CAM expres-
sion with CdCl2 for 24 h resulted in an
increased total Ep-CAM (A, immunoblot
of total cell lysates) and in an increased
presence of Ep-CAM molecules at the cell
surface (B, flow cytometry with anti-Ep-
CAM F(ab)-FLUOS conjugate). Cells deta-
ched with TC treatment were allowed to
aggregate in suspension for 30 min. in the
presence of Ca2+, and the degree of cell
aggregation was determined (C). The sta-
tistical significance of the observed diffe-
rences in aggregation rates was determ-
ined using Student’s t-test (p). Where
indicated, cells were cultured for 24 h
before the assay in the presence of CdCl2
in culture medium. The morphology of
aggregates formed in 30 min. by LEC-MC
and LEC-Mep.6 cells (the latter non-indu-
ced and induced with 10 (M CdCl2).
LEC-MEp.6 cells, appeared after 24 h. By that time, > 50% of all control cells had acqui-
red an epithelioid morphology, with a clear interconnection of the lateral domains of
neighbouring cells (Figure 7). In contrast, in cultures of LEC-MEp.6 cells, when cultu-
red at the same high debsity in the absence of Cd2+, <10% of all cells had the morpholo-
gy observed in control cultures (as was estimated from direct cell counting). When cul-
tured in the presence of 10 μM CdCl2, no cells with epithelial-like morphology were
observed in LEC-MEp.6 cultures (Figure 7). Interactions among the cells seemed to be
reduced to sporadic contacts, mainly involving filopodia-like structures.
The presence of Cd2+ in the culture medium had no effect on the morphology
of the control LEC-MC cells. The LEC-MEp.2 cells demonstrated a somewhat interme-
diate morphology when compared to the other two cell lines (not shown).
Expression of Ep-CAM Disturbs Association of E-cadherin with the
Cytoskeleton
The data presented so far suggest that expression of Ep-CAM does not affect the
number of E-cadherin molecules in cells, but does affect the ability of these molecules to
form stable adhesions. As the differences between LEC-MC and LEC-MEp.6 cell lines
were most clearly pronounced, we further investigated the changes of cadherin juncti-
ons in LEC-MEp.6 cells upon expression of Ep-CAM. Immunofluorescent staining
revealed that in dense cultures of LEC-MC cells, most of the cell surface E-cadherin
molecules were present in typical cadherin-type intercellular junctions and were absent
from the free domains of the cell membrane (Figure 8). However, at the basal level of Ep-
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after induction of Ep-CAM expression were loosely interconnected and even smaller
those formed by the non-induced cells.
Over time (≤ 24 h of suspension culture), even the induced LEC-MEp.6 cells
were able to form some larger multi-cellular aggregates. However, the internal structure
of these aggregates differed substantially from aggregates of LEC-MC cells, with the lat-
ter consisting of tightly interconnected cells, whereas the cells in LEC-MEp.6 aggregates
had only sporadic connections (Figure 5). This argues against the hypothesis that the
expression of Ep-CAM simply delayed, rather than inhibited, the E-cadherin-mediated
cell aggregation, as the loose interconnection of cells in LEC-MEp.6 aggregates clearly
points to a reduction in the number of the E-cadherin-mediated intercellular adhe-
sions.
As was revealed by immunoblotting, the total number of cadherin molecules in trans-
fectants was not affected by Ep-CAM expression or CdCl2 treatment, remaining
approximately at the same level in LEC-MC and LEC-MEp cells of both clones. Also, the
surface expression, as measured by flow cytometry, was almost identical (Figure 6).
Ep-CAM affects the Moprphology of E-cadherin-transfected L cells
When seeded at low density, both Ep-CAM-positive clones LEC-MEp.2 and
LEC-MEp.6 did not differ in morphology from the parental or control LEC-MC cells.
However, when the cells were seeded at high density to form a monolayer culture, some
morphological differences, which were especially pronounced between LEC-MC and
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FIGURE 5 The internal structure of the large aggregates formed by LEC-MC and LEC-Mep.6 cells in 24 h 
of suspension culture. The expression of Ep-CAM in LEC-Mep.6 cells was induced with 
10 μM CdCl2 for 24 h before the aggregation assay (+). The aggregates were fixed with 2%
paraformaldehyde/1.25% glutaraldehyde, embedded into Epon, and ultrathin sectioned.
Sections were analyzed by reflection contrast microscopy. Bar, 25 μm.
FIGURE 6 Expression of E-cadherin in blank vector 
(-MC) and Ep-CAM transfectants (clones -
Mep.2 and -Mep.6) of LEC cells. The cells
were cultured for 24 h in the presence of
10 μM CdCl2 in culture medium. Cells were
either (A) detached from the substrate
with EDTA and analyzed in flow cytometry
after staining with mAb ECCD-2 to murine
E-cadherin, or (B) lysed with 1% SDS, and
E-cadherin was detected in total lysates (5
μg protein/sample) by immuno-blotting
with mAb 36. 
MEp.6 cells regardless of the level of Ep-CAM expression in the latter. The detergent-
insoluble fraction of β-catenin was, however, reduced in the induced LEC-MEp.6 cells.
In contrast to β-catenin, a reduction in both detergent-insoluble and total cellular frac-
tions of α-catenin molecules was observed in induced LEC-MEp.6 cells (Figure 9A).
Apparently, the expression of Ep-CAM leads to a decrease in the cytoskeleton-
anchored fraction of E-cadherin molecules. To investigate whether some catenins were
still associated with the detergent-soluble fraction of E-cadherin molecules, the indu-
ced and non-induced LEC-MEp.6 cells were extracted with 0.5% Triton X-100, and
immunoprecipitations were performed from the extracts using antibodies specific to E-
cadherin or β-catenin (Figure 9B). Upon the induction of Ep-CAM in LEC-MEp.6 cells,
there was a clear increase in the amount of β-catenin co-precipitating with the deter-
gent-soluble E-cadherin molecules (Figure 9B). The reverse precipitations with anti-β-
catenin mAb produced similar results, with increased co-precipitation of E-cadherin
upon induction of Ep-CAM. However, when the immunoprecipitates of soluble E-cad-
herin were probed with anti-α-catenin antibody, no increased presence of (-catenin
associated with this fraction of E-cadherin molecules was observed. The latter result was
consistent with the observation of the decrease in total α-catenin in the cells.
Additionally, a certain in α-catenin molecules co-precipitating with β-catenin was
observed upon the induction of Ep-CAM (Figure 9B).
These results show that expression of Ep-CAM in cells results in accumulation of 
non-cytoskeletal-anchored E-cadherin/β-catenin complexes, and in a reduction of 
α-catenin molecules available for the formation of E-cadherin junctions. Since the
observations were made after induction of Ep-CAM for 24 h, these soluble 
E-cadherin/β-catenin complexes may originate from either (a) dissociation of the pre-
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CAM expression in in LEC-MEp.6 cells, only a fraction of the E-cadherin molecules was
present in junctions, with some E-cadherin molecules being located at the free domains
of the cell membrane. Induction of Ep-CAM for 24 h resulted in redistribution of E-
cadherin, which was found all over the cell surface, and in a substantial reduction of
structurally recognizable E-cadherin junctions (Figure 8). 
As was previously shown (Figure 6) by flow cytometry analysis and immunoblotting,
both the total number of E-cadherin molecules and the cell surface fraction of E-cadhe-
rin were not changed upon induction of Ep-CAM, suggesting that the latter did not
cause internalization or enhanced degradation of E-cadherin molecules, or suppression
of their transportation to the cell surface. Rather, the observed changes in subcellular
distribution of E-cadherin suggest some disturbance in the association of E-cadherin to
the cytoskeleton, an association required for the E-cadherin junction formation
(Nagafuchi and Takeichi, 1988). Indeed, the cytoskeleton anchored (Triton X-100-inso-
luble) fraction of cadherins was decreased upon the induction of Ep-CAM in LEC-
MEp.6 cells, as can be seen in immunoblotting for E-cadherin in detergent-extracted
cells (Figure 9A).
Interaction of E-cadherin molecules with the cytoskeleton is mediated by α-
and β-catenins (Ozawa and Kemler, 1992; Jou et al., 1995), which are absent in L cells,
but appear upon the transfection of E-cadherin (Nagafuchi et al., 1994). We compared
the total content and detergent solubility of both catenins in LEC-MC and LEC-MEp.6
cells. Approximately similar levels of β-catenin were observed in control and LEC-
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FIGURE 7 The morphology of LEC-MC 
and LEC-Mep.6 cells (the latter
shown after induction with 10 uM
CdCl2, marked by +). Note the
groups of the epithelial-like cells
interconnected along their 
lateral domain in the culture of
MEC-MC cells, which are absent in
the LEC-Mep.6+ cell culture.
FIGURE 8 Subcellular localization of E-cadherin in LEC-MC cells and in LEC-Mep.6 cells. Ep-CAM in 
LEC-Mep.6 was induced by 10 μM CdCl2 for 24 h before cell fixation. Immunofluorescent
staining of methanol-fixed cells was performed as described in Materials and Methods using
mAb ECCD-2 to murine E-cadherin. Bar, 10 mm.
specific for each cadherin), and in contrast to all other cell lines of epithelial origin
tested, contains no endogeneous Ep-CAM. Transfectants of a clonal cell line derived
from HBL-100 origin, HCA, were obtained using episomal vectors that do not integrate
into the genome and support themselves in transfected cells at high copy numbers. The
results obtained with HCA/C (blank pCEP4 vector transfectants) and HCA/CEp
(pCEP4/Ep-CAM transfectants) cells in coaggregation assays were similar to those
obtained with LEC cell transfectants, with the HCA/CEp segregating partially from the
parental cells. In mixed two-cell type aggregates, the cell patterning was similar to that
observed in the LEC cell model (not shown).
Transfection with Ep-CAM affected the aggregation from monocellular sus-
pensions of HCA cells. Afetr 30 min of aggregation in the presence of Ca2+, 50±4 %
aggregation was reached by HCA/C cells, and only 24±3 % by HCA/CEp cells. However,
after 90 min the degree of aggregation for both cell lines was approximately equal, rea-
ching 55%. This may be due to the formation of Ep-CAM-mediated intercellular adhe-
sions, since after 90 min in the absence of Ca2+ (allowing mainly Ep-CAM-mediated cell
aggregation), the degree of aggregation for HCA/CEp cells was approximately the same,
47±4 % (only 8.3 % for contol HCA/C cells).
Despite the fact that after 90 min no substantial differences in aggregation
extent were observed between the control and the Ep-CAM transfectants, the structure
of the aggregates formed by the two cell lines differed substantially. As can be seen on
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existing cadherin junctional complexes, or (b) may represent newly produced E-cadhe-
rin molecules that had formed a complex with β-catenin, but for which further ancho-
rage to the cytoskeleton was not possible because of the non-availability of α-catenin.
Experiments with short-time induction of Ep-CAM in LEC-MEp.6 cells (2, 4, and 6 h)
provided no clear support to either of these options, since the levels of cellular Ep-CAM
after 6 h of induction were only slightly higher than in non-induced cells, and were sub-
stantially lower than in cells induced for 24 h. After short-time induction, no substantial
changes in either solubility of cadherins, or in the level of cellular (-catenin were obser-
ved (data not shown).
Ep-CAM Affects Cadherin-mediated Junctions in Epithelial Cells
To investigate whether the expression of Ep-CAM in human epithelial cells
affects cadherin junctions in a similar way to what has been observed for E-cadherin
transfectants of L cells, we have chosen the immortalized mammary epithelial cell line
HBL-100. This cell line expresses low levels of E- and P-cadherin, and relatively high
levels of N-cadherin (as was tested in immunoblotting and flow cytometry with mAbs
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FIGURE 9 E-cadherin and catenins in LEC-MC and 
LEC-Mep.6 cells. (A) Cells were cultured
in the absence (-) or presence (+) of
CdCl2 for 24 h, and lysed in 1% SDS
either directly (Total lysate) or after
extraction with 0.5% Triton X-100
(Insoluble fraction). Samples of cell lysa-
tes, equalized by protein content, were
analyzed by immuno-blotting with anti-
bodies to E-cadherin (mAb 36), β-catenin
(mAb 14), or α-catenin (mAb 7A4). 5x
more protein was taken for the extrac-
ted cell preparations. (B) LEC-Mep.6
cells cultured in the absence (-) or pre-
sence (+) of CdCl2 were lysed in buffer
with 0.5% Triton X-100, and immuno-pre-
cipitations were performed from the
soluble fraction. The immuno-precipita-
tes were analyzed in Western blotting
with antibodies to E-cadherin (E) or
catenins (α and β, respectively). A rabbit
polyclonal serum was used for α-catenin
detection. The precipitations were 
performed from an excess of the lysate;
therefore, the total amount of an anti-
gen precipitated by an antibody remains
equal. FIGURE 10 Ultra-structure of the aggregates formed by HCA/C and HCA/Cep cells. Reflection
contrast micrographs (left panel) of cross-sections through the aggregates formed in 90 min
by each cell type reveals a tight organization of the HCA/C aggregates and loosely intercon-
nected cells forming the HCA/Cep aggregates. Electron microscopy (right panel) on the pre-
parations shows the abundant presence of the adherens junctions between HCA/C cells
(arrows, top). In
contrast, microvilli
(arrow, bottom)
were found at the
intercellular space
between the cells of
internal layers of
HCA/Cep cells. In
HCA/C cells, micro-
villi were present
almost exclusively
at the apical cell
membrane of the
outer layer of cells
in the aggregate and
not on the 
surface of the cells
from internal 
layers.
tion only at the highest (50 μM) concentration of Cd2+ tested, although some of these
changes could be observed for some cells or groups of cells at lower concentrations of
Cd2+ (2-5 μM), with changes increasing proportionally to the Ep-CAM levels. The effect
was reversible, and within 3 d of culture in the absence of the Cd2+ in the medium, the
cells regained their original morphology, consistent with the decrease of Ep-CAM levels
back to that of non-induced cells (flow cytometry data; not shown).
Induction of Ep-CAM in cells did not affect either the total level of cadherins as was
detected with immunoblotting using a pan-cadherin antibody (Figure 13), or the surfa-
ce expression of N-cadherin (as was detected by flow cytometry; not shown). The surfa-
ce expression of E- and P-cadherins in HCA cells was too low to be measured by flow
cytometry. However, upon induction of Ep-CAM, the subcellular distribution of cadhe-
rins was changed: the typical junctional structures, including cadherins that were pre-
sent in HCA cells (or control transfectants), were absent in induced (Figure 11), but not
in non-induced Ep-CAM transfectants. The disturbance of cadherin’s subcellular loca-
lization was suggested that the effect of Ep-CAM was similar to that observed for LEC
cells. Indeed, the detergent solubility of the cadherins in HCA cells was increased after
24 h of Ep-CAM induction (see Figure 13). Induction of Ep-CAM had no effect on the
level of total cellular β-catenin, but it negatively affected the level of total α-catenin
(Figure 12); the detergent-insoluble fraction for both molecules was reduced in relation
to the expression of Ep-CAM (Figure 12). All observations are based on 24-h induction
of Ep-CAM expression.
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cross-sections, the HCA/C aggregates were composed of tightly interconnected cells, in
contrast to the HCA/CEp aggregates, which were formed by loosely interconnected cells
(Figure 10). In the internal layers of the HCA/C aggregates, the membranes of the cells
were interconnected by multiple adherens junctions (Figure 10), whereas in HCA/CEp
aggregates the cell-cell contacts were rare and often did not contain morphologically
distinguishable adherens junctions. The membranes of neighboring cells in these aggre-
gates were mainly not in close proximity. In these intercellular spaces, microvilli were
often observed (Figure 10), wich were present in HCA/C aggregates at the outer surface
of the external layer of cells only.
To further investigate the effect of Ep-CAM on cell-cell contacts of HCA cells, the cells
were also transfected with Ep-CAM cDNA under the control of the metallothionein
promotor (Wt cells; Wt indicates wild-type Ep-CAM). This regulated the levels of Ep-
CAM expression from ~50% to 350% of the levels observed in HCA/CEp transfectants
(as estimated by flow cytometry on living cells; data not shown).
At the basal level of Ep-CAM expression, the morphology of Ep-CAM transfec-
tants in cell culture was quite similar to the control cells transfected with the blank vec-
tor. However, induction of high levels of Ep-CAM resulted in loss of the polygonal mor-
phology and in a more scattered phenotype, although the cells still remained attached to
another (Figure 11). This change in morphology was observed for the entire cell popula-
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FIGURE 11Changes in sub-cellular distribution 
of cadherins in HCA cells upon
expression of Ep-CAM. HCA cells
transfected with inducible pMep4
vector, either blank (HMC) or contai-
ning the Ep-CAM cDNA (Wt), were
induced with 50 μM CdCl2 24 h before
fixation, fixed, and stained with anti-
pan-cadherin mAb CH-19 (reacts
mainly with N-cadherin, the major
cadherin of HCA cells). Note the
redistribution of cadherins from
adherens junctions to free domains
of cell membrane in Wt Ep-CAM
transfectants, and a general shift of
the cell phenotype to a more scatte-
red one.
FIGURE 12 Detergent extractability of
catenins in HCA cells and Wt 
Ep-CAM transfectants.
Immunoblotting was performed
on total cell lysates and on lysa-
tes of cells pre-extracted with
0.5% Triton X-100. The + indica-
tes induction of cells with CdCl2
for 24 h before lysis.
The Cytoplasmic Domain of Ep-CAM Is Required to Affect the
Cadherin-mediated Junctions
In both L and HCA cell models, we observed a decrease in cadherin-mediated
adhesion and a reduction in cellular α-catenin upon the expression of Ep-CAM. Such
changes in adherens junctions suggest that Ep-CAM induced certain intracellular
effects, and we therefore investigated whether an Ep-CAM mutant lacking the cytoplas-
mic domain would be able to negatively affect cadherin-mediated adhesions. This
mutated form of Ep-CAM (Mu1) was generated as shown in Figure 13. When transfec-
ted into L or HCA cells, Mu1 was expressed at the cell surface, similar to wild-type Ep-
CAM, and was capable of mediating weak homotypic binding, but was not able to form
stable adhesions (investigated in more detail in Balzar et al., 1998; Chapter 4). No effects
produced by the wild-type Ep-CAM were observed in LEC cells transfected with Mu1
with respect to cell morphology, cell aggregation, and the number and extractability of
the cadherin and catenin molecules (not shown). However, the transfections of Mu1
constructs into LEC cells never gave rise to a clonal cell line with the levels of Mu1
expression comparable to the wild-type Ep-CAM expression in LEC-MEp.6 cells,
although the expression levels comparable to LEC-MEp.2 cells were achieved. This
makes strict interpretation of the effects of Mu1 on E-cadherin in LEC cells difficult.
In contrast, when transfected into HCA cells under the control of an inducible promotor,
FIGURE 13 The role of the cytoplasmic domain in the effect of Ep-CAM on cadherins. 
(A) The structural maps of the wild-type and mutant (Mu1) Ep-CAM molecules. The leader
peptide (L), EGF-like domains (EGF-I, EGF-II), cystein poor region (CPR), the transmembra-
ne domain (TM), and cytoplasmic domain (CYT) are marked. The cytoplasmic domain is dele-
ted in the Mu1 molecule. (B) HCA cells were
transfected with either blank vector (HMC),
or the wild-type Ep-CAM (Wt), or Mu1,
under the control of a methallothionein pro-
motor. Where indicated (+Cd), the cells
were cultured in the presence of 50 μM
CdCl2 for 24 h before lysis. Aliquots of total
cell lysates equalized by protein were pro-
bed in immuno-blotting using the Ep-CAM
specific mAb. Content of N-cadherin in
whole cell lysates and after extraction with
0.5% Triton X-100 was analyzed with anti-
pan-cadherin mAb CH-19. Note that the
expression of Wt Ep-CAM, but not of an
approximately equal level of Mu1, affects
the detergent solubility of cadherins.
Mu1 expression could reach levels similar to those of wid-type Ep-CAM expression in
these cells (Figure 13). Nevertheless, no effect on cell morphology, nor on the internal
structure of aggregates formed by the transfectants were observed upon expression of
Mu1 in HCA cells, as compared to non-transfected cells or cells transfected with blank
pMEP4 vector (HMC cells). Expression of Mu1 did not affect the total level of cadherins
in HCA cells or their solubility, as did the wild-type molecule expressed at the same level. 
Discussion
Ca2+ independent cell-cell adhesion molecules are present in epithelial and carcinoma
cells along with the classic cadherins, and, although the data is scarce, it suggests a possi-
ble influence of the non-cadherin cell-cell adhesion molecules on cadherin-mediated
cell-cell adhesion. Thus, the expression of non-cadherin adhesion molecules, such as
protein Zero (Doyle et al., 1995) or N-CAM (Michalides et al., 1994), may cause aug-
mentation of the cadherin-mediated adhesions.
In contrast to these observations, we demonstrate here that expression of Ep-
CAM in cells interconnected by classic cadherins results in abrogation of the cadherin-
mediated junctions in a direct correlation to the levels of Ep-CAM expressed. Despite
the fact that Ep-CAM, being an adhesion molecule, provides additional intercellular
connections to the cells, its expression leads to an overall decrease in the strength of
interactions for cells interconnected by the classic E- and N-cadherins, as shown in this
study. In modulating cadherin adhesions, Ep-CAM acted to some extent as an anti-
adhesion molecule, if the overall strength of the intercellular adhesion in transfected
cells is considered. This effect, however, differs from the previously demonstrated anti-
adhesion effects of N-CAM-bearing polysialic acid (Rutishauser, 1992; Yang et al.,
1992), since polysialylated N-CAM does not bear an adhesion function, and its action is
more similar to the anti-adhesion affects of some other sialoglycoproteins, such as episi-
alin (Wesseling et al., 1996) or CD43 (Ardman et al., 1992), which inhibit intercellular
adhesion by not allowing the membranes of interacting cells to reach the proximity
necessary to form adhesions. Ep-CAM not only weakens/abrogates the cadherin media-
ted adhesions, but replaces them with Ep-CAM adhesions becoming predominant (as
was seen with HCA/Cep cell aggregation) to some extent.
The observed effects originate more likely from a possible existing coordina-
tion between the two adhesion systems rather than a simple antiadhesion effect of Ep-
CAM. In epithelial cells a certain coordination between different adhesion systems was
demonstrated for keratinocytes, where an increase of in E-cadherin induces down-
regulation of β1-integrin (Hodivala et al., 1994). A similar coordination may exist bet-
ween other systems involved in intercellular adhesion, such as Ep-CAM and cadherins,
with E-cadherin in particular.
The molecular mechanisms behind the observed effect is not quite clear.
Expression of Ep-CAM did not affect the expression nor the number of the cadherin
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such as proliferating cells in hair follicles (Tsubura et al., 1992), cells of preneoplastic
lesions in the uterine cervix (Litvinov et al., 1996), colonic polyps (Salem et al., 1993), or
in intestinal metaplasia in gastric mucosa (this article). The previously reported associ-
ation of Ep-CAM expression with a poor prognosis in breast carcinoma patients
(Tandon et al., 1990), and our recent similar observations in patients with head and
neck cancer (Takes et al., 1997) as well as the increase in Ep-CAM expression from low to
high grade bladder carcinomas (Zorzos et al., 1995), indicate a possible role for Ep-
CAM in tumor progression.
The data presented in this paper demonstrate an interaction between Ep-CAM
and classic cadherin-based adhesion systems and suggest a cross-talk between adhe-
sions systems as a mechanism through which the strength of the intercellular adhesion
among epithelial cells may be regulated.
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fate, differentiation, and other biological characteristics [1,2]. Data are accumulating
that adhesion receptors do function not only as physical interconnectors between vari-
ous cell types and substrates, but represent an important group of signal-transducing
modalities, participating in tissue morphogenesis [3-7]. 
Cross-signaling between adhesion receptors is likely to be a common phenome-
non, being partly responsible for the orchestrated changes in the number and composi-
tion of cellular adhesion receptors during cell migration or differentiation. For exam-
ple, in keratinocytes undergoing terminal differentiation and stratification, a decrease
of β1-integrin expression is evidently related to an upregulation of E-cadherin, and is
negatively controlled by the formation of E-cadherin-mediated adhesions [8 -10].
Furthermore, the flexible and rapid changes of N-cadherin activity in migrating cells of
the neural crest were shown to be controlled by signals from β1 and β3 integrins [11].
Recently, β1-integrin expression was also reported to result in a decrease of total cadhe-
rin and α-catenin protein levels, together with redistribution of cadherin and α-catenin
from the detergent insoluble fraction to the detergent soluble fraction [12]. In mamma-
ry epithelial cells, blocking of β1 integrin was demonstrated to suppress the metastatic
potential of cells, likely by upregulating E-cadherin adhesions [13]. Lampe et al. [14]
demonstrated the subtle interactions in keratinocytes between α3β1, adhesion to lami-
nin-5, and Rho signaling, which promotes intercellular communication mediated by
gap junctions, while Braga described the impinge of the Rho family of small GTPases on
the regulation of cadherindependent adhesion and epithelial morphology [15]. 
We have previously demonstrated that the epithelial cell adhesion molecule Ep-CAM
negatively affects the cadherin-mediated adhesions in direct proportion to its expres-
sion levels [16]. Ep-CAM is a calcium-independent homophillic cell adhesion molecule
of 39-42 kDa [17,18] which is expressed by the majority of epithelial tissues, excluding
the adult squamous epithelium and some epithelium-derived cell types, such as hepato-
cytes [19,20]. However, de novo expression of Ep-CAM can be observed for these cell
types as well, during active cell proliferation in embryogenesis, or at the early stages of
tumorgenesis [19,21].
Ep-CAM does not structurally resemble any of the major families of the adhe-
sion molecules (cadherins, selectins, integrins, or cell adhesion molecules of the Ig
superfamily). It is a type I transmembrane glycoprotein, consisting of an extracellular
domain, containing two EGF-like repeats, and a short cytoplasmic domain of 26 amino
acids in which two binding sites for α-actinin are present (for review see Balzar et al.
[22]). α-Actinin is required to stabilize the intercellular adhesions mediated by Ep-
CAM, by connecting Ep-CAM to F-actin [23]. We have demonstrated that the cytoplas-
mic domain of Ep-CAM is required for its negative effect on cadherins [16]. Upon over-
expression of Ep-CAM, it was observed that cadherin adhesions dissociate, which leads
to accumulation of detergent-soluble E-cadherin/β- catenin complexes, and to a decre-
ase in total cellular α-catenin [16]. This may be the result of the E-cadherin/β-catenin
complex dissociating from α-catenin anchored to F-actin, or, alternatively, the total
and its disturbance during the development of a malignant phenotype 75
Expression of Ep-CAM shifts the state of cadherin adhesions from strong to weak without involvement of β-catenin
Chapter 4 
Expression of Ep-CAM shifts 
the state of cadherin adhesions 
from strong to weak without
involvement of β-catenin 
Exp Cell Res 2003, 285:50-58
Winter MJ, Nagelkerken B, Mertens AE, Rees-Bakker HA, Briaire-de Bruijn IH,
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Abstract
Various adhesion molecules play an important role in defining cell fate and
maintaining tissue integrity. Therefore, cross-signaling between adhesion receptors
should be a common phenomenon to support the orchestrated changes of cells’ connec-
tions to the substrate and to the neighboring cells during tissue remodeling. Recently,
we have demonstrated that the epithelial cell adhesion molecule Ep-CAM negatively
modulates cadherin-mediated adhesions in direct relation to its expression levels. Here,
we used E-cadherin/ α -catenin chimera constructs to define the site of Ep-CAM’s nega-
tive effect on cadherin-mediated adhesions. Murine L-cells transfected with either E-
cadherin/ α -catenin fusion protein, or E-cadherin fused to the carboxy-terminal half of
α-catenin, were subsequently supertransfected with an inducible Ep-CAM construct.
Introduction of Ep-CAM altered the cell’s morphology, weakened the strength of cell-
cell interactions, and decreased the cytoskeleton-bound fraction of the cadherin/cate-
nin chimeras in both cell models. Furthermore, expression of Ep-CAM induced restruc-
turing of F-actin, with changes in thickness and orientation of the actin filaments. The
results showed that Ep-CAM affects E-cadherin-mediated adhesions without involve-
ment of β-catenin by disrupting the link between α-catenin and F-actin. The latter is
likely achieved through remodeling of the actin cytoskeleton by Ep-CAM, possibly
through pp120.
Introduction
Various adhesion molecules that mediate cell’s interactions with the substrate
and the neighbouring cells are recognized to play an important role in defining the cell
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Antibodies
Depending on the expe-
rimental settings, E-cadherin
and its derivatives were detected
by either monoclonal antibody
(mAb) 36, recognizing the juxta-
membrane site of the cytoplas-
mic domain of E-cadherin
(Trans duction Laboraties,
Lexing ton, KY), or mAb ECCD2,
which has its epitope in the
extracellular domain (Thamer
Diagnostica BV, The Nether -
lands). mAb against β−catenin
and pp120 (both mouse) was
from Transduction Labora -
tories. mAb 323/A3 against
human Ep-CAM was from
Centocor Europe B.V., Leiden,
The Netherlands. Alexa-488-
conjugated phalloidin was from
Molecular Probes Europe B.V.,
Leiden, The Netherlands. Other
antibodies were to: (lysosomal
membrane proteins), LAMP1 (1D4B), and LAMP2 (ABL-93) (both were rat mAbs from
Hybridoma Bank). FITC-labeled lectin from Helix Pomatia Agglutinin (HPA) was from
Sigma, St. Louis, MO.
Cell dissociation and aggregation assay
For cell aggregation assays, cells growing in monolayers were washed with ice-
cold 25 mM HEPES in Hanks’ solution and detached by either 1.0% EDTA or 0.25%
trypsin/ 0.1% EDTA; 106 single cells were allowed to aggregate in 2 ml of normal DMEM
supplemented with 1% Nutridoma- SP in the presence of 1 mM CdCl2 during 2 h under
gentle gyration (75 rpm, 37°C, 5% CO2). 
For cell adhesion reformation assays, cells growing in monolayers were deta-
ched with 0.25% trypsin/0.1% EDTA and dissociated by gentle pipetting to monocellu-
lar suspension; 106 single cells were allowed to aggregate overnight in 2 ml of DMEM
supplemented with 1% Nutridoma-SP. The aggregates were resuspended 15 times.
Fractions before and after resuspension were fixed with 0.5% glutaraldehyde.
Aggregates were measured in a cell counter (Casy TCC; Schärfe Systems, Reultingen,
Germany).
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preexisting E-cadherin/β-catenin/α-catenin complex is eliminated from the surface
and destined for degradation via internalization, and the observed cytoplasmic E-cad-
herin/β-catenin complexes represent newly synthesized proteins. 
We used in this study cell lines transfected either with E-cadherin or with 
chimera proteins composed of E-cadherin directly linked to α-catenin [24]. Super -
transfection of Ep-CAM in these cell lines had a dramatic effect on (1) morphology, (2)
the aggregation ability of cells, (3) on subcellular localization, and (4) on the degree of
detergent extractability of chimera proteins. Both tested fusion molecules were affected
by expression of Ep-CAM, independent of the involvement β-catenin present in the
cadherin adhesions. Therefore, we suggest that Ep-CAM expression affects the link 
between α-catenin and F-actin within the E-cadherin-mediated adhesion complex as a
result of the Factin network being reconstructed, possibly through pp120.
Materials and methods
Cell culture
Murine fibroblast L-cells (clone L929) were from the American Type Culture
Collection (Rockville, MD). L-cells transfected with either fusion protein Eα or EαC
(see below) were developed earlier by Dr. A. Nagafuchi [24]. Selected clones were super-
transfected with full-length Ep- CAM. All cell lines were cultured in Dulbecco’s modi-
fied Eagle medium (DMEM), supplemented with 10% fetal bovine serum, 2 mM L-glu-
tamine and penicillin/streptomycin (all from GibcoBRL, Gaithersburg, MD) in a
humidified, 5% CO2, 37°C incubator. Although cells were stably transfected, 1 mg/ml
G418 and 1 mg/ml Hygromycin B were added to each eighth passage.
Constructs and transfections
L-cells transfected with a full-length E-cadherin (EL cells [17]), or Eα or EαC
constructs [24]. were used. The latter are hybrid molecules from E-cadherin and α-cate-
nin (see Table 1 and Figure 1A). In the Eαhybrid, the cytoplasmic tail of E-cadherin was
excised downstream of amino acid 657, and the remaining domains were fused to a full-
length α-catenin (amino acids 1-906). EαC was composed likewise, except that only the
C-terminal half of α-catenin (amino acids 509-906) was used in the hybrid (Figure 1A).
The constructs in the pBATEM vector were a kind gift from Dr. A. Nagafuchi [24]. and
transfected clones were selected at 1 mg/ml G418. 
Human Ep-CAM cDNA in pMep4 vector (Invitrogen, Leek, The Netherlands),
with metallothionein promoter, was used to supertransfect EL, EαL, EαCL as well as
parental L-cells (see table 1). Control cell lines were transfected with an empty vector.
DOTAP transfection reagent was used according to the manufacturer’s protocol
(Boehringer Mannheim, Mannheim, Germany). The transfectants were selected at 1
mg/ml Hygromycin B (Boehringer Mannheim) as previously described [23].
Manon Winter Co-ordination of epithelial junctional systems, 76
Chapter 4
TABLE 1 Nomenclature of transfected cell lines.
C O N S T R U C T S C E L L  L I N E S
pJΩ/ E-cadherin
pMep4/ - EL
pJΩ/ E-cadherin
pMep4/ wt Ep-CAM EL-Ep
pBATEM/ Eα
pMep4/ - EαL
pBATEM/ Eα
+ pMep4/ wt Ep-CAM EαL-Ep
pBATEM/ EαC
pMep4/ - EαCL
PBATEM/ EαC
+ PMEP4/ W T EP-CAM EαCL-EP
crylamide gel electrophoresis and were transferred electrophoretically onto PVDF
membrane (Millipore, Bedford, MA). The membranes were blocked with 5% skim milk
in PBS for 1 hr, incubated with a primary monoclonal antibody for 2 h, washed for 1 h in
PBS/0.05% Tween 20, and incubated for 1 h with an anti-mouse IgG horseradish peroxi-
dase (HRP) conjugate (Transduction Laboratories). The blots were developed using the
ECL detection substrate (Amersham Pharmacia Biotech, Buckinhamshire, UK).
Immunofluorescent microscopy
Overnight induced (10 μM CdCl2) cell cultures were rinsed three times with
ice-cold PBS/1 mM CaCl2/1 mM MgCl2, fixed either with cold methanol (15 min, -
20°C) or with paraformaldehyde (as previously described [23]). Fixed cells were rehy-
dratated with PBS, blocked with 5% skim milk in PBS, incubated with a primary mono-
clonal antibody for 2 h, washed with PBS, and incubated for 1 h with goat IgGs against
antibody isotypes (PickCell Laboratories BV, Amsterdam, The Netherlands), conjuga-
ted with Alexa-488 or Alexa-546 (Molecular Probes Europe, Leiden, the Netherlands).
Stained cells were analyzed by confocal microscopy (Zeiss LSM 510; Jena, Germany).
For analysis of the cytoskeleton, cells were permeablized with 0.3% Triton X-100 and
incubated for 1 h with 0.5 mM Alexa- 488-conjugated phalloidin (Molecular Probes). 
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Flow cytometry
Eighty percent density cultures were induced overnight with 10 μM CdCl2,
detached with 0.1% EGTA in Hanks’ buffer on ice, and counted; 106 cells were incubated
with 0.1 μg of the primary antibody for 30’, the Alexa-488- labeled respective IgG-speci-
fic conjugate (Molecular Probes Europe B.V.) for 30’, and propidium iodide solution 
(1 μg/ml) for 15’. Fluorescent intensity was measured for 104 events, using a
FACSCalibur Flow Cytometer (Becton Dickinson, San Jose, CA).
Detergent extraction, lysis of cells, and Western blot analysis
Overnight induced (10 μM CdCl2) cell cultures were rinsed with ice-cold 1 mM
CaCl2/1 mM MgCl2 in phosphate- buffered saline (PBS) and extracted with 50 mM
NaCl/10 mM Tris-HCl (pH 7.0) 1 mM CaCl2/1 mM MgCl2/ 300 mM sucrose/complete
protease inhibitor (Boehringer Mannheim)/1% Triton X-100. Cells were scraped and
gently shaken on ice for 45 min. Samples were collected and spun down (15 min, 15,000 g).
The detergent insoluble fraction was separated from supernatant (the detergent-soluble
fraction) and further lysed in hot 1% sodium dodecyl sulfate (SDS)/10 mM EDTA. For
total lysates, the cells were lysed in hot 1% SDS/10 mM EDTA immediately after rinsing.
Protein concentration in lysates was measured using Bio-Rad Dc Protein Assay
(Bio-Rad Lab, Hercules, CA). Samples of protein lysates were separated by SDS- polya-
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FIGURE 1 E-cadherin/α-catenin fusion proteins. 
(A) Schematic representations of the full-
length E-cadherin and the α-catenin
molecules. The binding domains (amino
acid numbers) for β-catenin (b), α-actinin
(a-A), pp120 (p120), and F-actin (F-a) are
indicated. The two lower schemes 
represent the fusion molecules Ea and
EaC. 
(B) Immunoblotting of cell lysates of 
L-cells transfected with blank vector (L),
full-length E-cadherin (EL), the E a 
construct (Eα L), or the EαC construct
(EαCL). The 120-kDa fulllength E-cadhe-
rin, 220-kDa Eα and 145-kDa EαC molecu-
les are indicated. Note that only the cells
with the full-length E-cadherin express 
β-catenin. 
(C) Detection by immunoblotting of 
Ep-CAM in the blank vector transfectants
(EαL and EαCL) and Ep-CAM cDNA 
transfectants (EαL-Ep and EαCL-Ep). “+”
indicates overnight incubation of 10 μM
CdCl2; “-”, no induction.
FIGURE 2 The cell morphology and aggregation capacity are changed after Ep-CAM introduction. 
(A) The mock transfectants EαL and EαCL show the tightly interconnected phenotype
expected for E-cadherin-mediated cell-
cell contacts, in contrast to the Ep-CAM-
transfected cells EαL-Ep and EαCL-Ep.
These cells are more loose and less spre-
ad, which was even enhanced upon
induction with 10 μM CdCl2 (EαL-Ep and
EαCL-Ep Magnification, 200x. 
(B) An enlarged detail of the cells shown
in A. 
(C) The results of aggregation of EαCL
and EαCL-Ep are shown. The graph repre-
sents the degree of 2-h aggregation in
the presence of calcium after EDTA
detachment. Aggregates are grouped by
diameter size: single cells, small aggre-
gates (20-40 μm), and large aggregates
(40-140 μm) 
(D) The panel shows the overnight aggre-
gation in DMEM/Nutridoma-SP after
trypsin/EDTA detachment (cells/RS,
resuspended) and subsequent 15’ resus-
pension. Aggregates are grouped by dia-
meter size: single cells, and small and
large aggregates.
Regulated expression of Ep-CAM in EαL and EαCL cell transfectants
L-cells, EL (full-length E-cadherin transfectants), EαL, and EαCL cells were
supertransfected with either the pMep4 vector only, or pMep4 containing the full-
length Ep-CAM cDNA (Table 1). The pMep4 vector contains the metallothionein pro-
motor, which can be induced by divalent heavy metal ions (i.e., Cd2+ or Zn2+). At least 10
selected clones were tested for Ep-CAM expression of Ep-CAM and the CdCl2 inducibi-
lity by Western blotting of total lysates (Figure 1C). The cDNA transcription is under
control of the methallothionein promoter and transcription can be enhanced by biva-
lent cations, and a stepwise expression of a molecule can be achieved by the following:
(1) the mock transfection (promoter only), (2) the transfection with “normal” tran-
scription Ep-CAM cDNA, and (3) the transfection after CdCl2 incubation resulting in
enhanced transcription of Ep-CAM cDNA. Membrane expression of Ep-CAM, and its
increase upon CdCl2 induction, was confirmed by flow cytometry (results not shown).
Ep-CAM affects cell-cell interactions in E-cadherin, Eα,and EαC trans-
fectants
Both Eα and EαC constructs did promote intercellular adhesion in L-cell cultu-
res, as was observed by the changes in cell morphology of the respective transfectants
(Figure 2A and B). Introduction of Ep-CAM in both EαL and EαCL cells resulted in a
change of cell culture morphology (Figure 2A and B): upon expression of Ep-CAM the
number of cell-cell interaction sites, as well as the areas of the cell membrane involved in
contact, became reduced. This effect was more pronounced upon enhancing expression
levels of Ep-CAM with 10 μM CdCl2. On average, Ep-CAM transfectants (both EαL-Ep
and EαCL-Ep) showed more membrane protrusions resembling filopodia. These mem-
brane protrusions were often observed in the full-length E-cadherin transfectants, but
not in cells transfected with the chimera constructs. None of the changes were observed
in the mock transfectants (EαL and EαCL) of both cell lines, either in the presence or
absence of CdCl2, providing evidence that the effects were specifically related to the
expression of Ep-CAM. 
To evaluate to what degree cell-cell interactions were affected in the cultures of
the Ep-CAM-expressing transfectants, the cells were subjected to an aggregation assay.
To leave the E-cadherin and Ep-CAM molecules intact, cells were detached by using
EDTA. Both EαL-Ep and EαCL-Ep cells were able to aggregate in the presence as well as
in the absence of calcium, although to a different extent (Figure 2C). The parental cells
E_L and E_CL did not aggregate in the absence of Ca2+. This confirms participation of
Ep-CAM in cell-cell adhesion of the transfectants.
The aggregates formed by Ep-CAM transfectants in the presence of Ca2+ diffe-
red in morphology from those formed by their respective parental cell lines (not
shown). No large aggregates were found to be formed by EL-Ep cells, whereas the oppo-
sing was observed for EL cells. No differences in structure of aggregates or aggregation
rate, however, were observed between EαCL and EαCL-Ep. This suggested that the
adhesions mediated by the chimeras were not affected by Ep-CAM. 
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Results
To investigate the molecular basis of the negative effect of Ep-CAM on E-cadherin-medi-
ated adhesions [16], L-cells were transfected with two chimerized molecules, Eα and
EαC, obtained by fusing E-cadherin and α-catenin, and supertransfected with Ep-C AM
(see material and methods section). Nomenclature of all transfected cell lines is summa-
rized in Table 1. As shown in Figure 1A, in both constructs the binding site for β-catenin
was excluded from the Ecadherin sequence. The binding site for β-catenin was still pre-
sent in the α-catenin fragment within the Eα construct, but not in the EαC construct. A
potential α-Actinin-binding site of α-catenin is present in Eα, but not in EαC. L-cells
stably transfected with the full-length E-cadherin were used as a control (EL; see Table 1).
Selected clones of L-cells transfected with Eα or EαC constructs showed
expression of both constructs, and were recognized by both anti-E-cadherin and anti-
α-catenin mAbs (see also Nagafuchi et al. [24]). Figure 1B shows the full-length E-cad-
herin (120 kDa) and the fusion proteins in the transfectants with their corresponding
molecular weights (200 and 145 kDa, respectively). A protein with a molecular weight
similar to the wild-type α-catenin was detected with anti-α-catenin antibody in Eα
transfectants, but it may represent a degradation product originating from the hybrid
molecule, as was reported earlier [24]. 
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FIGURE 3 Surface expression of the Eα and EαC fusion proteins after Ep- CAM introduction. 
(A) Flow cytometry analysis of living cells with the E-cadherin monoclonal antibody ECCD2
in mock and Ep-CAM transfectants. x-axis represents the mean fluorescence; y-axis repre-
sents the number of cells. 
(B) Western blots stained for E-cad-
herin in EαL and EαL-Ep, as well as
in EαCL and EαCL-Ep. 
(C) Differences in cytoskeleton-
bound and “free” E-cadherin/α−
caterin are represented as Triton X-
100-soluble and insoluble fractions.
Both soluble and insoluble fractions
of the two cell lines were stained for
the E-cadherin construct.
Upregulation of the soluble fraction
is found in both EαL-Ep and induced
EαL-Ep, as well as in EαCL-Ep and
induced EαCL-Ep+, while the insolu-
ble fraction is decreased.
Everywhere: “+” indicates overnight
incubation of 10 μM CdCl2; “-”, no
induction.
was observed, representing adherens junctions [28-30]. Upon Ep-CAM introduction,
this staining pattern turned into a diffuse cytoplasmatic staining, whereas Ep-CAM was
localized on the membrane (EαL-Ep and EαCL-Ep; Figure 4A). Several previous studies
demonstrated that Ep-CAM was localized mainly at the membrane, where it is involved
in intercellular homotypic adhesions [17,23,30]. 
Judging from the fluorescent intensity of staining for E-cadherin in various cell
compartments, most of the Eα molecules in EαCL-Ep cells can be observed in the perin-
uclear zone, while in EαCL it is still present at cell-cell junctions (Figure 4B, indicated by
arrows). Double staining for lysosomal membrane glycoprotein (LAMP1 or LAMP2)
and E-cadherin in the EL and EαCL-Ep cells did not show any colocalization (results not
shown). To investigate whether the intracellular staining reflects newly synthesized pro-
teins, cells were probed with lectin from Helix Pomatia (HPA), but no colocalization
was found for the EαC protein and HPA. (results not shown). Since HPA binds to glyco-
silated groups of synthesized proteins in the trans Golgi network, the intracellular stai-
ning for E-cadherin/α-catenin molecules probably does not reflect their de novo syn-
thesis. The perinuclear presence of the molecules probably represents an internal
(storage) compartment for proteins internalized from the plasma membrane [31]. but
remains to be studied.
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Detaching cells with trypsin/EDTA damages E-cadherin but not Ep-CAM molecules,
and therefore the reformation of cadherin-mediated adhesions from intracellular
pooled cadherins in the presence of fully active Ep-CAM is measured in such an
aggregation assay. The cadherins are fully recovered after 10 h, as was seen by immu-
noblotting for the intact and trypsin-digested cadherins (not shown). Cells aggrega-
ting for an extended time after trypsin/EDTA digestion allows the cadherin adhesion
to be reformed when the Ep-CAM mediated adhesions are already established.
Overnight aggregation of EL and EL-Ep in the presence of Ca2+ showed a similar
aggregation profile as was observed with EDTA detachment (Figure 2D). EαCL and
EαCL-Ep both showed enhanced capability to aggregate compared to EL and EL-Ep
and their aggregation profile was almost identical. However, the aggregates formed
by EαCL-Ep cells could easily be dissociated by pipetting in contrast to the aggregates
formed by EαCL.
Reformation of E-cadherin-mediated cell-cell contacts by intracellularly poo-
led proteins was more affected by Ep-CAM expression after trypsin/EDTA digestion,
compared to the same cells detached with only EDTA. Newly assembled E-cadherin-
mediated adhesions in EαCL-Ep differ in the presence of Ep-CAM from those establis-
hed in parental cells. Despite the equal aggregation rate of EαCL and EαCL-Ep cells, the
adhesion is much weaker in Ep- CAM transfectants.
Expression of Ep-CAM results in internalization of Eα and EαC 
molecules
Since expression of Ep-CAM results in the abrogation of E-cadherin-mediated
adhesions, the total expression level of the Eα and EαC molecules was analyzed in the
presence of different levels of Ep-CAM. Flow cytometry analysis showed no decreased
membrane expression of both Eα and EαC fusion proteins (Figure 3A). Upregulation of
Ep-CAM by CdCl2 induction did not affect the expression level of Eα, neither did the
addition of CdCl2 itself to the control cell lines. The expression levels of Eα or EαC pro-
teins in total lysates remained equal upon low and high Ep-CAM expression when
Western blotted and probed with E-cadherin (Figure 3B) and α-catenin (not shown)
antibodies. 
It has been shown for E-cadherin that a distinction can be made by Triton X-100
extraction between the cytoskeletonanchored fraction and the fraction stored in cyto-
plasmic depots, or floating at the cell membrane [25-27]. Therefore, to discriminate
functional E-cadherin molecules (meaning E-cadherin that is anchored to the actin ske-
leton) from the nonfunctional pools, the cells were extracted with 1% Triton X-100.
Western blotting showed increasing amounts of extractable Eα and EαC, in direct pro-
portion to Ep-CAM expression levels (Figure 3C).
Immunofluorescent stainings confirmed that Ep-CAM abrogates the Eα and
EαC chimera-mediated adhesions. To track down the subcellular distribution of both
constructs, EαL and EαCL as well as EαL-Ep and EαCL-Ep were stained for E-cadherin.
In EαL and EαCL cells, typical E-cadherin “spike-like” intercellular membrane staining
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FIGURE 4 Intracellular localization of Ea and EaC hybrids.
(A) EαCL and EαCL-Ep stained for E-cadherin show a different localization pattern. Upon Ep-
CAM expression (EαCL-Ep), the membranous spike-like expression observed in EaCL cells
has shifted to a diffuse intra-
cellular pattern. 
(B) Intensity for E-cadherin
staining was calculated to a
rainbow pallet; black repre-
sents no fluorescence and
white the highest fluorescent
intensity. Arrowheads indica-
te the highest intensity of E-
cadherin-positive staining at
cell-cell boundaries in EαCL
cells, while most E-cadherin
staining was found in the
cytoplasm in EαCL-Ep cells. 
unknown regulatory molecules are unable to dock, thereby leaving normal regulation
and feedback mechanisms incomplete. 
In summary, pp120 colocalized with both E-cadherin and EαC, also when Ep-
CAM was expressed. Ep-CAM expression increased the total expression levels of pp120,
but CdCl2-upregulated expression of Ep-CAM did not result in additional increased
pp120 expression levels.
Ep-CAM expression results in cytoskeletal rearrangements 
Proper anchoring of the chimera constructs would require at least binding of the
α−catenin domain to F-actin or to other unknown anchor points. To investigate whether
the overexpression of Ep-CAM is accompanied by the rearrangements of the cytoskele-
ton, the transfectants were stained with fluorochrome-conjugated phalloidin (Figure 6). 
Interestingly, transfection of Eα or EαC constructs had different effects on the
organization of F-actin in L-cells. The Eαconstruct in L-cells induced the formation of a
very diffused cytoskeleton with some cortical actin; the transfection of the EαC con-
struct in L-cells induced an astral arrangement of actin filaments. Introduction of Ep-
CAM in both EαL and EαCL clearly changed the actin organisation. In EαL-Ep, Ep-
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Ep-CAM expression results in rearrangement of the cadherin-
mediated junctions
Since the cell morphology and aggregation assays demonstrated that Ep-CAM
can affect EαC molecule in EαCL-Ep cells, we investigated the effect of Ep-CAM on the
catenin-like molecule pp120. pp120 can bind E-cadherin at the juxtamembrane domain
and is capable of regulating cadherin-mediated adhesions [32]. In Figure 5A, cells are
stained for pp120 (green) and E-cadherin or EαC (red). Colocalization was observed for
EL and EαCL. Upon Ep- CAM introduction, E-cadherin was still present at the plasma
membrane in EL-Ep; colocalizing with pp120; however, more pp120 was found in the
cytoplasm of the cells, compared to EL. In EαCL-Ep cells, EαC and pp120 molecules
colocalized to a lesser extent than in EαCL, and some cells showed cytoplasmic pp120.
Western blots probed for pp120 showed substantial differences between EL/EL-Ep and
EαCL/ EαCL-Ep (Figure 5B). An upregulation in pp120 expression levels was detected
in EαCL-Ep compared to EαCL, while a slight decrease of its total cellular level was
found in EL-Ep compared to EL. That EαC, in contrast to full-length E-cadherin, does
not increase the amount of pp120 remains unexplained. In contrast to the full-length E-
cadherin molecules, EαC chimeras are functionally challenged, since several known and
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FIGURE 5 Localization of components of the cadherin junction. 
(A) Double stainings for pp120 (green) and E-cadherin (red) in L-cells expressing full-length
the E-cadherin (EL) or the EαC chimera (EαCL) upon Ep-CAM expression (EL-Ep and EαCL-
Ep). From each picture a box with zoom is placed next to the scanned overview. 
(B) Western blot of total cell
lysates of parental L-cells (L), 
L-cells expressing full-length E-
cadherin (EL), L-cells expres-
sing the EαC fusion protein
(EαCL), and these cells, trans-
fected with Ep-CAM, were pro-
bed for pp120 and E-cadherin
(E-cad). Expression of Ep-CAM
was induced by addition of
CdCl2 (+). 
FIGURE 6 Cytoskeletal changes upon expression of Ep-CAM. Actin stainings of L-cells expressing the 
fusion proteins (EαL and EαCL) show an altered actin cytoskeleton upon Ep-CAM expression
(EαL-Ep and EαCL-Ep). Cortical actin has disappeared and actin fibers are condensed in both
Ep-CAM transfectants
(EαL-Ep and EαCL-Ep)
compared to the mock
transfectants (EαL
and EαCL).
Ep the reduction is substantional. The increase in small aggregates in resuspended
EαCL-Ep may be accounted for by the Ep-CAM-Ep-CAM cell adhesions taking over. 
In this study, actin stainings showed that expression of Ep-CAM led to cytoskeletal rear-
rangements in all cell lines described, although the exact character of F-actin rearrange-
ments varied between the studied models. Data have been accumulating, showing that
RhoA, Rac1, and Cdc42 mediate cytoskeletal dynamics and thereby regulate cadherin
activity [44,45]. Adaptor protein Shc or adaptor molecule IQGAP1, an effector of Rac1
and Cdc42, are unlikely to affect Eα or EαC molecules upon activation of Ep-CAM,
since the interaction epitopes are absent in the chimeras [34,38,41]. However, an inverse
correlation between RhoA activity and noncadherin-bound pp120 was demonstrated
for fibroblasts and CHO cells [46,47]. Furthermore, it was shown that selective uncoup-
ling of pp120 from E-cadherin destroys the strong adhesion mediated by E-cadherin
[32,48]. The binding site for pp120 is available in the fusion proteins Eα and EαC
[24,46]. From our results, it is possible to conclude that signaling from Ep-CAM to E-
cadherin involves pp120. Upon Ep-CAM expression, both E-cadherin and EαC fusion
molecules were detected intracellularly. Total levels of pp120 are elevated in EαCL-Ep
cells, but not in EL-Ep cells compared to their control cells (EαCL and EL), and more
pp120 is found to be in the cytoplasm. These data suggest involvement of pp120 upon
Ep-CAM expression, thereby changing RhoA activity.
In summary, E-cadherin-mediated cell-cell adhesions are abrogated by expres-
sion of Ep-CAM, without involvement of the regulating molecule β-catenin. Ep-CAM
affects the E-cadherin-mediated adhesion indirectly by disrupting the link between α-
catenin and F-actin, likely by modulating the organization of the latter, involving
pp120. Studies are currently being performed to examine which molecules are involved
in the communication pathway between E-cadherin and Ep-CAM.
Acknowledgments
We greatly appreciate Dr. A. Nagafuchi (Department of Cell Biology, Kyoto
University, Kyoto, Japan), for providing the Eα and Eα C constructs.
References
[1]. G.M. Edelman, A golden age for adhesion, Cell. Adhes. Commun. 1(1993) 1-7.
[2]. B.M. Gumbiner, Cell adhesion: the molecular basis of tissue architecture and morphogenesis,
Cell 84 (1996) 345-357.
[3]. M. Takeichi, Cadherin cell adhesion receptors as a morphogenic regulator, Science 251 (1991)
1451-1455.
[4]. C. Rosales, V. O’Brien, L. Komberg, R. Juliano, Signal transduction by cell adhesion receptors,
Biochimica et Biophysica Acta 1242 (1995) 77-98.
[5]. L. Kjoller, A. Hall, Signaling to Rho GTPases [review], Exp. Cell Res. 253 (1999) 166-179.
and its disturbance during the development of a malignant phenotype 87
Expression of Ep-CAM shifts the state of cadherin adhesions from strong to weak without involvement of β-catenin
CAM expression led to the disappearence of the cortical actin, which was replaced by
fibers concentrating in the area of the nucleus. In the EαCL-Ep cells, enlongated stress
fibers along the cell body were observed. Although understanding the mechanism
requires further investigation, Ep-CAM expression is likely to result in signaling events
leading to rearrangement of the F-actin network.
Discussion
Cell-cell adhesions in epithelial cells, primarily those formed by E-cadherin, are closely
involved in regulation of cell proliferation, differentiation, and migration [7,33]. We
have previously demonstrated that expression of Ep-CAM, another epithelial cell-cell
adhesion molecule, is capable of abrogating the cadherin-mediated cell-cell junctions
[16]. This study aimed to find the interaction site in E-cadherin complexes that is affected
by Ep-CAM expression. Using hybrid molecules of E-cadherin and α-catenin, several
mechanisms regulating cadherins can be bypassed, since several binding domains are no
longer present (Figure 1). Expression of Ep-CAM did affect the junctions mediated by
the shortest E-cadherin/ α-catenin construct. Ep-CAM introduction changed cell mor-
phology of EαL and EαCL cells to a more loose and less spread phenotype of EαL-Ep and
EαCL-Ep cells (Figure 2A and B). The chimera EαC lacks binding sites for α-actinin, Shc,
and β-catenin, and therefore for IQGAP1 [34-39]. Thus, it is likely that the key for regula-
ting E-cadherin complexes by Ep-CAM must be found either at the juxtamembrane
domain of E-cadherin, or at the carboxy-terminal half of α-catenin. This may demon-
strate a pathway for Ep-CAM to regulate E-cadherinmediated junctions, which excludes
β-catenin and regulation of its binding to E-cadherin of α-catenin.
Despite that pathways involving β-catenin are recognized as the main regulating
pathways for the E-cadherinmediated adhesion, it is not unlikely that E-cadherin can be
affected via molecules other than β-catenin [40-42]. Ecadherin- mediated adhesions can
exist in a weak or a strong state, and it has been proposed that the shift of E-cadherin
mediated adhesion from the weak to strong state does not require β-catenin [41]. It was
shown that a weak state of cadherin-mediated adhesion in EαC-transfected L-cells was
easily destroyed by repetitive pipetting, concomitant wit increased levels of tyrosine
phosphorylation of proposedly cytoplasmic ezrin, radixin, and/or moesin proteins [43].
Results presented here show that repetitive pipetting of Ep-CAM-transfected
EαCL cells, EαCL-Ep, can destroy the cell-cell adhesions in aggregates in the presence of
Ca2+, suggesting that E-cadherin-mediated contacts had shifted from a strong to a weak
state upon Ep-CAM expression. E-cadherin that was attracted from intracellular pools
during overnight aggregation in DMEM/Nutridoma-SP did reduce the number of large
aggregates in EL, compared to EL-Ep, a phenomenon observed between EαCL and
EαCL-Ep as well (Figure 2D). The E-cadherin may be pooled intracellularly, and can be
recycled to the membrane and be available for junction formation [31]. Resuspension of
EL and EαCL resulted in a slight reduction of large aggregates, but in EL-Ep and EαCL-
Manon Winter Co-ordination of epithelial junctional systems, 86
Chapter 4
[20]. C.J. Boer de, H. Krieken van, C.M. Janssen-van Rhijn, S.V. Litvinov, Expression of Ep-CAM in nor-
mal, regenerating, metaplastic and neoplastic liver, J. Pathol. 188 (1999) 201-206.
[21]. C.J. Boer de, R. Sharon, H. Krieken van, S.V. Litvinov, Dramatic changes in organization of cell-
cell adhesions related to development of intestinal metaplasia in gastric epithelium, Am. J. Pathol.
(1999), in press.
[22]. M. Balzar, M.J. Winter, C.J. Boer de, S.V. Litvinov, The biology of the 17-1A antigen (Ep-CAM)
[review], J. Mol. Med. 77 (1999) 699-712.
[23]. M. Balzar, H.A.M. Bakker, I.H. Briaire-de Bruijn, G.J. Fleuren, S.O. Warnaar, S.V. Litvinov,
Cytoplasmic tail regulates the intercellula adhesion function of the epithelial adhesion molecule,
Mol. Cell. Biol. 18 (1998) 4833-4843.
[24]. A. Nagafuchi, S. Ishihara, S. Tsukita, The roles of catenins in the cadherin-mediated cell adhe-
sion: functional analysis of E-cadherin/ _-catenin fusion molecules, J. Cell Biol. 127 (1994) 235-245.
[25]. M.S. Kinch, G.J. Clark, C.J. Der, K. Burridge, Tyrosine phosphorylation regulates the adhesions of
ras-transformed breast epithelia, J. Cell Biol. 130 (1995) 461-471.
[26]. A. Skoudy, A. Garcia de Herreros, The protein kinase C activator TPA modulates cellular levels and
distribution of E-cadherin in HT-29 human intestinal epithelial cells, FEBS Lett. 374 (1995) 415- 418.
[27]. B.R. Francis, L.A. Bulla Jr., Further characterization of BT-R1, the cadherin-like receptor for
Cry1Ab toxin in tobacco hornworm (Manduca sexta) midguts, Insect Biochem. Mol. Biol. 27 (1997)
541-550.
[28]. M. Itoh, S. Yonemura, A. Nagafuchi, S. Tsukita, S. Tsukita, A 220-kDa undercoat-constitutive
protein: its specific localization at cadherin-based cell-cell adhesion sites, J. Cell. Biol. 115 (1991)
1449-1462.
[29]. S. Tsukita, S. Tsukita, A. Nagafuchi, S. Yonemura, Molecular linkage between cadherins and
actin filaments in cell-cell adherens junctions, Curr. Opin. Cell Biol. 4 (1992) 834-839.
[30]. M. Balzar, P.A. Prins, H.A.M. Bakker, G.J. Fleuren, S.O. Warnaar, S.V. Litvinov, The structural ana-
lysis of adhesions mediated by Ep-CAM, Exp. Cell Res. 246 (1999b) 108-121.
[31]. T.L. Le, A.S. Yap, J.L. Stow, Recycling of E-cadherin: a potential mechanism for regulating cadhe-
rin dynamics, J. Cell Biol. 146 (1999) 219-232.
[32]. S. Aono, S. Nakagawa, A.B. Reynolds, M. Takeichi, pp120ctn acts as an inhibitory regulator of
cadherin function in colon carcinoma cells, J. Cell Biol. 145 (1999) 551-562.
[33]. B.M. Gumbiner, Regulation of cadherin adhesive activity, J. Cell. Biol. 148 (2000) 399-403.
[34]. Y. Imamura, M. Itoh, Y. Maeno, S. Tsukita, A. Nagafuchi, Functional domains of _-catenin requi-
red for the strong state of cadherin-based cell adhesion, J. Cell Biol. 144 (1999) 1311-1322.
and its disturbance during the development of a malignant phenotype 89
Expression of Ep-CAM shifts the state of cadherin adhesions from strong to weak without involvement of β-catenin
[6]. X.D. Ren, W.B. Kiosse, M.A. Schwartz, Regulation of the small GTP-binding protein Rho by cell
adhesion and the cytoskeleton, EMBO J. 18 (1999) 578-585.
[7]. V.M.M. Braga, The crossroads between cell-cell adhesion and motility, Nature Cell Biol. 2 (2000)
E182-E184.
[8]. K.J. Hodivola, F.M. Watt, Evidence that cadherins play a role in the downregulation of integrin
expression that occurs during keratinocyte terminal differentiation, J. Cell Biol. 124 (1995) 589-600.
[9]. N.A. Hotchin, A. Gandarillas, F.M. Watt, Regulation of cell surface _1 integrin levels during kerati-
nocyte terminal differentiation, J. Cell Biol 128 (1995) 1209-1219.
[10]. V.M.M. Braga, K.J. Hodivala, F.M. Watt, Calcium-induced changes in distribution and solubility
of cadherins, integrins and their associated cytoplasmic proteins in human keratinocytes, Cell
Adhes. Commun. 3 (1995) 201-215.
[11]. F. Monier-Gavelle, J.L. Duband, Cross talk between adhesion molecules: control of N-cadherin
activity by intracellular signals elicited by _1 and _3 integrins in migrating neural crest cells, J. Cell
Biol. 137 (1997) 1663-1681.
[12]. C. Gimond, A. Flier van der, S. Delft van, C. Brackebusch, I. Kuikman, J.G. Collard, R. Fa¨ssler, A.
Sonnenberg, Induction of cell scattering by expression of _1 integrins in _1-deficient epithelial cells
requires activation of members of the Rho family GTPases and down regulation of cadherin and
catenin function, J. Cell Biol. 147 (1999) 1325-1340.
[13]. G.E. Plopper, S.Z. Domanico, V. Cirulli, W.B. Kiosses, V. Quaranta, Migration of breast epithelial
cells on laminin-5: differential role of integrins in normal and transformed cell types, Breast Cancer
Res. Treat. 51 (1998) 57-69.
[14]. P.D. Lampe, B.P. Nguyen, S. Gil, M. Usui, J. Olerud, Y. Takada, W.G. Carter, Cellular interaction of
integrin _3_1 with laminin 5 promotes gap junctional communication, J. Cell Biol. 143 (1998) 1735-1747.
[15]. V.M. Braga, Epithelial cell shape: cadherins and small GTPases, Exp. Cell Res. 261 (2000) 83-90.
[16]. S.V. Litvinov, M. Balzar, M.J. Winter, H.A.M. Bakker, I.H. Briaire- de Bruijn, F. Prins, G.J. Fleuren,
S.O. Warnaar, Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated
by classic cadherins, J. Cell Biol. 139 (1997) 1337-1348.
[17]. S.V. Litvinov, H.A.M. Bakker, M.M. Gourevitch, M.P. Velders, S.O. Wamaar, Evidence for a role of
the epithelial glycoprotein 40 (Ep- CAM) in epithelial cell-cell adhesion, Cell. Adhes. Commun. 2
(1994a) 417-428.
[18]. S.V. Litvinov, M.P. Velders, H.A.M. Bakker, G.J. Fleuren, S.O. Wamaar, Ep-CAM: a human epitheli-
al antigen is a homophilic cellcell adhesion molecule, J. Cell Biol. 125 (1994b) 437-446.
[19]. S.V. Litvinov, W. Driel van, C.M. Rhijn van, H.A.M. Bakker, H. Krieken van, G.J. Fleuren, S.O.
Wamaar, Expression of Ep-CAM in cervical squamous epithelia correlates with an increased prolifera-
tion and the disappearance of markers for terminal differentiation, Am. J. Pathol. 148 (1996) 865-875.
Manon Winter Co-ordination of epithelial junctional systems, 88
Chapter 4
Chapter 5 
Downregulation of Ep-CAM
induces growth retardation 
and terminal differentiation of
squamous carcinoma cells
Abstract
The squamous carcinoma cell lines UMSCC2 and -22B, derived from a head
and neck carcinoma, are both highly proliferative in vitro and tumorigenic in vivo.
These cells express high levels of Ep-CAM, a cell adhesion molecule of normal simple,
transitional and pseudostratified epithelia, but not of squamous epithelia, where its
expression is associated with preneoplastic changes or malignancy. To investigate the
role of Ep-CAM in cell-cell adhesion, anti-sense mRNA constructs for Ep-CAM were
introduced in UMSCC2 and -22B cells. 
Transfectants expressing the anti-sense constructs showed a remarkable mor-
phological change resembling squamous/terminal differentiation. As compared to the
mock transfectants, the antisense construct has markedly suppressed the number of Ep-
CAM molecules in cells. Suppression of Ep-CAM resulted in relocation of E-cadherin
and β-catenin to the cell-cell junctions and anchorage of the E-cadherin junctional
complex to the cytoskeleton. Retardation of cell proliferation and expression of involu-
crin and cytokeratin 13, markers for terminal and squamous differentiation respective-
ly, were observed. 
These results suggest that suppression of Ep-CAM expression in carcinoma cell
lines augments E-cadherin mediated adhesions, and promotes the expression of squa-
mous differentiation markers.
Introduction
Tissue development and remodelling, as well as various physiological and
pathological processes, are governed by cell-cell adhesion and interactions of cells with
the extracellular matrix and basement membrane.
E-cadherin is one of the major constituents of the adherens junctions formed in
epithelial cells. Via α-catenin and β-catenin it is associated with the actin cytoskeleton,
and in this way mediates cell-cell adhesion, the rigid structure of epithelial tissues, and
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Materials and Methods
Cell culture
The cell lines used in this study, UMSCC-2 and UMSCC-22B derived from a
head and neck squamous carcinoma (U2 and U22B, University of Massachusetts
Squamous Carcinoma Cell line clone 2 and 22B), were kindly provided by Dr. E
Schuuring (Dept. of Pathology, Groningen, the Netherlands). Parental and transient
transfected cells were cultured in DMEM supplemented with 10% fetal bovine serum, 2
mM L-glutamine, 50 U/ml penicillin, 50 μg/ml streptomycin (all purchased from
GibcoBRL, Gaithersburg, MD) in a humidified incubator at 37˚C with 5% CO2.
Constructs
The 150 bp antisense construct of Ep-CAM was derived from a PCR product of
150 bp from the wild type human Ep-CAM (nt 141 - 272, including the ATG; Genbank
accession number M76124). The PCR product used in this study was cloned into two
inducible expression vectors: the pIND/pVgRXR system for transcient expression, or
into pTracer/cmv2, for tracing the construct in transfected cells by expressing green flu-
orescent protein (GFP, all from Invitrogen, San Diego CA). 
For transient expression, the PCR product was cloned in the antisense orienta-
tion into the multiple cloning site of pInd, and the resulting construct was cotransfected
with pVgRXR for transient expression. Transcription of the antisense Ep-CAM was
induced upon 24 hrs incubation with MuristeroneA (Invritrogen).
To locate and trace the construct, the PCR product was cloned in the antisense
orientation into the pTracer/cmv2 according to the manufacturer’s recommendations.
Transfection
For all transfections, cells were plated in 6-wells plates and grown over-night to
a 30% confluency with mostly single cells. Cells were incubated with 15 (g DNA con-
struct, for 2 days using Fugene6TM transfection reagent (Boehringer) according to the
manufacturer’s recommendations. 
The pInd/pVgRXR transfected clones were selected by neomycin (G418, Gibco
BRL), the pTracer transfected cells were not selected, but traced with GFP. To enhance
transcription of the construct in the pInd/pVgRXR system, 25 μM MuristeroneA
(MuA) was added 72 hours prior to experiments. 
Detergent extractions, cell lysis, and Western blot analysis
Cells were grown to 75% density, left on ice for 10 minutes and rinsed with ice-
cold PBS/1mM CaCl2 /1mM MgCl2. For extraction, cells were incubated with 0.5%
Triton-X-100 in extraction buffer (50 mM TrisHCl, pH7.4, 100 mM NaCl, 1 mM CaCl2,
1 mM MgCl2, 300 mM sucrose, 1 tablet complete protease inhibitor (Boehringer
Mannheim), gently scraped from the dish, collected and rotated for 30 minutes at 4˚C.
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epithelial cell polarity (for review see Gumbiner, 2000). In various malignant tissues, a
causal relationship exists between loss of E-cadherin mediated adhesions and malig-
nancy [StCroix et al., 1998; Perl et al., 1998]. Loss of either E-cadherin expression or
function renders the cell more invasive and tumorigenic, in particular in squamous car-
cinoma [Takeichi et al., 1995; Schipper et al., 1991].
Another epithelial cell-adhesion molecule, Ep-CAM, is expressed in nearly all
epithelia like simple, transitional and pseudostratified, but not in mature squamous
epithelium (for review see Balzar et al., 1999; Winter et al., 2003). In squamous epitheli-
um, it is de novo expressed upon malignancy, from the early stages on, as we have shown
for cervical tissues. With tumor progression, more areas of the tissue are expressing 
Ep-CAM, indicating the association with proliferation, while differerentiation is lost or
decreased [Litvinov et al., 1996]. Expression of Ep-CAM is associated with a proliferati-
ve cellular phenotype. Studies in liver development showed that Ep-CAM is downregu-
lated upon maturation of cells [De Boer et al., 1999]. Previously, we have demonstrated
that in vitro introduction of Ep-CAM by transfection with human Ep-CAM, abrogates
the E-cadherin mediated adhesions, resulting in decrease of total cellular α-catenin
expression levels [Litvinov et al., 1997]. These results suggest the existence of an inverse
correlation between Ep-CAM and E-cadherin mediated adhesions.
These E-cadherin suppressing properties of Ep-CAM indicate that upon malig-
nant transformation of cells, Ep-CAM may contribute to both the proliferative epitheli-
al as well as the malignant phenotype. Furthermore, a developmentally regulated
expression and function of Ep-CAM was found in pancreatic islet ontogeny, showing an
inverse correlation between expression of Ep-CAM and functional differentiation of
cells [Cirilli et al., 1998]. Moreover, a phenomenon of Ep-CAM regulating tissue deve-
lopment and differentiation was demonstrated in the mammary gland of transgenic
mice overexpressing Ep-CAM [Balzar et al., 2001]. Compared to non-transgenic litter-
mates, the mammary glands of transgenic mice show a hyperplastic phenotype after ter-
mination of lactation, probably because of inhibited involution. Likely, as a regulator of
cadherins, Ep-CAM is crucial in tissue development, normal or abnormal with respect
to cell growth, differentiation and motility. 
In this study we present evidence that suppression of Ep-CAM expression by
antisense constructs results in augmentation of E-cadherin mediated adhesions, and
the cells tend to differentiate towards a squamous, terminal differentiation state, as
shown by expression of cytokeratin 13 and involucrin respectively. 
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Morphological changes upon Ep-CAM downregulation
The squamous carcinoma cell lines U2 and U22B used in this study, show relati-
vely high (U2) or intermediate (U22B) levels of Ep-CAM expression. Introduction of
the 150 bp antisense Ep-CAM construct in U2 cells resulted in a pronounced effect on
the morphology of these cells (Figure 1A). The U2/AS cells were much larger as compa-
red to mock transfectants, with more cytoplasma and more polarized orientation.
Furthermore, in U2/AS cells, vacuoles were present, and an increased cell death was
observed.Confluency was substantionally delayed in the U2/AS, suggesting a reduced
proliferation rate (data not shown). 
Cell surface levels of Ep-CAM in mock, pInd-transfected and MuA induced
transfected U2 cells were measured quantitatively by flow cytometric analysis (Figure
1B). Using the pInd system, transcription of the antisense construct was induced with 0,
10 or 25 μM MuA incubation. Upon 10 μM MuA, the Ep-CAM expression on the cell
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The samples were collected and spun down (15 minutes, 15000 rpm). The detergent
insoluble fraction (pellet) was separated from the supernatant and further lysed in
100°C SDS buffer (1% SDS, 10 mM EDTA, 10 mM TrisHCl pH7.4, 1 tablet complete
protease inhibitor). For total protein lysate, cells were lysed in hot-SDS buffer immedia-
tely after rinzing. Protein concentrations in lysates were measured using Bio-Rad DC
Protein Assay (Bio-Rad Lab., Hercules, CA), for equalized loading of the individual
samples.
Lysates were size fractionated by SDS/PAGE and semi-dry blotted onto polyv-
inyl difluoride membrane (Millipore, Bedford, MA). Filters were blocked for 1 hour in
5% skim milk, incubated with a primary antibody for two hours, washed in PBS/ 0.05%
Tween-20, and incubated for 1 hour with an anti-mouse IgG HRP-conjugate
(Transduction Laboratories, Lexington, KY). The filter was developed with ECL detecti-
on substrate (Amersham Pharmacia Biotech, Buckinghamshire, UK).
Immunofluorescence Microscopy
Cell cultures transfected with the pIND vector were incubated 72 hours with 25
μM MuA to induce transcription. Then they were rinsed with ice-cold PBS / 1mM
CaCl2/1mM MgCl2 and fixed with either cold methanol (15 minutes, -20°C) or 4%
paraformaldehyd (as previously described; Balzar et al., 1999b) and air-dried. Fixed
cells were re-hydrated with PBS, blocked with 5% skim milk in PBS, incubated with a
primary antibody for 2 hours, followed by 1 hour incubation with fluorchrome-conju-
gated IgGs. Cells were examined by confocal microscopy (Zeiss LSM 510, Jena,
Germany). For analysis of the cytoskeleton, pTracer transfected cells were incubated for
1 hour with 4% paraformaldehyde, and membranes were permeabilized using 0.5%
TritonX-100/PBS and incubated with TRITC-labeled phalloidin (Molecular Probes
Europe B.V., Leiden, the Netherlands).
Antibodies
Ep-CAM was detected with mAb 323/A3 (Centocor Europe BV, Leiden, NL), E-
cadherin with mAb HECD-1 (Thamer Diagnostica BV, Uithoorn, NL), β-catenin with
clone 14 (Transduction Lab., Lexington, KY), involucrin with clone SY5 (Sigma-Aldrich
Chemie Gmbh, Steinheim, Germany), and ck13 with clone 1C7 (Thamer Diagnostica
BV). For cytoskeletal stainings, TRITC-labeled phalloidin was used (Sigma-Aldrich).
Results
Ep-CAM is de novo expressed during tumorgenisis in squamous carcinomas of the head
and neck tissues [Winter et al., 2003]. The carcinoma cell lines UMSCC-2 and -22B (U2
and U22B) were derived from tumors and are highly proliferative in vitro, as well as
highly tumorigenic in vivo. They display relatively high (U2) or intermediate (U22B)
levels of Ep-CAM expression, and express various types of classic cadherins at the sites
of cell-cell contacts, of wich mainly E-cadherin.
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FIGURE 1 A: Phase contrast microscopic photographs of transciently transfected U2 cells. The 
highly proliferative and tumorgenic mock transfectant cells (U2/mock) are small and have
relatively little cytoplasm. Upon downregulation of the Ep-CAM expression by 
72 hrs incubation with MuA, the antisense transfectant cells (U2/AS) are larger with 
relatively more cytoplasm and are more polarized (U2/AS). 
B: Flow cytometric analysis of Ep-CAM expression in Ep-CAM antisense transfected U2 cells
and transcription induction by 0, 10, or 25 μM MuA incubation for 72 hours. C: Westen blot
analysis for Ep-CAM expression in total lysates of mock transfected and Ep-CAM antisense
(AS) transfected U2 cells after 72 hour incubation with 0, 10, or 25 μM MuristeroneA.
suppression of Ep-CAM in these cell has forced the cells from proliferation towards dif-
ferentiation state. Immunofluorescence microscopical analysis showed that both the
terminally differentiation marker involucrin and the squamous differentiation marker
cytokeratin 13 (ck13) were observed in U2/AS cells, while immunostaining for involu-
crin and ck13 was absent in the parental cells (Figure 3B). 
These results indicate that upon downregulation of Ep-CAM, a more differen-
tiated phenotype can be induced in squamous carcinoma cells. The cells resemble in a
way the normal differentiation of squamous cells in vivo.
Cytoskeletal rearrangements upon Ep-CAM downregulation
Previously, we demonstrated that Ep-CAM expression can shift the balance of
GTPase activity within epithelial cells from Rho to Rac activity (Winter et al., unpublis-
hed results). The cytoskeletal rearrangments were studied upon downregulation of Ep-
CAM in U2 and U22B cells. U22B cells display a more organized phenotype and are the-
refore more suitable for cytoskeleton studies. Therefore, the results for U2 cells are not
shown. 
The U22B cells were transfected with the mock or antisense Ep-CAM
pTracer/cmv2 plasmid construct. so transfectants can be identified with confocal
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membrane was decreased. This effect was more pronounced upon induction with 25
μM MuA. These results show that Ep-CAM surface expression can be reduced by this
antisense construct and the reduction is induced dose dependently. 
Samples of equalized protein concentration were Western blotted and showed a
dose-dependent reduction in expression levels for Ep-CAM upon MuA induction
(Figure 1C). No effects were observed for the mock transfected cells.
Augmentation of adherens junctions in cells with decreased level of
Ep-CAM
Whether the reduction in surface expressed Ep-CAM has any effect on the E-
cadherin expression was tested in Western blotting. 80% confluent cell cultures were
overnight incubated with the antisense construct with or without incubation with 25
μM MuA (pIND-system). Samples were equalized for protein concentration and
Western blotted. Figure 2A shows that the total levels of Ep-CAM may be reduced, but
the total amount of E-cadherin expression remained unchanged (Figure 2A).
However, immunofluorescence staining showed an increased presence of E-
cadherin at the cell membrane in the U2/AS as compared to the parental cell line (Figure
2B). Relatively more Ep-CAM was present in the cytoplasm and the amount of Ep-CAM
at the cell membrane was decreased. Most striking was the induction of classical E-cad-
herin mediated adhesions. The observed staining pattern resembled the typical ‘spike-
like’ cadherin staining pattern. The reduced staining intensity was the result of the E-
cadherin molecules being engaged in cell-cell adhesions, i.e. the binding epitope for the
antibody was no longer available. In paralel, a substantial portion of the β-catenin was
detected at the cell membrane in the typical spike-like staining. For proper E-cadherin
mediated adhesions, the presence of β-catenin is required in the adherens juntion com-
plex. Immunofluorescent staining of the parental cells showed the presence of β-catenin
at the cell membrane and in the cytoplasm, in U2/AS a punctate staining and relocation
of β-catenin along the cell membrane was observed. The β-catenin was mostly present
in the ‘spike-like’ pattern at the cell membrane, i.e. probably in cadherin-mediated junc-
tions. The cytoplasmic pools of β-catenin (ready for degradation?) were more or less
reduced. Reduced expression levels of Ep-CAM augmented the presence of β-catenin at
the cell membrane, indicating that E-cadherin and β-catenin are structurally involved
in cell-cell adhesions in U2/AS. 
Downregulation of Ep-CAM induces terminal differentiation
To distinguishes between cytoskeleton bound and non-bound E-cadherin, cell
cultures were extracted with detergent. Western blotting of lysates with equal amounts
of total protein showed that the expression of the insoluble fraction of E-cadherin (i.e.
cytoskeleton bound Kinch et al., 1995; Skoudy 1995; Francis et al., 1997) increased dra-
matically in the Ep-CAM suppressed cells (Figure3A). 
Western blotting for the terminally differentiation marker involucrin showed
an increased expression level in the Ep-CAM antisense transfectants, suggesting that the
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FIGURE 2 A: Western blot analysis for total 
lysates of transiently transfected,
72 hours 25 μM MuA incubated U2
cells (pInd vector). Upon decrea-
sed Ep-CAM expression in U2/AS,
the total amount of E-cadherin
remained equal in both U2/mock
and U2/AS. 
B: Immunofluorescent stainings
of transiently transfected, 72
hours 25 μM MuA incubated U2
cells (pInd vector). Confluent cell
cultures were stained for 
Ep-CAM, E-cadherin (Ecad), and 
β-catenin (β-cat).
1999; Winter et al., 2003]. Therefore, the question was raised, whether the malignant
phenotype could be reverted in vitro by downregulating Ep-CAM in a squamous car-
cinoma cell line. 
The transfection of Ep-CAM antisense constructs in U2 cells resulted in decrea-
sed Ep-CAM expression, affecting altered cell morphology. Immunofluorescent stai-
nings showed that downregualtion of Ep-CAM resulted in the reappearance of E-cad-
herin and β-catenin in cell-cell adhesions. The total level of expression of E-cadherin
remained equal in both mock and antisense transfection models, but extraction experi-
ments showed an increased level of cytoskeleton-bound E-cadherin, confirming that E-
cadherin is involved in adhesions when Ep-CAM expression is downregulated.
Another important phenomenon, is the ‘re-differentiation’ capacity of the cells
upon Ep-CAM downregulation. Positive staining for terminal and squamous differen-
tiation markers involucrin and cytokeratin 13 (ck13) were vitually absent in mock
transfectants, but were clearly expressed in the antisense transfectants. From our results
it is unclear whether the expression of ck13 and involucrin is induced by cell-cell adhe-
sions mediated by E-cadherin, or simply due to the absence of Ep-CAM expression.
Further research is required to detect similar effects in vivo. 
Immunofluorescent stainings for cytoskeleton structure showed a difference
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microscopy by GFP. TRITC-conjugated phalloidin stainings of both U2 and U22B mock
transfectants, showed two different cytoskeleton compostions as opposed to Ep-CAM
antisense transfectants (Figure4, results for U2 not shown). In U22B, most actin was
observed in the cortical areas of the cell where junctions are formed with neighbouring
cells, while stress fibers formation is induced upon Ep-CAM suppression. These obser-
vations suggest that the balance of GTPase activity is shifted upon either lack of Ep-
CAM expression, presence of E-cadherin expression, or both.
Discussion
While in normal adult squamous epithelium Ep-CAM expression is absent, in cervical
intraepithelial neoplasia de novo expression was detected which is correlated with the
severity of the lesion [Litvinov et al., 1996]. The increased expression of 
Ep-CAM was associated with activated proliferation, as was shown by co-expression of
the proliferation marker Ki-67 [Litvinov et al., 1996]. Furthermore, overexpression of
Ep-CAM was observed in carcinomas derived from simple epithelium [Balzar et al.,
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FIGURE 3 A: Cells were extracted with TritonX-100 to separate the cytoskeleton bound portion 
from the non-cytoskeleton bound fraction. The triton-insoluble fraction represents the
cytoskeleton bound fraction. Western blot analysis for the insoluble E-cadherin and involu-
crin in transiently transfected,
72 hours 25 μM MuA incubated
U2 cells (pInd vector). Upon
decreased Ep-CAM expression in
U2/AS, both cytoskeleton bound
E-cadherin, as well as the squa-
mous differentiation marker
involucrin are increased. 
B: Immunofluorescent stainings
of transiently transfected, 72
hours, 25 μM MuA incubated U2
cells (pInd vector). Confluent
cell cultures were stained for
cytokeratin 13 (ck13) and involu-
crin.
FIGURE 4 Actin staining of U22B cells, stable transfected with mock or Ep-CAM antisense (AS). 
Using the pTracer plasmid system, positively transfected cells appear as green cells. Actin
was stained by incubation with TRITC-labelled phalloidin incubation (red). In U22B / mock
transfectants, merely cortical actin was observed. Upon downregulation of the Ep-CAM
expression (AS), long and thick stress fibers are formed.
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between the mock and antisense transfected cells, and it is generally known that the
family of small GTPases regulate the structure of the epithelial cytoskleton. The inducti-
on of stress fibers in U22B/AS cells is in line with observations by others in epithelial cells
when Rho activity is induced [Braga et al., 200a; Takaishi et al., 1995]. Stress fiber forma-
tion suggests Rho activity in the cells, and the cell status must have changed upon Ep-
CAM suppression. As previously described, Ep-CAM and E-cadherin expression and
the activity of the small Rho GTPases are tightly regulated. Rac activation caused disas-
sembly of cadherin junctions in normal human keratinocytes in a time and concentra-
tion dependent manner [Williams et al., 1997]. Transfection of constitutively active Rac,
V12Rac, in MCF10A carcinoma cells decreases E-cadherin activity, as well as Ras trans-
formation decreased cell-cell adhesion in several cell types (for review see Braga et al.,
2000b). On the other hand, Rho activity is required for the establishment of E-cadherin
based cell-ell adhesion [Braga et al., 200a,b; Takaishi et al., 1995]. GTPases are involved
in cytoskeletal rearrangements upon signals for proliferation, cellular adhesions and
migration [Braga et al., 2000a; Williams et al., 1997]. In Drosophila, decreased p120 acti-
vity results in accumulation of Rho1 at sites of cadherin based adhesions [Magie et al.,
2002]. In vitro, α-catenin and p120 co-immunoprecipitate with Rho1 [Magie et al.,
2002]. Ep-CAM expression may shift the GTPase balance within cells towards Rac activi-
ty [Winter et al., unpublished results]. and Ep-CAM (indirectly) inhibits binding of
pp120 to E-cadherin [Winter et al., 2003]. Downregulation of Ep-CAM with antisense
constructs is likely to shift the GTPase activity balance from Rac activity to Rho activity.
We have demonstrated that E-cadherin mediated adhesions can be shifted from a strong
to a weak state and vice versa, requiring actin cytoskeletal rearrangements [Winter et al.,
2003]. These rearrangements are likely to involve Ep-CAM expression, since Ep-CAM is
capable of shifting E-cadherin adhesions when truncated E-cadherin is chimerized to α-
catenin [Noren et al., 2000]. In the chimerized Eα molecules where α-catenin is directly
linked to the extracellular and transmembranal domein of E-cadherin, the binding site
for pp120 in E-cadherin is still present, allowing Rho and pp120 to regulate cytoskeleton
and E-cadherin junctions [Anastadiadid et al., 2000; Nagafuchi et al., 1994; Winter et al.,
2003]. Our results of the cytoskeletal stainings of mock and antisense transfected U22B
cells indicate that downregulation of Ep-CAM by antisense constructs may not only
augment E-cadherin cell-cell contacts, but also affects the downstream processes. The
balance of the GTPase activity has shifted from Rac activity to Rho activity. 
In summary, results presented here show the possibility to downregulate 
Ep-CAM expression in carcinoma cell lines and thereby reversing the malignant pheno-
type. Both restoration of E-cadherin mediated adhesions and squamous differentiation
are observed in this model when Ep-CAM transcription is downregulated. The future
strategies of treatment of epithelial cancer may include the use of antisense contructs.
The treatment of colorectal cancer has been shown clinically effective by administration
of antibodies (edecrolomab) directed against Ep-CAM [Riethmuller et al., 1998].
Further research is needed to establish whether the use of antisense constructs is more
targeted and more effective. 
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Cadherins are regulated by 
Ep-CAM via activation of 
phosphaditylinositol-3 kinase
Mol Cell Biochem 2007, 302:19-26
Winter MJ, Cirulli V, Biaire IB, Litvinov SV.
Abstract
The cross-signaling between (cell) adhesion molecules is nowadays a well
accepted phenomenon and includes orchestrated cellular changes and changes in the
microenvironment. For example, Ep-CAM is an epithelial adhesion molecule that pre-
vails in active proliferating tissue and is suppressed in a more differentiated state of the
cell. E-cadherin adhesion complexes are typical for the advanced and terminal differen-
tiated cell status. During normal proliferation, E-cadherin is not suppressed. We have
demonstrated the effect of overexpression of Ep-CAM on E-cadherin, which probably
affects the connection of cadherins and F-actin. Phosphatidylinositol 3-kinase (Pi3K)
participates in various regulating mechanisms, for example in signaling to nuclei, vesi-
cle transport, and cytoskeletal rearrangements. 
The effect of Ep-CAM on E-cadherin mediated junctions as well as the involve-
ment of Pi3K in regulating adherens junctions, led us to investigate the potential inter-
action between Pi3K and Ep-CAM. Introduction of Ep-CAM in the epithelial cells cau-
sed abrogation of N-cadherin mediated cell-cell adhesion, which could be inhibited by
Pi3K inhibitor LY294002. Moreover, the Pi3K subunit p85 was precipitated with Ep-
CAM from cell lysates, and this complex showed kinase activity. The Pi3K activity shutt-
led from N-cadherin to Ep-CAM.
From our results, we conclude that Ep-CAM cross signaling with N-cadherin
involves Pi3K, resulting in the abrogation of the cadherin adhesion complexes in epithe-
lial cells.
Introduction
The maintainance of tissue integrity is a complex and dynamic process, requi-
ring a balance between a variety of signaling pathways. Responding to external signals
requires many secondary pathways within the cells in order to respond accurately and in
a coordinated fashion [Alahari et al., 2002]. Disturbances in these pathways could lead
to dramatic dysfunctioning of the cell, for example carcinogenesis. Diagnosis of early
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Material and methods
Cells, constructs and cell culture
Human breast epithelial cells HBL100 (clone HCA, kindly provided by 
Dr. Hilkens, The Netherlands Cancer Institute, Amsterdam. The Netherlands) were
trans iently transfected with full length human Ep-CAM cDNA that was subcloned into
the pMep4 vector (Invitrogen BV., Leek, the Netherlands), using the HindIII/Bgl restric-
tion sites [Litvinov et al., 1997]. The contruct is placed under the control of the methal-
lothionin promotor, which can be induced by divalent heavy metal ions (e.g. Cd2+or
Zn2+). This allows a stepwise expression of Ep-CAM. Transfection was performed with
FugeneTM6 Transfection Reagent (Boehringer Mannheim, Mannheim, Germany) and
selected by 1 mg/ml Hygromycin B (Boehringer Mannheim), as described earlier
[Litvinov et al., 1997]. 
For total-Akt and phospho-Akt blots, cells were serum starved overnight, and
re-administered 2% foetal bovine serum during 8 hours in the presence or absence of
CdCl2 or 25 μM LY294004 (LY) before lysing. CdCl2 induces the transcription of 
Ep-CAM, LY294004 inhibits the Pi3K activity.
Antibodies and chemicals
The monoclonal antibodies anti-N-cadherin (clone #32), anti-E-cadherin
(clone #36), anti-α-catenin, anti-β-catenin and anti-p85 were obtained from
Transduction Laboratories (Lexington, KY). Polyclonal antibodies against total-Akt
and phospho-Akt are from Cell Signaling Tech. (Beverly, MA). The monoclonal antibo-
dy 323/A3, directed against Ep-CAM, was kindly provided by Centocor B.V., the
Netherlands. Secondary antibodies for immunoblotting were labeled with HRP
(Tansduction Laboratories) and for immunofluorescent stainings isotype specific anti-
bodies were labeled with either Alexa-488, Alexa-546 (Molecular Probes Europe BV,
Leiden, the Netherlands) or Cy-5 (PickCell, Amsterdam, the Netherlands). 
For immunoprecipitations, Protein G Sepharose beads from Amersham were
labeled (Amersham Pharmacia Biotech, Buckinhamshire, UK). At least 16 hours prior to
fixation or lysis of cells, 25 μM LY294002 (Biomol Research Laboratories Inc., Plymouth
Meeting, PA) was added to the culture medium to inhibit Pi3K. Ep-CAM expression in
transfected cells was enhanced by overnight incubation of 10 or 25 μM CdCl2. 
Immunoprecipitation
Cells were grown to 80% density and overnight induced (25 μM CdCl2). The
procedure was followed as described previously [Balzar et al., 1998], using TritonX100,
β-octyl glucopyranoside or CHAPS as detergents.
Detergent extraction, total lysates and Western Blot analysis
For extraction, overnight induced (25 μM CdCl2) cell cultures were rinsed with
ice-cold 1 mM CaCl2/ 1 mM MgCl2 in PBS and extracted with 1% TritonX-100 or 50 mM
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pathological development is very difficult. First, insight and understanding of the
disturbed regulating pathways is required.
Ep-CAM is an adhesion molecule that is expressed in all simple, pseudostrati-
fied epithelia, but not in mature squamous epithelia. It is strongly associated with cellu-
lar proliferation in vitro as well as in vivo [Litvinov et al., 1996]. Tumors originating
from epithelial cells over-express or express de novo Ep-CAM. De novo expression is
already detected in the precursors of carcinomas of squamous epithelium, where Ep-
CAM expression serves as an early marker [Litvinov et al., 1996; Winter et al., 2003]. 
Phosphatidylinositol 3 kinase (Pi3K) is an ubiquitous enzyme involved in many
intracellular signal transduction pathways. It participates in various regulating mecha-
nisms, for example in cytoplasmic- to nuclear signaling, vesicle transport, cytoskeletal
rearrangements and CD28-B7 outside-inside signaling [Alahari et al., 2002; Cefai et al.,
1996; Fukui et al., 1998]. Important target molecules are the small Rho GTPases, which
are involved in cytoskeletal organisation. Cytoskeleton (re-) arrangement results in sig-
naling to integrins and cadherins. Ras/GTP, activated by growth factors, promotes Pi3K
activity and thereby inhibits apoptosis [Marshall 1996]. The Pi3K protein consists of an
85 kDa and a 110 kDa subunit. The p85 subunit is recognized as being the regulatory
subunit, while the p110 subunit employs the actual kinase activity that converts plasma
membrane lipid PIP2 into PIP3. 
E-cadherin adhesion complexes are typical for the advanced and terminal diffe-
rentiated cell status. The Ep-CAM expression in epithelia inversely correlates with cad-
herin-mediated junction complexes. In vitro studies demonstrated that cadherin-
mediated adhesions are abrogated upon Ep-CAM introduction, probably by affecting
the connection between cadherin adhesion complexes and F-actin [Litvinov et al., 1997;
Winter et al., 2003]. This results in reversing the E-cadherin-induced epithelial pheno-
type of L-cells into a mesenchymal phenotype [Litvinov et al., 1996,1997]. Our in vivo
studies revealed a regulated expression of Ep-CAM in pancreatic islet ontogeny [Cirulli
et al., 1998]. During maturation of the pancreatic islet-like cells, Ep-CAM expression
decreases and simultaneously the (endocrine) differentiation increases. Pi3K was
demonstrated to negatively regulate the differentiation in human foetal pancreatic cells
[Ptasznik et al., 1997]. In cells expressing cadherin, cytoskeletal rearrangements are
observed upon Ep-CAM introduction [Winter et al., 2003]. These rearrangements may
be the result of involvement of small GTPases or Pi3K.
The results described here, show that signaling between Ep-CAM and cadhe-
rins involves activation of Pi3K.
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mock transfectant (promotor only, HMC), 2) transfectant with ‘normal’ transcription
(HME), and 3) transfectant with enhanced expression (HME + 25 μM CdCl2) [Balzar et
al., 1998]. Cell surface expression of Ep-CAM was measured by flow cytometry analysis
(Figure 1A). 
Cross-signaling between E-cadherin and Ep-CAM has previously been demon-
strated to involve the connection between cadherin-mediated cell-cell junctions and F-
actin [Balzar et al., 1998; Winter et al., 2003]. Cytoskeletal rearrangements are observed
upon Ep-CAM introduction in cells expressing N-cadherin (Figure 1B). In HME cells,
the actin cytoskeleton is concentrated in the cortical area, in contrast to HMC cells
where more fibers can be found. 
Co-immunoprecipitation for N-cadherin (Figure 1C) or Ep-CAM showed that
the Pi3K regulatory subunit, p85, shuttles between cadherin and Ep-CAM; most p85 is
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CHAPS in extraction buffer as described previously [Balzar et al., 1998]. The samples were
collected and spun down (15’, 15000 rpm). The detergent-insoluble fraction of cells was
separated from supernatant (the detergent-soluble fraction), and further lysed in hot 1%
SDS/ 10 mM EDTA. For total lysates, the cells were lysed in hot lysis buffer immediately
after rinsing off the culture medium with ice-cold 1 mM CaCl2/ 1 mM MgCl2 in PBS. 
Protein concentrations in homogeneous lysates were measured using Bio-Rad
DC Protein Assay (Bio-Rad Lab., Hercules, CA). For all Western blots, 10 μg of homo -
genous lysate was loaded per lane of the 10% SDS-gel, representing equal protein load
per lane while avoiding control stainings [Balzar et al., 1998; Litvinov et al., 1997; Winter
et al., 2003]. Proteins were separated by SDS/PAGE, and transferred electrophoretically
onto PVDF-membrane (Millipore, Bedford, MA). The membrane was stained as descri-
bed previously [Litvinov et al., 1997]. The blots were visualized using the ECL detection
substrate (Amersham). 
Pi3K activity assay 
The Pi3K activity of anti-p85 immunoprecipitates was analyzed as described
previously [Ptasznik et al., 1997].
Briefly, aliquots of cell lysates normalized for protein content were incubated
with anti-Ep-CAM antibodies and absorbed onto protein A-Sepharose and washed. The
reaction was carried out for 10 min in a buffer that also contained 10 μg of PI (Avanti Polar
Lipids, Alabaster, AL) and 10 μCi [γ-32P]. ATP (6,000 Ci/mmol; DuPont/NEN, Wil -
mington, DE). After the incubation, the reaction was stopped with methanol plus 2.4 N
HCl (1:1, vol/vol), and lipids were extracted, and analyzed by thin-layer chromatography.
Confocal Microscopy
Cells at 80% density and overnight induced (25 μM CdCl2) were washed with
ice-cold 1 mM CaCl2/ 1 mM MgCl2 in PBS, and fixed during 15 minutes with -20°C
methanol and allowed to dry. Cells were blocked with 5% skim milk in PBS, the primary
monoclonal antibody was incubated for 1 hour, followed by an hour incubation with an
fluorochrome labeled secondary antibody. 
For actin staining, cells were fixed for 1 hour in 4% paraformaldehyd, permea-
bilized with 0.3% TritonX-100 [Balzar et al., 1998]. and incubated with TRITC-labeled
phalloidin (Sigma-Aldrich Chemie Gmbh, Steinheim, Germany). After drying, cells
were mounted and examined by confocal microscopy (Zeiss LSM 510, Jena, Germany).
Results 
Pi3K switches between Ep-CAM and N-cadherin
The breast epithelial cell line HBL100 was transiently transfected with pMep4
plasmids containing either wt Ep-CAM cDNA, HME, or empty vector, HMC. cDNA
transcription under control of the methallothionin promotor can be enhanced by incu-
bation with divalent cations. This enables a 3-step increase in expression level by 1) the
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FIGURE 1 Expression of Ep-CAM in HbL100 cells. 
A: Flow cytometry analysis of mock
(HMC) and Ep-CAM transfected HbL100
cells (HME). The mock transfected cells,
HMC, did not express Ep-CAM at the
cell surface (white). The Ep-CAM
expression was detected in HME (grey),
which was increased upon overnight
incubation with CdCl2 (black) 
B: F-actin staining of overnight CdCl2
induced HMC and HME cells, using
TRITC-conjugated phalloidin. In HME
cells, the actin cytoskeleton is concen-
trated in the cortical area, in contrast
to HMC cells, where more fibers can be
found 
C: 10 μg of homogenous lysate was loa-
ded per lane of the 10% SDS-gel, repre-
senting equal protein load per lane.
Western blotting total lysates of HMC
and HME and probed for N-cadherin,
Ep-CAM and the Pi3K subunit p85. Cell
cultures were lysed after overnight
incubation with CdCl2 and LY. P85
shuttled between N-cadherin and Ep-
CAM. In HMC cells, p85 precipitated
with N-cadherin. Upon Ep-CAM intro-
duction, HME cells, p85 now precipita-
ted with Ep-CAM. 
D: Immunoprecipitation for Ep-CAM
and p85 on high (H) or low (L) density
cell cultures, and Western blotted for
Ep-CAM and p85. P85 and Ep-CAM only
co-precipitated in HME cells from high
densed cultures.
complexed with N-cadherin in HMC cells, while in Ep-CAM expressing HME cells, the
precipitation complex with N-cadherin has ‘lost’ most of the p85 molecules.
Immunoprecipitation with Ep-CAM only precipitated molecules in the Ep-CAM
expressing HME cells, where p85 has appeared in the complex. Interestingly, performing
the immunoprecipitation for Ep-CAM on high (95%) or low (15%) density cell cultures,
p85 and Ep-CAM only co-precipitated in HME cells from high density cultures (Figure
1D). 
Effect of Ep-CAM on N-cadherin can be blocked by LY
Western blotting of total lysates of HMC, HME, and HME + CdCl2 cells showed
that the amount of the regulatory subunit of Pi3K, p85, had not changed in these cells
(Figure 2A). Pi3K inhibitor LY294004 (LY) incubation resulted in a slight decrease of
total N-cadherin in both HMC + CdCl2 and HME + CdCl2. Ep-CAM expression was
strongly upregulated in HME + CdCl2 cells, but upon LY incubation the total expression
of Ep-CAM had decreased.
Immunofluorescent staining for N-cadherin and α-catenin showed that these
molecules were present at the cell-cell boundaries in HMC, most likely in cadherin-
mediated adhesion complexes (Figure 2B). The cadherin mediated adhesion complex
had turned more diffuse in HME cells, where Ep-CAM was expressed. Upon LY incuba-
tion, the N-cadherin and α-catenin re-located to the cell plasma membrane, showing
the ‘spike’-like staining pattern in HME + CdCl2/LY, while Ep-CAM had left the cell-cell
boundaries.
Ep-CAM transcription and expression in cell cultures (80% monolayer) were
induced with 10μM CdCl2. Cells were subsequently incubated with 25 μM Pi3K inhibi-
tor LY. Cells were CHAPS detergent extracted before lysing them, allowing discrimina-
tion between the soluble and insoluble proteins. Figure 2C shows the soluble fraction
that represents the cadherins and catenins that are not bound the cytoskeleton, i.e. not
complexed in cell-cell adherens junctions. As a lysate, the soluble fractions of CHAPS
extracted cells (i.e. non-bound to F-actin) were Western blotted and stained for N-cad-
herin, p85, Ep-CAM, β-catenin and α-catenin. Per lane, 10 μg of each homogenous lysa-
te was loaded, representing equal protein load per lane while avoiding control stainings.
Figure 2C demonstrates that the N-cadherin, β-catenin and α-catenin levels had increa-
sed upon CdCl2 enhanced Ep-CAM (Figure 2C). Only the soluble fraction of cadherins
and catenins increased while the total amount remained unchanged (not shown, see
[Litvinov et al., 1997]). The increased proteins in the soluble fraction indicates that
more cadherin junctional complexes are disconnected from the cytoskeleton upon Ep-
CAM introduction, and not the result of increased cadherin and catenin expression (the
total amount of cadherins and cadherins did not change). By blocking Pi3K activity by
LY incubation, levels of soluble N-cadherin, β-catenin and α-catenin decreased,
although Ep-CAM expression levels were still high. 
It is plausible that Ep-CAM, which is associated with proliferation both in vitro
and in vivo [Litvinov et al., 1996], regulates epithelial cell differentiation via the
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FIGURE 2 Abrogation of N-cadherin mediated adhesions. 
A: 10 μg of homogenous lysate was loaded per lane of the 10% SDS-gel, representing equal
protein load per lane. Western blotting of total lysates of CHAPS extracted HMC and HME
cell cultures after CdCl2 and/ or LY incubation, stained for N-cadherin, Ep-CAM and p85. In
HME cells, LY incubation decreased the high Ep-CAM expression levels. 
B: Immunofluorescent staining of HMC and HME for Ep-CAM, α-catenin and N-cadherin
after incubation with CdCl2 and LY. Ep-CAM expression in HME cells, abgrogated the pre-
sence of N-cadherin and α-catenin at the cell-cell boundaries. In these same HME cell, inhi-
bition of Pi3K by LY, resulted in re-location of N-cadherin and α-catenin at the cell-cell
boundaries 
C: Western blotting of the soluble fraction of CHAPS extracted HMC and HME cell cultures
after CdCl2 and/ or LY incubation, stained for N-cadherin, Ep-CAM, Pi3K subunit p85, β-cate-
nin and α-catenin. The soluble fraction represents the cadherins and catenins that are not
bound the cytoskeleton, i.e. not complexed in cell-cell adherens junctions. In HME cells, the
soluble fraction of Ep-CAM increased upon LY incubation, while the soluble fractions of β-
and α-catenin decreased. 
D: Western blotting for total Akt and phosphorylated Akt (P-Akt) in HMC and HME total
lysates after serum starvation and subsequent addition of FBS, CdCL2 and LY. In serum star-
ved HMC and HME cells (first lanes of both) there was hardly any phos-phorylated Akt
detectable. Addition of FBS induced the p-AKT in HMC and HME, and upon increased
expression of Ep-CAM (CD induced), more P-AKT was detected in HME. This increase in P-
Akt in HME was only partially partially blocked by LY, although the levels of P-Akt in HME
appeared to be decreased more than in HMC.
Pi3K is associated with Ep-CAM
Immunoprecipitations with the Pi3K regulatory subunit, p85, using different
cell lysing buffers, demonstrated that Ep-CAM is present in the precipitated complex
(Figure 3A). 
It remained unclear whether this Ep-CAM/p85 complex included the Pi3K sub-
unit p110 that employes the kinase activity. Therefore, a kinase activity assay was perfor-
med (Figure 3B): The Ep-CAM/p85 complex was precipitaed with the anti-Ep-CAM
antibody and subsequently incubated with 32-P labeled ATP and PI. If the Ep-CAM/p85
complex would have kinase activity, this would result in the formation of PI3P, while no
PI3P was formed when precipitated with a control antibody.
Discussion
Cross-signaling between cadherins and other adhesion molecules is a common pheno-
menon [Alahari et al., 2002]. Ep-CAM expression is associated with proliferation and
inhibits epithelial differentiation [Cirilli et al., 1998; De Boer et al., 1997; Litvinov et al.,
1997]. In a previous study we showed that the communication between Ep-CAM and E-
cadherin does not involve the regulatory molecule β-catenin [Winter et al., 2003]. Ep-
CAM abrogated the E-cadherin-mediated adhesion complex by disrupting the connec-
tion between α-catenin and the actin cytoskeleton. An identical response to Ep-CAM
introduction was found for N-cadherin [Balzar et al., 1998]. Since this is not the result of
a physical interaction, one or more other molecules have to be involved [Winter et al.,
2003]. In the present study, we show that cross- signaling between Ep-CAM and classical
cadherins involves the Pi3K signaling pathway. This was already suggested by the fact
that Rac/Pi3K activation induced disassembly of cadherin- mediated adhesions. The
same findings have been described for Ep-CAM expression [Braga et al., 2000; Litvinov
et al., 1994; Potempa et al., 1998]. As previously described, both Ep-CAM and p85, the
regulatory subunit of Pi3K, are capable to bind α-actinin, although under different con-
ditions [Balzar et al., 1998; Shibasaki et al., 1994]. Our results demonstrating co-preci-
pation of Ep-CAM and p85 suggest for the first time that these molecules do interact.
Furthermore, our results indicate that this complex has kinase activity. Both Ep-CAM
and E-cadherin mediated adhesions are localized at the basal-lateral membrane and
mediate cell-cell contacts by themselves. Ep-CAM also regulates cadherin-mediated
adhesions, which might be modulated by shuttling of p85. Nelson et al. reported that
Pi3K activity is required for cell-cell contact induced proliferation, which in line with
our results [Nelson and Chen 2002]. 
Pi3K activation promotes the cell entering the S phase of the cell cycle and Pi3K
activation promotes cellular changes that are characteristic of premalignant transfor-
mation [Klippe et al., 1998]. Ep-CAM is associated with proliferation both in vitro and
in vivo and was de novo expression was demonstrated in adult squamous carcinomas
[Litvinov et al., 1996; Winter et al., 2003a]. Akt has been shown to repress transcription
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Pi3K/Akt signaling pathway. To validate the active state of Pi3K, the level of phosphory-
lation of Pi3K substrate, Akt, was measured. Serum-starved HMC and HME were
Western-blotted for total Akt and phosphorylated Akt (P-Akt, Figure 2D). Total lysates
of both HMC and HME hardly showed any P-Akt. Addition of 2% serum had activated
Pi3K, as can be concluded from the increase in P-Akt per 10 μg in both HMC and HME.
Incubation with CdCl2, which enhanced the expression of Ep-CAM in HME, increased
the level of P-Akt in HME, as compared to serum-induced HME cells. This increase of
Pi3K activity could partially be blocked by LY, although the levels of P-Akt in HME
appeared to have decreased more than in HMC. Since equal protein concentrations were
blotted and the total levels of Akt did not change, this demonstrates Pi3K activity as a
result of Ep-CAM expression. 
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FIGURE 3 Ep-CAM and Pi3K in signaling. 
A: 10 μg of homogenous lysate was loaded per lane of the 10% SDS-gel, representing equal
protein load per lane. Immunoprecipitation with Pi3K subunit p85 in lysates of several
detergents, and blotted for p85 and Ep-CAM. OGP: β-octyl glucopyranoside. Ep-CAM is pre-
sent in the precipitated com-
plex 
B: Kinase activity assay for
precipitates from HMC and
HME. The formation of PI3P in
HME cells is the result of kina-
se activity in the Ep-CAM/p85
complex (lane 1; precipitate
with anti Ep-CAM antibody),
while no PIP3 was formed
when precipitated with a con-
trol antibody (lane 2; anti-
IgG).
motility and/or invasive capacity. Disturbed regulation of these molecules may result in
increased metastatic capacity, possibly by affecting the small Rho GTPases and thereby
inducing cytoskeletal rearrangments. 
It can be concluded from the results described here that Pi3K can act downstre-
am from Ep-CAM. The question of a potential feedback loop from Ep-CAM to Pi3K
remains to be studied. Our first experiments do not eliminate the possibility. E.g.
expression of Ep-CAM deletion mutants incapable of adhesion, results in altered p85
expression levels (unpublished observations). These preliminar observations would be
in line with conclusions from other research groups. For example, Akt, acting downstre-
am of Pi3K, is activated by the formation of E-cadherin-mediated junctions [Pece et al.,
1999], while formation of E-cadherin-mediated junctions was demonstrated to be
inversely correlated to Ep-CAM expression [Litvinov et al., 1997]. Although the mecha-
nism of a putative regulation loop needs further investigation, such a mechanism may
explain the observations of both a de novo Ep-CAM expression in cervical carcinoma
[Litvinov et al., 1996]. and the amplification of the gene encoding for Pi3K subunit
p110α in cervical and ovarian carcinomas [Ma et al., 2000; Shayesteh et al., 1999]. 
The experiments reported here demonstrate that Pi3K can act downstream
from Ep-CAM. Abnormal signaling between these molecules may play a crucial role in
the biology of some epithelial tumors.
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other tissues. Every tissue type and state of maturation can be defined by specific expres-
sion patterns of adhesion molecules. Changes in expression patterns of one or several
adhesion molecules may suggest altered tissue differentiation or maturation. In other
words, a disturbed tissue maintenance may be concomitant by ectopic or overexpres-
sion of adhesion molecules, and this can be used as a tool in surgical pathology. For
example, in epithelial tissues many studies have been conducted to study the morphore-
gulatory role of E-cadherin [1]. A tumor suppressor function for E-cadherin has been
proposed frequently, and has been demonstrated in breast and gastric cancer.
Inactivation of E-cadherin is an early and crucial step in the formation of lobular car-
cinoma in situ, as a precursor of invasive lobular breast cancer and hereditary gastric
cancer [2-6]. Furthermore, co-expression of E-, N-, and P-cadherin was demonstrated
for several breast tumors, but unique expression patterns were distinguishable for each
type of tumor [7]. Here we analyze in detail the biological significance and diagnostic
value of the expression changes of a novel adhesion receptor, Ep-CAM. 
Ep-CAM 
Ep-CAM has first been identified as a tumor-specific antigen on several carcin-
omas of different origin. Several independent studies generated different antibodies
directed against the tumor-specific molecule expressed on carcinomas (figure 1). In
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Abstract
Cell adhesion receptors (CAMs) are actively involved in regulating various cell
processes, including growth, differentiation, and cell death. Therefore, CAMs represent
a large group of morphoregulating molecules, mediating cross-talk between cells and of
cells with their environment. From this perspective, CAMs do contribute to cells and tis-
sue organization, and in diseased tissue, to the disease development and biological cha-
racteristics. Therefore, observed changes in expression patterns of adhesion molecules
may contribute to establish a diagnosis. A distinct shift in expression patterns in neo-
plastic epithelium has been described, for example for cadherins, integrins, and CD44.
A relatively novel cell CAM, Ep-CAM, was first reported to be a pan-carcinoma antigen,
although it is rather a marker of epithelial lineage. Several antibodies directed to Ep-
CAM have been generated, and many epithelial tissues and their neoplastic appendages
have been studied. This article outlines the results of these studies. Based on the results
of these studies, we conclude that Ep-CAM immunohistochemistry can be a useful tool
in the diagnosis of disturbed epithelial tissues.
Introduction
Four major families of cell adhesion molecules (CAMs) are recognized on the
basis of their structure: integrins, selectins, CAMs of the immunoglobulin gene (IgG-
like) super family, and cadherins. Also other types of molecules with adhesion proper-
ties have been reported, for example, syndecans, CD44, and Ep-CAM. Nowadays, CAMs
defined as morphoregulatory molecules that affect cellular processes, based on data
about inside-out and outside-in signaling and signal transduction pathways. During
embryogenesis, but also in tumor development, the maturation and differentiation of
epithelial cells is regulated by signals within the epithelium and between epithelia and
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TABLE  1 Known antibodies directed against the epithelial adhesion molecule Ep-CAM.
A N T I B O D Y E P I T O P E R E F E R E N C E
AUA1 EGF-like domain I Durbin et al., 1990 [66]
Ber-EP4 EGF-like domain I Latza et al., 1990 [67]
CO 17-1A EGF-like domain I Herlyn et al., 1979 [68]
C215 EGF-like domain I Bjork et al., 1993 [69]
ESA, EGP-2, EGP40 Not established Simon et al., 1990 [70]
FU-MK-1 Not established Watanabe et al., 1993 [22]
GA733-2 EGF-like domain I Szala et al., 1990 [71]
HEA125 Not established Momburg et al., 1987 [20]
K928 Not established Quak et al., 1992 [72]
K931 EGF-like domain I Copper MP, 1993 [73]
KSA, KS-1, KS1/4 EGF-like domain I Varki et al., 1984 [74]
MM104 Cysteine-poor region Schön et al., 1993 [75]
MH99 EGF-like domain I Mattes et al., 1983 [76]
MOC31 EGF-like domain I Myklebust et al., 1991 [77]
MT201 Not established Naundorf et al., 2002 [78]
VU-1D9 EGF-like domain I Tsubura et al., 1992 [53]
2G8 EGF-like domain II unpublished data
311-1K1 Cysteine-poor region Helfrich et al., 1994 [79]
323/A3 EGF-like domain I Edwards et al., 1986 [80]
sion declines and higher levels of E-cadherin mediate intercellular adhesions and direct
cellular differentiation. Based on a large study on the expression of Ep-CAM, the possi-
bilities to target Ep-CAM for immunotherapy were explored [20]. Patients with Dukes’
C colorectal carcinoma who had undergone curative surgery, were treated in a mono-
therapy in the adjuvant setting with edrecolomab, the murine IgG2a monoclonal anti-
body that recognizes and binds with low affinity to Ep-CAM. After 7 years of follow-up,
the edrecolomab-treated group had a 32% reduction in mortality, and a 23% reduction
in recurence, as compared to the observation arm [20]. More clinical trials are ongoing. 
Ep-CAM expression is believed to be an early marker for (pre-) malignancies
[21]. Immunohistological stainings of dysplastic colon cells showed overexpression of
Ep-CAM. Not only the basolateral membrane was Ep-CAMpositive, apical positivity
was also observed. For mature squamous epithelium, a de novo expression has bee des-
cribed in weak, mild, and severe dysplasia [21]. Because it is important to diagnose (pre-
) malignancies at early stages, Ep-CAM immunohistochemistry can be of use to diagno-
se aberrant tissue morphology. 
Ep-CAM in Various Malignant Tissues
As mentioned, throughout the last 3 decades many antibodies were raised
against a widely detected tumor antigen that later was designated Ep-CAM. Several
histological studies of expression patterns of Ep-CAM were conducted on different tis-
sues, but because of the variety of names for antibodies and types of studies a compre-
hensive overview of the results is lacking. These are listed below and summarized in
table 2. The findings for Ep-CAM expression patterns in adult tissue, premalignancy,
and malignancy will be discussed.
Head and Neck Region
In the squamous epithelium of the oral cavity expression of Ep-CAM is a relia-
ble marker for the development of neoplasia. Weak, mild, and severe oral mucosal dys-
plasias displayed high expression levels of Ep-CAM in dysplastic basal and suprabasal
cells, whereas normal epithelial cells are Ep-CAM-negative [22]. 
In glottic squamous epithelium, Ep-CAM [using monoclonal antibody (mAb)
323/A3]. was expressed in all dysplastic areas with the border of the expression corres-
ponding to the border of the dysplasia. In all dysplasia a full layer expression of Ep-CAM
was observed, indicating complete dysplasia of the epithelium (Sjogren EV, unpublis-
hed results).
In invasive tumors, a strong heterogeneity in Ep-CAM expression within and
between tumors was observed. Besides proliferation, this heterogeneity was found to
correspond to keratinization, with keratinizing areas being low or negative in Ep-CAM
expression (Sjogren EV, unpublished results). 
Nodal metastases and their corresponding primary tumors of head and neck
squamous carcinoma were examined for gene expression [23]. The expression of most
genes involved in tumorigenesis, for example E-cadherin, was similar in primary
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addition, the corresponding cDNA had been
independently cloned by a number of
groups [8-11]. Therefore, the molecule was
first known by many different names, ie, the
human pan-antigen epithelial glycoprotein
EGP40, CO17-1A antigen, KSA1/4, ESA,
GA733-2, MOC31, Ber-EP4, and so forth
(table 1). In the early 1990s, the reports on
the carcinoma antigens and the cloning of
the cDNA were combined and it became
clear that the described molecules were vir-
tually identical. Initial studies on the charac-
teristics of the molecule revealed that the
molecule is a marker of epithelial lineages. 
It is a type I transmembrane glyco-
protein, not structurally related to one of
four the major families of the adhesion
molecules. The molecule consists of an
extracellular domain containing two epider-
mal growth factor (EGF)- like repeats, and a
short intracellular domain of 26 amino acids
in which two binding sites for α-actinin are
present for linkage to the actin cytoskeleton
(Figure 1)[12]. It is a relatively small protein that is highly conserved during evolution
and mediates calcium-independent homotypic cell-cell adhesions [13,14]. It is normal-
ly expressed at the basolateral membrane of cells by the majority of epithelial tissues,
except in adult squamous epithelium and some specific epithelium cell types, such as
hepatocytes [15-17]. Based on the properties of this molecule, it was renamed epithelial
cell adhesion molecule, Ep-CAM [15,16]
Further studies revealed that in murine fibroblaststransfected with Ep-CAM,
the expression of Ep-CAM is associated with proliferation [15,16]. On (over-) expres-
sion of Ep-CAM, cadherin adhesions dissociate, which leads to accumulation of deter-
gent soluble E-cadherin/β-catenin complexes, and to a decrease in total cellular α-cate-
nin [18]. This suggests that during cell division, the strong, tight E-cadherin-mediated
cellular adhesion is abrogated, while the weaker intercellular adhesion mediated by Ep-
CAM still holds the cell in place [18,19]. After the proliferative phase, Ep-CAM expres-
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FIGURE 1 Schematic composition of Ep-CAM. 
SP, signal peptide; EGF, EGF-like domain;
TM, transmembrane. The numbers indi-
cate the amino acid residues that mark
the regions in the molecule.
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tumors and metastases. Surprisingly, Ep-CAM expression was detected less frequently
in metastases, compared to the corresponding primary tumor, suggesting involvement
in metastasis. To identify high-risk patients having small numbers of disseminated
tumor cells in early tumor stages, a reverse transcriptasepolymerase chain reaction assay
for Ep-CAM expression that detects a single tumor cell within normal cells was success-
fully developed [24]
Esophagus
The squamous epithelium of the esophagus is clearly negative for Ep-CAM,
while the columnar epithelium in Barret’s esophagus displays a diffuse and low expres-
sion pattern for Ep-CAM.25 In biopsies of Barret’s esophagus a heterogeneous pattern
of Ep-CAM staining is present. Within several patients, the expression of Ep-CAM
(mAb KS-1) differed among various regions of the columnar esophageal epithelium of
the intestinal type [26]. 
Preliminary data of Kumble and collegues [26] showed high expression levels of
Ep-CAM (mAb KS-1) in four tested adenocarcinomas of the esophagus. The authorshy-
pothesized that Ep-CAM is positively correlated with the progression to adenocarcin-
oma of the esophagus. 
Gastric
In normal gastric epithelium no Ep-CAM expression can be observed, only in
the basal layer of crypts. However, with the development of intestinal metaplasia, a
strong up-regulation of Ep-CAM expression is observed in all cases studied with 323/A3
(De Boer CJ, unpublished results). Ep-CAM expression appeared throughout thecrypts
and is constitutive to the foveola. The authors found that expression of Ep-CAM can
already be detected on some cells on the border of normal and metaplastic cells that have
no metaplastic phenotype yet, and suggested that expression of Ep-CAM may be an
early event in the development of gastric metaplasia that corresponded completely with
increased proliferation as measured by an increase in Ki-67-positive cells. Using the FU-
MK1 antibody, similar results were obtained [27]. 
Songun and colleagues [28]. studied whether Ep-CAM expression in primary
tumor specimens from primary gastric adenocarcinoma was indicative for the presence of
lymph node metastases, but it was not. However, loss of Ep-CAM expression is an inde-
pendent prognostic value for poor survival prognosis. This can be explained by the fact
that loss of Ep-CAM expression, as an epithelial adhesion molecule, may reflect a loss of
epithelial differentiation. Furthermore, low expression levels of Ecadherin in carcinoma,
increases the role for Ep-CAM adhesions in interconnecting cells. The loss of Ep-CAM
expression probably results in loss of cell-cell adhesion, which promotes metastasis [29]
Colon
Ep-CAM is widely expressed in the highly proliferative cells of the intestinal
epithelium. Ep-CAM is expressed from cells in the basal cells throughout the crypts at
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TABLE 2 Expression pattern of Ep-CAM in normal tissue, dysplasia and carcinoma (ca).
EPITHELIUM AB EXPRESSION PAT TERN EP-CAM
(species) normal tissue premalignant carcinoma
oral mucosa, KS1/4 negative dysplasia: positive
head&neck 323/A3 positive positive positive
region
esophagus KS-1 negative (columnar cells) metaplasia:
negative (squamous) positive (BE)
gastric 323/A3 positive only in crypts positive constitutive 
negative (mucosa) from crypts till villae
colon KS1/4 positive adenomas: enhanced 
323/A3 enhanced (colorectal ca)
liver 323/A3 negative positive positive (CHC)
17-1A positive (regenerating/ negative (HCC)
MOC31 proliferating hepatocytes)
Ber-EP4
pancreas KS1/4 positive enhanced
kidney Ber-EP4 positive (*) heterogeneous (clear 
FU-MK-1 cell ca)
bladder AUA1 positive enhanced
FU-MK-1
testes HEA125 positive (*) positive (*)
prostate 323/A3 positive enhanced
FU-MK-1
mammary 2G8 positive enhanced
ESA 
323/A3
17-1A
ovary AUA-1 low positive (oocyte) enhanced (serous)
Ber-EP4 enhanced (mucinous)
uterine cervix 323/A3 negative dysplasia: positive
positive
lung Ber-EP4 low positive positive (SCC)
negative (mesothelioma)
lymph node metastasis 
from NSCLC: positive
skin Ber-EP4 negative (squamous) positive (BCC)
MH99 positive (sweat ducts/ positive (basosquamous)
proliferating squamous cells) negative (SCC)
(*) for details on cell types and tumor types: see text.
did not react for Ep-CAM (mAb17-1A) in cholangiocarcinoma, whereas neoplastic
liver cells acquired cytoplasmic-positive staining in clustered areas in HCC. The intensi-
ty of staining and Ep-CAM distribution were inversely related to the grade of tumor dif-
ferentiation.
Pancreas
In the mature pancreas, the ductal compartment strongly stained for Ep-CAM
exhibited the highest proliferation index [39]. The authors established a correlation
between frequency of proliferating cells and increased expression of Ep-CAM (mAb
KS1/4) in each cell compartment. The highest Ep-CAM expression was recorded at the
cell-cell boundaries of intercalar ductal cells, in interlobular ducts, and in main ducts.
Islets of Langerhans, identified by the insulin- and glucagon-specific antibodies, exhibit
a significantly less intense Ep-CAM expression. The authors suggest that Ep-CAM
expression negatively regulates the endocrine differentiation in pancreatic islet cells. 
In cell lysates, increased expression levels of Ep-CAM were detected in human
islet β-cell tumors (insulinoma) [39]. This increase is most likely also detectable with
immunohistochemistry on tissue sections, but this has not yet been performed.
Kidney
Few studies have described Ep-CAM in normal and neoplastic kidney. Normal
renal tubules are in general strongly positive, while clear cell carcinomas show a more
heterogeneous pattern. Five of twelve cases were positive for Ep-CAM (mAb Ber-EP4),
whereas only one of five cases of renal carcinoma was weakly positive with the FU-MK1
antibody [40,41]. Concluding from the stained sections presented in the study, the use
of the FU-MK1 antibody may not be the best suitable antibody to use for diagnostic pur-
poses.
Urothelium
Transitional epithelium of the bladder is only slightly positive for Ep-CAM
(mAb AUA1/FU-MK1). In dysplastic lesions of urothelium and transitional cell carcin-
oma, enhanced expression of Ep-CAM was observed, although antigenic heterogeneity
exists between tumors of the same grade and within the same tumor [42]. Using the FU-
MK-1 antibody, only two of five bladder carcinomas were positive [41]. 
Testes
In tissues of the male genital tract, some of the cells in testis (spermatogonia,
low Ep-CAM expression), epididymis (ciliated, basal and cuboidal cells, intermediate
expression), and seminal vesicle (positive expression) reveal Ep-CAM expression when
using the HEA125 antibody [25]. 
Kommoss and colleagues [43]. concluded that among other antibodies, immu-
nohistochemical staining for Ep-CAM in testicular neoplasms are helpful in the diffe-
rential diagnosis when distinction on morphological grounds is difficult. Using
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the basolateral membranes, and only the apical membrane facing the lumen is negative
[30]. The development of adenomas is accompanied by an increased Ep-CAM expres-
sion and Ep-CAM overexpression (mAb GA733) has been frequently demonstrated in
colorectal carcinomas [31,32]. 
In clinical trials, colorectal cancer has been targeted with the monoclonal anti-
body CO17-1A and anti-idiotypic antibodies mimicking the CO17-1A or GA733-2 epi-
tope. An improved survival was accompanied by a prolonged systemic immune reaction
to the antibody [33]. Presently, its anti-tumor effect is being studied as monotherapy
after resection of stage II colon cancer, and in combination with chemotherapy in
patients with stage II or III rectal cancer [34]. Patients with resected Dukes’ C colorectal
cancer were randomly allocated to infusions of CO17-1A antibody [20]. The follow-up
study shows that 17-1A antibody administered after surgery prevents the development
of distant metastasis in approximately one-third of patients. The therapeutic effect is
maintained after 7 years of follow-up.20 Various mechanisms can be responsible for the
clinical observed effects of Ep-CAM immunotherapy. According to Haller [34], the
murine IgG2a mAb against Ep-CAM mediates an antibody-dependent cellular cyto-
toxicity, complement-mediated cytolysis, and anti-idiotypic network.
Liver
Ep-CAM (mAb 323/A3) is expressed on hepatocytes in embryonic liver and
maturing liver cells, but is absent in adult hepatocytes [35]. Ep-CAM does mark a pluri-
potent stem cell, the progenitor for both bile duct cells and hepatocytes. The de novo
expression of Ep-CAM in regenerating/proliferating hepatocytes is explained by the
fact that these stem cells replace the damaged cells, and decreased intercellular adhesion
by E-cadherin is required for proliferation. On maturation of the new cells, ie, on diffe-
rentiation, Ep-CAM expression is lost again. The down-regulation of Ep-CAM and the-
reby the signal for proliferation precedes the restoration of cadherin-mediated cellular
adhesion. 
Diseased liver tissue displayed a strong Ep-CAM expression (mAb 17-1A) in the
epithelium of typical and atypical bile ducts [36]. In addition, periportal or periseptal
hepatocytes revealed variable staining of Ep-CAM, which is directly related to acute and
chronic inflammatory changes. The Ep-CAM expression in hepatocytes was most pro-
nounced in acute and chronic active hepatitis, with Ep-CAM expression levels that are
common to bile ductular cells. This suggests that the hepatocytes in diseased liver repre-
sent transformed hepatocytes. 
It was demonstrated that all hepatocellular carcinomas (HCCs), including the
pseudoalveolar type, were uniformly negative for Ep-CAM [37,38]. In the mixed HCC-
cholangiocarcinoma cases, Ep-CAm (mAb MOC31) highlighted the glandular compo-
nent, but did not stain the HCC portion of the neoplasm. 
Furthermore, Ep-CAM differentiated between HCC and metastatic adenocar-
cinoma from the colon, lung, breast, pancreas, small intestine, kidney, or ovary [37,38].
However, according to Sansonno and Dammacco [36], neoplastic bile duct epithelium
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related significantly with disease- free and overall survival, independent of tumor size,
nodal status, histological grade, and hormone receptor expression. Specific immuno-
therapy with mAbs against Ep-CAM in minimal residual stages of breast cancer should
be considered [32]
Ovary
In ovaries, the oocytes display a moderate Ep-CAMpositive staining (Ab
HEA125), but the follicular epithelial cells are negative. In the oviduct, (non-) ciliated
cells show a low reactivity [25]. 
Ovarian clear cell carcinomas showed Ep-CAM positivity with both AUA1 and
Ber-Ep4 [40,49]. Cherchi and coworkers [50]. showed 50% and 79% Ep-CAM positivity
(mAb Ber-EP4) in ovarian cancer of serous and mucinous type. Furthermore, Ep-CAM
positivity (mAb Ber-EP4) was directly proportional to tumor differentiation; 70% of
the well-differentiated tumors were Ep-CAM-positive, compared to 37.5% of the poor-
ly differentiated tumors. No positivity was observed for Ep-CAM (mAb Ber-EP4) in
either metastatic ovarian tumors or germ cell tumors.
Uterine Cervix
Normal, mature squamous epithelium of the uterine cervix does not express
any Ep-CAM (323/A3)[21]. Squamous differentiation marker cytokeratin 13-positive
staining appears from parabasal cells, and the staining intensity increased toward the
lumen in normal squamous epithelium. This is also observed for the squamous terminal
differentiation marker involucrin.
Sections of the uterine cervix stained for Ep-CAM and Ki67 have demonstra-
ted that in squamous dysplasia, both low and high grade, Ep-CAM is associated with
proliferation [21]. In cervical intraepithelial neoplasia (CIN) grade I, Ep-CAM-positi-
ve areas were found in the parabasal layer, where now cytokeratin 13 was absent (figure
2). In progressing grades of CIN, grade II and III, larger layers of Ep-CAM expression
were observed, while cytokeratin 13 almost disappeared. Similar staining patterns were
found for the terminal differentiation marker involucrin. In progressing CIN lesions,
involucrin staining is lost and Ep-CAM expression expanded. The highly proliferative
activity in undifferentiated cells of CIN layers is associated with Ep-CAM expression.
The Ep-CAM expression is inversely correlated with E-cadherin participating in cell-
cell junctions [17]. Ep-CAM can be used as an early marker for disturbed tissue prolife-
ration and differentiation in cervical premalignant stages. In the majority of both
squamous and adenocarcinomas of the cervix a strong expression of Ep-CAM was
observed, although some decrease in the expression (both the intensity and the num-
ber of positive cells), as compared with CIN III lesions, was observed in the areas of
squamous differentiation [21]. Because it is unlikely that E-cadherin-mediated adhe-
sion had returned and the tissue was differentiating, the population of cells that are less
positive for Ep-CAM may be submitted to genetic imbalance where Ep-CAM tran-
scription was lost. 
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HEA125, he demonstrated Ep-CAM reactivity in cases of seminoma (3 of 12, 25%),
embryonal carcinoma (3 of 12, 25%), yolk sac tumor (6 of 8, 75%), teratoma (1 of 2,
50%), whereas juvenile granulosa cell tumor, Sertoli cell tumor, primary and metastatic
Leydig cell tumor, choriocarcinoma, and sex cord tumor all were negative [43]
Prostate
Secretary, basal, and ductal cells of the prostate revea an intermediate Ep-CAM
expression when using the HEA125 antibody [25]. 
Positive Ep-CAM staining (mAb FU-MK-1) was detected in normal prostate
and in adenocarcinoma, although a small number of cases was studied.41 However, no
clear staining pattern was observed with this antibody. 
A low immunoreactivity was found for Ep-CAM (mAb323/A3) in benign pro-
static epithelium, concentrated on the luminal cells [44]. Strong immunopositivity was
detected in luminal cells of high-grade prostatic intraepithelial neoplasias, as well as in
adenocarcinomas, suggesting that increasing levels of Ep-CAM expression represent
early events in the development of prostatic adenocarcinoma. However, Ep-CAM posi-
tivity was not correlated to the clinical outcome of patients.
Mammary Gland
The mammary gland epithelium undergoes several stages of development and
dedifferentiation. In normal human mammary glands, Ep-CAM is mainly expressed in
luminal epithelium [45]. Ep-CAM expression during the developmental phases was
extensively studied in C57BL6 mice by Balzar and colleagues [46]. Using the mAb G8.8,
it was clearly demonstrated that endogenous Ep-CAM expression very well correlated
with the proliferative state of the mammary gland postnatal development, while the E-
cadherin expression was unchanged during this period. With the start of milk producti-
on, the epithelium is differentiated and Ep-CAM expression decreases. Mice transfected
with human Ep-CAM under the control of the MMTV-LTR promotor showed not only
an association of Ep-CAM with regulation of mammary gland morphogenesis, but also
direct involvement. The virgin mammary glands of transgenic mice displayed increased
budding and secondary branching as compared to their nontransgenic littermates. 
The staining pattern of mAb 323/A3 in benign breast disease was analyzed by
Courtney and colleagues [47]. Patients who have had both a benign biopsy and a later
biopsy for breast carcinoma were screened. In apocrine metaplasia, the cytoplasm of
benign tissue did not stain with 323/A3, whereas in the biopsies with associated breast
cancer did (five of seven). The authors noted a positive predictive value of 100% for
strong cytoplasmic staining to indicate the presence of carcinoma. 
An immunohistochemical study on breast cancer biopsies showed that Ep-
CAM (mAb 17-1A) was expressed in the majority of the breast carcinomas, especially on
paraffin sections [32] Spizzo and colleagues [48]. stated that the overexpression of Ep-
CAM, detected with mAb ESA, in 205 cases of localized invasive breast cancer was an
independent prognostic marker by multivariate analysis. Ep-CAM overexpression cor-
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epidermis, some Ep-CAM reactivity can be observed in the reserve cells with mAb
MH99 [58]. 
Cutaneous neoplasms reported to stain for Ep-CAM (mAb Ber-EP4) include
basal cell carcinoma (BCC), Merkel cell carcinoma, and mixed tumor of skin (chon-
droid syringoma). In BCC, Ep-CAM (mAb Ber-EP4) is constantly and diffusely expres-
sed, while SCC, squamous intraepithelial neoplasia, and actinic keratosis are Ep-CAM-
negative [57,59,60]. This pattern was observed in nodular, cystic, superficial, and
infiltrative BCC, but not in SCC, irrespective of the degree of differentiation. Using Ber-
EP4, the identification of basosquamous carcinoma is also possible, because the studied
tumors all showed at least some areas of Ep-CAM positivity [61]
Discussion and Conclusions
This report has presented an overview of the expression patterns for Ep-CAM in several
epithelial tissues, and the pathology thereof. Ep-CAM can be detected in all simple,
columnar, and pseudostratified epithelia, but is absent in adult squamous epithelium.
In vitro, a clear association was demonstrated between Ep-CAM and cell proliferation.
Overexpression of Ep-CAM, as well as a de novo expression was observed in colon car-
cinoma and in squamous carcinoma of the uterine cervix [15,16]. Simultaneously, Ep-
CAM expression abrogates the cadherinmediated adhesions, which has serious implica-
tions for differentiation of epithelial tissues, and may by itself be the reason behind
increased cell proliferation. We believe that the enhanced expression and de novo
expression is an early step in the malignant transformation of epithelium, and can be
used as a marker for diagnostic purposes. 
The discussed studies here all used antibodies that have their epitope in the
EGF-like domain I. Other antibodies are known to have their epitope in the EGF-like
domain II or in the cysteine-poor region (table 1) but were apparently not suited for
immunohistochemistry because we retrieved no published reports in which reliable
results on histological slides with these antibodies were described. To our knowledge, no
antibodies have been developed that have their epitope in the intracellular domain of
Ep-CAM. 
The most frequently used antibodies are the monoclonal antibodies 323/A3,
KS1/4, and Ber-EP4. They are known to have a high affinity and specificity for human
Ep-CAM. Observed reported heterogeneity in reactivity of Ep-CAM-specific antibo-
dies with subpopulations of Ep-CAM with cell or tissue suggests that intracellular and
cell surface Ep-CAM differ in the conformational state of the protein, and that some
epitopes may be masked on the molecules participating in intercellular adhesions [62].
One study described the favor of MOC31 to Ber-EP4: one case of HCC (Ep-CAM-nega-
tive) was detected with Ber-EP4, but not with MOC31 [37]. This was independently
confirmed, and the authors concluded that the MOC31 staining was readily interpreta-
ble with rare exceptions [38]. 
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Lung
In normal lung tissue, the ciliated bronchial epithelium, alveolar duct, and alve-
olar epithelial cells type I and II all show a low Ep-CAM expression. In pulmonary fibro-
sis, Ep-CAM could further be detected on the cell surface of epithelial remnants [25,51]. 
Two studies by Piyathilake and collegues [52,53],  reported strong Ep-CAM
positivity in 98% of the squamous cell cancers (SCC) and uninvolved bronchial mucosa
and in 100% of the hyperplasias and dysplasias. There was increased Ep-CAM expression
in luminal cells as compared to basal cells and was more consistent in hyperplasia than in
uninvolved mucosa. The authors described a statistically significant stepwise increase in
Ep-CAM expression from uninvolved bronchial mucosa to epithelial dysplasia to SCC. A
significant association was detected with lower tumor differentiation, advancing nodal
status, and advancing clinical stage. Well-differentiated SCCs expressed more Ep-CAM
than poorly to moderately differentiated SCCs, and the increase in the Ep-CAM expres-
sion tends to correspond with increasing size or local extent of the primary tumor and
involvement of regional lymph nodes. In contrast to squamous carcinomas, Ep-CAM is
not expressed in mesothelioma. Using MOC31, a distinction between carcinoma and
mesothelioma can be made on the basis of Ep-CAM expression [54]. 
The Ber-EP4 antibody was used to discover small tumor cell deposits in regio-
nal lymph nodes in patients with resected non-small cell lung cancer. In a prospective
study of 125 patients, the detection of single Ep-CAM positive (mAb Ber-EP4) cells pro-
ved to be an independent prognostic factor for the overall survival [55]
Skin
In the skin, the keratinocytes and melanocytes are Ep-CAM-negative, while
the sweat ducts (eccrine and apocrine coils, apocrine ducts) and the proliferative zone
of the hair follicle are Ep-CAM-positive.56,57 However, within the basal layers of the
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FIGURE 2 Immunofluorescent double staining for Ep-CAM (red) and squamous differentiation marker 
cytokeratin 13 (green) in uterine cervix, stage CIN 1 (A), and stage 2 (B). The area where 
Ep-CAM is expressed is larger in CIN 2 as compared to CIN 1. For details see text and Litvinov
and colleagues [21]
can always be detected in the basal layers of squamous tissues, Ep-CAM positivity is only
found in aberrant tissue. To discriminate between (hyper-) proliferative squamous tis-
sue and premalignant squamous tissue, Ep-CAM is only expressed in the latter. In sim-
ple epithelia, Ep-CAM is always detectable on the basolateral sides of the cell.
Premalignancies display overexpression of Ep-CAM and the apical membrane becomes
Ep-CAM-positive as well, for instance in colon. 
A useful application of Ep-CAM immunohistochemistry is to discriminate
tumors of epithelial and nonepithelial origin. In human tissue, Ep-CAM is only expres-
sed in epithelium or neoplasias from epithelial origin. Most squamous carcinomas are
positive for Ep-CAM, except for squamous carcinoma of the skin. BCC can therefore be
distinguished from SCC of the skin, squamous intraepithelial neoplasia, and actinic
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For our research, the 323/A3 antibody is routinely usedon both frozen and paraffin-
embedded tissue samples. After standard xylene and graded alcohol series, formalin-
fixed and paraffin-embedded tissues are fixed in methanol and incubated in 0.3% H2O2
in methanol. For 323/A3 staining, tissues are pretreated with 0.1% trypsin (w/v) in 0.1%
CaCl2. Standard two-step biotin/streptavidin labeling is often used for detection. Fresh
tissue samples can be stained with standard methods, without any pretreatments (see
table 3). Immunofluorescent labeling for co-localization studies has been reported fre-
quently by Balzar and colleagues [12,30], Litvinov and colleagues [18], Cirulli and colle-
agues [39], and Winter and colleagues [9]. The staining can be scored easily; for normal
squamous tissues, staining is negative, whereas premalignant lesions display positive
cellmembranes. For other epithelial cell types, aberrant cells show a more intense Ep-
CAM positivity than normal tissue at the basolateral membranes. Furthermore, the
cytoplasm and apical membranes can be positive as well in case of Ep-CAM overexpres-
sion.
To summarize the discussed studies, Ep-CAM expression can be detected at
membranes of proliferating (epithelial) cells of colon, pancreas, mammary gland, lung,
and regenerating liver, and is absent in normal liver, oral mucosa, gastric mucosa, skin,
and uterine cervix. In those tissues with pre-existing Ep-CAM expression, Ep-CAM
positivity is enhanced during neoplastic development. In tissues where Ep-CAM is
absent in the normal situation, de novo expression of Ep-CAM indicates dysplasia or
malignancy. The dysplastic squamous epithelia start to express Ep-CAM de novo at the
basal layer. Tumors of epithelial origin virtually all express Ep-CAM at a high level, often
the apical membrane is also Ep-CAMpositive. In some tumors, intracellular Ep-CAM-
positive vesicles can be detected. Cervical dysplasia is correlated with Ep-CAM positivi-
ty; in low-grade dysplasia Ep-CAM is confined to the basal and parabasal cell layers,
whereas in severe dysplasia the luminar cells are positive as well. 
The association of Ep-CAM with metastases is less clear. One would expect to
find higher Ep-CAM expression in metastasized cells, because these cells are more likely
to escape the epithelium than well-differentiated cells anchored by E-cadherin-media-
ted junctions. Momburg and co-workers [25]. demonstrated that micrometastases ori-
ginating from carcinomas could be detected with for instance the HEA125 antibody.
However, in nodal metastasis originating from head and neck squamous carcinomas,
Ep-CAM expression was found to be reduced compared to the primary tumor [23]. In
contrast, Chaubal and co-workers [24]. concluded that Ep-CAM gene expression could
be used as a useful tool to identify disseminated tumor cells. In both SCC and non-small
cell cancer of the lung, Ep-CAM-positive cells were detected in the regional lymph
nodes. In metastases from primary tumors in the ovary, Ep-CAM expression is decrea-
sed. Although loss of Ep-CAM expression is associated with the progression of intesti-
nal metaplasia, it is not an indicative marker for the presence of lymph node metastases
in patients with adenocarcinoma of the stomach. 
Ep-CAM expression in immunohistological diagnostics may have additional
value over the use of Ki-67 in suspected neoplasias. While using Ki-67, proliferative cells
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TABLE 3 Staining for the three most frequently used antibodies directed against Ep-CAM. 
Tr: room temperature; 
A N T I B O D Y S TA I N I N G  M E T H O D
Paraffin Cryostat
323/A3 Fixation: methanol (5 min; Tr) and Fixation: acetone (10 minute; Tr)
0.3% H2O2 (20 min; Tr)
Pretreatment: 0.1% trypsin (w/v) Pretreatment: -
in 0.1% CaCl2  (w/v) (20 min; Tr)
Incubation 1st Ab: 1-5 μg/ml Incubation 1st Ab: 5 μg/ml in 
(overnight; Tr) PBS/1.0% BSA (1 hour; Tr)
Detection: 2-step biotin/ Detection: two-step biotin/
streptavidin system streptavidin system or envision
Ber-EP4 Fixation: formalin Fixation: formalin
Pretreatment: 0.1% trypsin (w/v) Pretreatment: -
in 0.1% CaCl2  (w/v) (20 min; Tr) 
Incubation 1st Ab: 6 μg/ml Incubation 1st Ab:
(overnight; Tr) 5 μg/ml (45 min; 40 °C)
Detection: 2-step biotin/ Detection: Vectorstain Elite kit
streptavidin system
KS1/4 Fixation: formalin Fixation: 4.0% formaldehyde 
(20 min; 4 °C) 
Permabilization: 0.1% saponin 
(5 min; Tr), 50 mM glycine in PBS
Pretreatment: 0.1% trypsin (w/v) Pretreatment: -
in 0.1% CaCl2 (w/v) (20 minute; Tr)
Incubation 1st Ab:  5-10 μg/ml Incubation 1st Ab: 5 μg/ml (1h; Tr)
(overnight; Tr)
Detection: two-step biotin/ Detection: immunofluorescent 
streptavidin system labelled 2nd Ab
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keratosis [57,60]. The positive staining pattern in BCC is a useful tool to locate latent
BCC in inflammatory Mohs margins [63]. In liver, surprisingly, not all liver neoplasias
are positive for Ep-CAM. Almost all analyzed cholangiocellular carcinomas were Ep-
CAM-positive, whereas the majority of HCCs were not [27,35,37,38]. One of the two
Ep-CAM-positive HCC cases in our own study was diagnosed as fibrolamellar carcin-
oma, a rare variant of primary liver carcinoma [35]. In combined type tumors con-
sisting of a mixture of HCC and cholangiocellular carcinoma, only the cholangiocellu-
lar carcinoma areas react Ep-CAM-positive [27]. Sheibani and co-workers [64]. used
the Ber-EP4 mAb, which may have great use in the differential diagnosis of mesotheli-
oma versus adenocarcinoma, particularly when only formalin-fixed tissue is available. 
According to Friedman and co-workers [65], using the combination of mAbs
Ber-EP4, carcinoembryonic antigen, and vimentin are useful immunohistochemical
markers in differentiating malignant mesotheliomas from adenocarcinomas, whereas
immunohistochemistry does not reliably distinguish malignant from benign hyper-
plastic mesothelial cells. The addition of DNA ploidy studies is useful for differentiating
the latter two groups. Roberts and colleagues [66]. postulated that mesotheliomas, ade-
nocarcinomas, and reactive pleura could only be accurately diagnosed with a panel of
antibodies, in which the Ber-EP4 is only positive in adenocarcinomas. To distinguish
peritoneal mesothelioma in women from serous papillary ovarian and peritoneal car-
cinoma, the use of Ber-EP4 is discriminative in contrast to other mesothelial markers
thrombomodulin, cytokeratin 5/6, and CD44H and carcinoma markers polyclonal and
monoclonal CEA, and Leu- M1 [67]. Also, the AUA1 antibody was demonstrated to
distinguish between carcinoma cells and mesothelial cells in serous effusion [68]
Taken together the above-described findings, it is clear that expression of (epi-
thelial) adhesion molecules may represent different stages in tissue development.
Extending the definition of adhesion molecules to morphoregulating molecules is
nowadays accepted. To diagnose disturbed or suspected lesions in epithelium, the
expression pattern of epithelial adhesion molecule Ep- CAM can be of help. Normal,
Ep-CAM-negative epithelia (squamous tissue) show a de novo expression in metaplasia,
whereas an enhanced Ep-CAM expression can be found in other preneoplastic epithe-
lia. The advantage of Ep-CAM staining over Ki-67 staining is described above. Also, Ep-
CAM can serve in determining the tissueorigin of tumors. Therefore, we conclude that
Ep-CAM immunohistology proves to be a useful tool in the diagnostics of epithelial
lesions.
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Chapter 8 
Summary and future 
perspectives
Tissues are dynamic groups of cells with specific functions for each cell type. Healthy, matu-
re tissues are in perfect balance concerning growth, differentiation, repair or adaptation. In
order to respond to external and internal stimuli, cells are in constant communication with
the environment and each other for orchestrated responses of various cell types. A distur-
bed communication between the cells of the same or different type can lead to a variety of
diseases, for example diabetes mellitus or cancer. A number of signal transduction pathways
of varying complexity enable cells to adequately respond to the (dynamic) conditions of the
microenvironment. Cell adhesion Molecules (CAMs) and adhesion receptors are modali-
ties that mediate direct contact and signaling between various cell types.
The General Introduction in chapter 1 describes the fading border between adhe-
sion molecules and adhesion receptors. Adhesion molecules were formerly considered to act
solely as mechanical connections between cells whereas only the adhesion receptors were
assigned a role in signal transduction. Nowadays, the signaling and regulatory properties of
adhesion molecules are widely acknowledged, and the term ‘morphoregulating molecule’
seems more appropiate. The characteristics of a relatively novel epithelial morphoregulating
molecule, Ep-CAM, are presented, together with plausible signaling pathways that may affect
the epithelial morphoregulating molecule E-cadherin, a key protein in epithelial cell biology.
Since little is known of Ep-CAM and its morphoregulatory properties, this thesis focuses on
the question if and how Ep-CAM mediated adhesions affect cell functions.
Biology of Ep-CAM, (chapter 2) 
The properties and putative function of Ep-CAM as well as its role in tumor biology
are reviewed on the basis of the literature . Ep-CAM was formerly known as the 17-1A anti-
gen, named after the monoclonal antibody 17-1A. Ep-CAM expression was detected in
most carcinomas, and later studies have demonstrated the association between (epithelial)
expression of Ep-CAM and cell proliferation. Ep-CAM is capable of mediating Ca2+-inde-
pendent homotypic cell adhesions. Co-expression with E-cadherin results in abrogation of
cadherin-mediated junctions, blocking cellular differentiation. A role for Ep-CAM in nor-
mal tissue development and tumor development and progression is discussed. 
Introduction of active Ep-CAM molecules into cells interconnected by E-
cadherin leads to abrogation of E-cadherin mediated adhesions (chapter 3)
In this chapter we described a negative effect of Ep-CAM expression in cells on E-
cadherin-mediated cellular adhesions. E-cadherin transfected fibroblasts (L-cells), with
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ted a protein complex, including the Pi3K subunit p85, and this complex showed Pi3K
activity. Similar experiments with Ep-CAM deletion mutants suggest a regulation of
Ep-CAM by Pi3K. Abrogation of the N-cadherin adhesion complexes in epithelial cells
by cross signaling Ep-CAM involves Pi3K.
Ep-CAM as a tool in surgical pathology (chapter 7)
After reviewing the literature on immunohistochemical studies of EpCAM
expression in tumors, we conclude that Ep-CAM is a useful diagnostic marker for the
identification of neoplastic epithelial changes and tumors of epithelial origin. 
Clinical implications
Aberrant expression of cell adhesion molecules is usually characteristic for
[pre-]neoplastic cells. As discussed in chapter 7, immunohistochemistry can be a use-
ful tool for the diagnosis of carcinomas, and the level of differentiation of the carcin-
omas. Recently, Xie and collegues concluded that Ep-CAM was distributed differently
in various colon cancers compared to normal colon gland epithelium [Xie et al.,
2005]. Staining patterns in tissue arrays showed that in adenocarcinoma and papillary
adenocarcinoma the expression of Ep-CAM increased from grade I to grade III. These
observations may have a diagnostic value in the correct recognition of carcinoma
type.
Overexpression of Ep-CAM appears to correlate with impaired survival of
patients with different types of carcinomas [Trzpis et al, 2007]. Exceptions to this
rough-and-ready-rule are renal cell carcinoma and gastric carcinoma [Songun et al.,
1997; Trzpis et al, 2007].
Over the past years, immunohistochemical studies of large series of cases have
shown an increased or de novo expression of Ep-CAM in premalignant lesions. These
data form a compelling argument/reason for developing immunotherapy or other ways
of treatment targeting Ep-CAM.Theoretically, anti-Ep-CAM antibodies may be the
easiest way to therapeutic implementation of this knowledge. Ep-CAM is mainly
expressed at the baso-lateral cell membrane and the majority is complexed in cell-cell
adhesions. Only aberrant cells express Ep-CAM at the apical cell site due to the overex-
pression, so for example local administration of anti Ep-CAM antibodies in the lumen
of the colon in case of a colorectal carcinoma might be able to reduce tumor size and
growth. A systemic approach was tested for edrecolomab/ Panorex®. Although earlier
studies had shown promising results, the adjuvant treatment of patients with resected
stage III colon cancer or postoperative adjuvant treatment with edrecolomab in patients
with resected stage II colon cancer did not improve overall or disease-free survival [Punt
et al., 2002; Hartung et al, 2005]. Short half-life and rapid neutralisation may have con-
tributed to the low clinical benefit. This may be overcome by modifying the murine anti-
body edrecolomab to a subcutaneously administered vaccine, IGN101. This molecule
IGN101 was only succesful in prolonging disease free survival of patients with stage IV
rectal cancer, but not in other carcinomas [poster at ASCO, 2005].
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and without Ep-CAM supertransfection, were subjected to segregation assays, which
resulted in E-cadherin transfected cells in the core of the aggregate, while E-
cadherin/Ep-CAM transfected cells formed the outer layer, with decreased strength of
the intercellular adhesions. Cell morphology had changed upon Ep-CAM introduction
in fibroblasts transfected with both E-cadherin/Ep-CAM, as well as in Ep-CAM trans-
fected epithelial cells. In these transfectants, biochemical analysis showed a decrease of
insoluble β- and α-catenin. This demonstrates that the E-cadherin mediated adhesion
complex is abrogated by introduction of Ep-CAM .
Expression of Ep-CAM shifts the state of cadherin adhesions from
strong to weak without involvement of β-catenin, (chapter 4)
We investigated which mechanisms may underly the regulation of E-cadherin
mediated adhesions by EpCAM, The chimerized E-cadherin/α-catenin, Eα, or the chi-
merized E-cadherin/ c-terminal half of α-catenin, EαC, were transfected into L-cells
and mediated cell-cell juncions. Introduction of Ep-CAM weakened the strength of
cell-cell interactions, and decreased the cytoskeleton-bound fraction of the
cadherin/catenin chimeras of both types of established junctional complexes. By seem-
ingly disrupting the link between α-catenin and F-actin, Ep-CAM affects E-cadherin-
mediated adhesions. Since the binding site for β-catenin was not available in the chime-
rized molecules, and no β-catenin was expressed, this showed that β−catenin, the
acknowledged key regulator of cadherin mediated adhesions, was not involved. 
Downregulation of Ep-CAM leads to augmentation of cadherin media-
ted junctions in tumor cells, (chapter 5)
Overexpression of Ep-CAM introduction results in abrogation of the cadherin
junctional complex, but is this effect reversible? Immortalized UMSCC-2 and -22B
cells (U2 and U22B) are poorly differentiated squamous carcinoma cells that over-
express Ep-CAM to high (U2) or moderate levels (U22B), while E-cadherin expression
is virtually gone. Stable and transient transfection of antisense DNA of Ep-CAM resul-
ted in decreased cell proliferation and to morphological changes that are related to
squamous differentiation. These observations are easily explained by the marked
downregulation of Ep-CAM expression and the restauration of E-cadherin mediated
adhesions, and the re-appearence of the squamous differentiation markers involucrin
and cytokeratin-13. The restauration of cadherin mediated adhesions by suppressing
the Ep-CAM expression, is of great importance in the quest for new modalities for
curing cancer .
Cadherins are regulated by Ep-CAM via activation of Pi3K, (chapter 6)
It was demonstrated that Ep-CAM can affect cadherin-mediated adhesions
without direct physical interaction, so other molecules have to be involved. Ep-CAM
transfected epithelial cells were capable of abrogating N-cadherin mediated cell-cell
adhesion, which was inhibited by Pi3K inhibitor LY. Ep-CAM from cell lysates precipita-
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Other antibodies, including human anti-Ep-CAM antibody adecatumumab
(MT201) [Neundorf etal. 2002], and tri-specific Ep-CAM/CD3/APC hybrid antibody
catumaxomab, have entered the phase I and phase II clinical trials [Kiman and Whelan,
2007]. and Ep-CAM/CD3 bispecific antibody MT110 [Brischwein et al., 2006]. showed
promising results in immunodeficient mice and human cancer cell lines.
An immune response against tumour cells can aslo be elicited by Ep-CAM spe-
cific immunotoxins. Local presentation of the immunotoxin might elicit an immune
response that may eradicate the tumour cells. For head and neck carcinoman, Ep-CAM
specific immunotoxin Proxinium® is being tested in phase II/III clinical trials and other
immunotoxins are under development [Di Paolo et al., 2003; Baeuerle and Gires, 2007].
Focuss in this process is on the new routes of local delivery of the toxin [Baeuerle and
Gires, 2007].
Alternatively, (local) downregulation of Ep-CAM expression and signalling
may halt tumor growth. Osta and collegues tested the hypothesis if silencing EpCAM
gene expression with EpCAM short interfering RNA (siRNA) could have any clinically
relevant effect [Osta et al., 2004]. They found that Ep-CAM siRNA decreased the rate of
cell proliferation in four different breast cancer cell lines, as well as decreased cell migra-
tion and cell invasion in vitro. Consistent with results discussed in this thesis, EpCAM
silencing was also associated with an increase in the detergent-insoluble protein fracti-
on of E-cadherin, α-catenin, and α-catenin. The clinical approach, i.e. local administra-
tion, and dose etc., needs to be developed and explored further before the first patient
can be enrolled in a phase I clinical trial.
Future perspectives
In this thesis, we demonstrate that expression of Ep-CAM regulates cadherin-
mediated complexes via a Pi3K -linked signaling pathway. However, many open
questions remain.
1. Ep-CAM is most likely one of the earliest steps in the transformation from
normal squamous epithelium to a dysplastic lesion. Only 10% of the cells in the basal
layer of squamous tissue are tissue stem cells that supply the tissue with ‘new’ cells. The
stem cells are located in clusters, and differentiation starts as they migrate sidewards
along the basal membrane [Watt, 1998]. It will be interesting to study the expression
pattern of Ep-CAM in the normal stem cells, transformed/abnormal/neoplastic stem
cells and the internal or external signals to which these cells react.
2. The role of Ep-CAM in embryogenesis is unknown. Ep-CAM is associated
with proliferation, but is it mere a participant in the proliferative signal or does it
more? The fact that Ep-CAM regulates insulin and glucagon gene transcription and
translation in fetal pancreatic cell clusters [Cirulli et al., 1998]. suggests a morphore-
gulatory function for Ep-CAM. What signal(s) balance(s) the proliferation and diffe-
rentiation status in developmental epithelial tissue? 
3. The signaling through Ep-CAM, soluble or committed in cell-cell adhesion, is
facillitated by proteases; cleavage of Ep-CAM results in the release of intracellular pep-
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tide EpIC. The role of EpIC needs further investigation, in both normal cells as well as
in preneoplastic and malignant cells.
4. During mitosis in normal epithelium, Ep-CAM mediated cell-cell adhesions
may provide the integrity while the E-cadherin mediated adhesions are abrogated.
With the destruction of the cadherin/catenin complex, β-catenin is set free from this
complex and pooled/ stored in other compartments. The β-catenin bound in the
Adenomatous Poliposis Coli (APC) /axin complex is phosphorylated by kinase GSK3β
and phosphorylated β-catenin is subjected to degradation. However, Wnt signaling
antagonizes the GSK3β, resulting in the accumulation of cytoplasmic β-catenin, indu-
cing gene transcription via Tcf4/LEF1. Interestingly, Pi3K was demonstrated to block
GSK3β. Is there a correlation between Ep-CAM expression, Pi3K activity and inducti-
on of Tcf4/LEF1?
5. The role of Ep-CAM in cell motility needs further attention. Our preliminary
data from wound-healing experiments suggest that Ep-CAM expression decreases cell
migration in experimentally wounded monolayers only where cadherin mediated
adhesion complexes are intact. Ep-CAM increased the motility of fibroblasts when
deletion mutants of E-cadherin were expressed, or no E-cadherin was expressed. The
role of Ep-CAM in regulation of motility may involve accumulation of cytoplasmic
Pi3K and β-catenin. Ep-CAM signaling involves Pi3K and abrogates E-cadherin medi-
ated adhesions, leading to ‘free’ β-catenin. Pi3K was demonstrated to block the GSK3β
leaving β-catenin available for motility/ intergin signaling.
6. Ep-CAM is not the initial step in the transformation to a malignant phenoty-
pe. Therefore it will be interesting to find out at which stage of (malignant) transfor-
mation the Ep-Cam/Pi3K complex is formed. Both Ep-CAM and Pi3K are capable of
binding α-actinin [Balzar et al, 1998]. and the role of α-actinin is still unclear.
7. Furthermore, amplification of PIK3CA, the gene coding for Pi3K, may provi-
de an answer to the question what the signal is for the de novo or over-expression of
Ep-CAM. PIK3CA acts as an oncogene in cervical- and ovarian carcinomas [Ma et al.,
2000; Shayesteh et al, 1999]. In these tumours, elevated Pi3K activity may induce de
novo expression of Ep-CAM. Kobayashi concluded that PIK3CA is not an oncogene,
but merely a gene that drives progression towards a more malignant type. The authors
describe two poorly differentiated tumor cell lines, KATO-III and MKN45, that
express Ep-CAM to very high levels [Kobayashi et al, 1999]. Wennström and
Downward demonstrated that the activation of Ras and ERK by physiological relevant
concentrations of EGF can be reduced by LY or Wortmannin. A basal activity of Pi3K is
present in (epithelial) cells, and may be provided by signal transduction by Ep-CAM.
8. GTPases are key players in epithelial cytoskeletal rearrangements. It was
demonstrated that Ep-CAM affects the E-cadherin complex in its juxtamembrane
domain, where it can bind pp120. Pp120 regulates and is regulated by Rho activity.
Changes in Ep-CAM and E-cadherin affect the balance of Rho, Rac and Cdc42 activa-
tion. The GTPase activity is also extensively studied by other groups in relation to the
regulatory signaling of integrins. The integrins, involved in migration, are of impor-
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tance in the transition of a carcinoma in situ to an invasive carcinoma. Cdc42 and Rac1
induce integrin-mediated cell motility and invasiveness through Pi3K [Keely et al,
1997]. It will be of interest to study the effect of Ep-CAM on integrins in vitro, as well
as in tissue samples.
9. The demonstration of Ep-CAM complexing and interacting with both a
tumor metastasis-promoting cell adhesion molecule CD44v4-v7 and a tight junction
protein claudin-7 is intriguing. Although CD44v4-v7 is found to promote metastasis,
the other partner in the complex, claudin-7, is underexpressed during invasion and
metastatis of breast and esophageal carcinoma [Usami et al., 2006]. Therefore, study-
ing the role of Ep-CAM in a complex may explain the contradicting observations.
It is fair to conclude that Ep-CAM is a major player in the development and maintenan-
ce of epithelial tissues that deserves further attention in future cell biology research.
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gemaakt van twee fusie eiwitten: E-cadherine/α-catenine, Eα, en E-cadherine/ c-termi-
nale helft van α-catenin, EαC. Deze fusie eiwitten zijn ieder in L-cel fibroblasten
getransfecteerd en konden cel-cel contacten mediëren. Na introductie van Ep-CAM was
de sterkte van de cel-cel contacten afgenomen in zowel de Eα als de EαC getransfecteer-
de cellen. Tevens was de cytoskelet gebonden fractie van cadherine/catenine chimeren
toegenomen. Deze resulaten zijn opvallend, aangezien β-catenin niet tot expressie
kwam en dus geen regulerende rol kon vervullen. Het aangrijpingspunt in het cadheri-
ne/catenine complex om de binding met het cytoskelet te verzwakken is dus gelegen in
het juxta-membraan deel van E-cadherine of in de COOH-helft van α-catenine. 
Cross signaling tussen E-cadherine en Ep-CAM is reversibel, hoofd-
stuk 5
Uitgaande van het feit dat introductie van Ep-CAM in cellen kan leiden tot het
afbreken van cadherine gemediëerde adhesies, zijn experimenten uitgevoerd om het
omgekeerde te bestuderen. UMSCC-2 en -22B cellen (U2 en U22B) zijn twee plaveisel-
cellijnen die veel Ep-CAM (U2) of redelijk veel Ep-CAM tot expressie brengen. De E-
cadherine expressie is laag (U2) en redelijk laag (U22B). Wanneer de cellijnen stabiel of
voorbijgaand worden getransfecteerd met antisense Ep-CAM DNA, vermindert deze
Ep-CAM expressie, is de celproliferatie verlaagd en veranderen de cellen voor wat
betreft de morfologie die nu squameuze differentiatie toont. Deze observaties kunnen
eenvoudig verklaard worden door de enorme afname van Ep-CAM expressie als gevolg
van de antisense DNA en de vorming van E-cadherine gemediëerde adhesies. 
Cadherinen worden gereguleerd door Ep-CAM via de activatie van
Pi3K, hoofdstuk 6
Het is aan te nemen dat Ep-CAM geen fysieke, directe interactie met E-cadheri-
ne aangaat. Derhalve is het aannemelijk dat andere moleculen betrokken zijn bij de sig-
naaloverdracht tussen Ep-CAM en cadherines. Ep-CAM getransfecteerde epitheliale
cellen toonden een verstoorde N-cadherine gemedieerde cel-cel adhesie, en dit effect
van Ep-CAM op N-cadherine kon worden voorkomen door toevoeging van Pi3K inhi-
bitor LY. In Ep-CAM precipitaten uit celextracten kon Pi3K subunit p85 worden aange-
toond in het eiwit complex. Het geprecipiteerde eiwit complex was in staat tot kinase
activiteit.
De betekenis van Ep-CAM expressie in epitheliale tumoren (review),
hoofdstuk 7
De afgelopen twintig jaar zijn door diverse onderzoekers diverse antilichamen
tegen Ep-CAM gegenereerd en is met deze antilichamen de aankleuring van verschillen-
de epitheliale weefsels onderzocht. In dit hoofdstuk zijn deze bevindingen samengevat.
Op basis van de beschreven onderzoeken blijkt dat Ep-CAM goed als hulpmiddel kan
dienen bij het vaststellen van de juiste diagnose van het afwijkend gedrag van epitheliale
weefsels.
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In de algemene inleiding, hoofdstuk 1, is een aantal karakeristieken beschreven van sig-
naal transductie tussesn adhesie moleculen. Bijzondere aandacht is besteed aan de bio-
logische kenmerken van E-cadherine en Ep-CAM. Bij aanvang van de studies zoals
beschreven in dit proefschrift, was er voldoende over Ep-CAM bekend om te suggereren
dat Ep-CAM dusdanig kon interfereren in de E-cadherine gemedieerde cell-cell contac-
ten, dat er wellicht een verandering in het epitheel kon optreden met een kans op
kwaadaardige celgroei. Vanwege deze veronderstelling is het onderzoek voortgezet met
de experimenten zoals beschreven in dit proefschrift. De experimenten waren gericht
op de morforegulerende eigenschappen van Ep-CAM en de betekenis ervan in epitheli-
ale weefsels.
In hoofdstuk 2 is de kennis over Ep-CAM samengevat. Het is een relatief klein
adhesie molecuul, dat niet behoort tot de vier bekende families adhesiemoleculen en dat
Ca2+-onafhankelijke cell-cell juncties medieert. Het komt tot expressie in alle eenlagige,
kubische epithelia, maar niet in plaveisel epitheel. Ep-CAM komt tot overexpressie of de
novo expressie in tumoren van epitheliale oorsprong.
Ep-CAM moduleert de E-cadherine gemedieerde adhesies, hoofdstuk 3
Ep-CAM komt tot expressie in de meeste epitheliale weefsels, in goedaardige en
kwaadaardige proliferatieve laesies of tijdens embryogenese. De rol van het adhesiemo-
lecuul Ep-CAM in deze weefsels was echter nog onduidelijk. Introductie van Ep-CAM
in murine fibroblasten die zijn getransfecteerd met E-cadherine, of introductie in
humane epitheliale cellen induceerde seggregatie van Ep-CAM transfectanten en cellen
die Ep-CAM niet tot expressie brachten. Daarnaast veranderde Ep-CAM introductie de
celmorfologie, reduceerde de sterkte van aggregatie, en detergent -niet oplosbare fractie
van cadherines en cateninen. Al deze veranderingen werden traden niet op wanneer een
deletie mutant van het Ep-CAM molecuul in de cellen werd geïntroduceerd. Deze
mutant, waarvan het cytoplasmatisch domein van Ep-CAM is gedeleteerd, werd welis-
waar correct op de celmembraan van murine fibroblasten en humane epitheliale cellen
tot expressie gebracht, maar deze was niet in staat homotypische cel-cel adhesies te vor-
men. Met andere woorden, het cytoplasmatisch domein van Ep-CAM is in staat de cad-
herine gemediëerde adhesies negatief te beïnvloeden.
Ep-CAM expressie verschuift de cadherine adhesies van sterk naar
zwak zonder dat β-catenine hierbij is betrokken, hoofdstuk 4
Als Ep-CAM (over-)expressie de E-cadherine gemediëerde adhesies ontman-
telt, is het van belang te weten hoe dit gebeurt. Om te onderzoeken welke factor in het E-
cadherine/catenine complex door Ep-CAM aangezet wordt tot afbraak, is gebruik
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